[{
    "brand_id": "150",
    "generic_id": "5",
    "company_id": "276",
    "aky": "acaril",
    "brand_name": "Acaril",
    "form": "Tablet",
    "strength": "50mg",
    "price": "15.00",
    "packsize": "30's pack",
    "company_name": "White Horse Pharma",
    "company_order": "0",
    "generic_name": "Acarbose",
    "precaution": "Monitor LFT every 3 mth for 1st yr and periodically thereafter especially for doses >50 mg tid. Reduce dose or withdraw therapy if transaminases elevations persist. If hypoglycaemia occurs, give glucose orally as a 1st aid measure. Adhere strictly to the prescribed diabetic diet to avoid intensification of GI symptoms.\r\n\r\nLactation: not known if crosses into breast milk, avoid using in nursing women.",
    "indication": "Type 2 DM",
    "contra_indication": "Patients <18 yr; diabetic ketoacidosis or cirrhosis; malabsorption; inflammatory bowel disease; with or pre-disposed to intestinal obstruction; intestinal diseases that affect digestion or absorption; conditions that worsen as a result of increased gas formation e.g. hernias; colonic ulcers; hepatic impairment; CrClr< 25 ml\/min\/1.73m2. Pregnancy, lactation.",
    "side_effect": ">10%\r\nabdominal pain (19%),diarrhea (31%),elevated serum transaminases, flatulence (74%)\r\n\r\nPotentially Fatal: Hepatotoxicity.",
    "pregnancy_category_id": "2",
    "mode_of_action": "Acarbose competitively and reversibly inhibits pancreatic alpha-amylase and intestinal brush border alpha-glucosidases, resulting in retardation of glucose absorption from hydrolysed complex carbohydrates and reduction of blood-glucose concentrations.",
    "interaction": "May enhance effects of other antidiabetics including insulin. Diminished effects w\/ GI adsorbents (e.g. charcoal) and digestive enzyme preparations containing carbohydrate splitting enzymes (e.g. amylase, pancreatin). Neomycin and colestyramine may enhance effects of acarbose. May inhibit absorption of digoxin.",
    "pregnancy_category_note": "",
    "adult_dose": " Dosage  Adult: PO Initial: 25 mg\/day q8hr. May adjust gradually. Maintenance: 50-100 mg 3 times\/day. \r\nMax: <60 kg: 50 mg 3 times\/day.\r\n>60 kg: 100 mg 3 times\/day.\r\n\r\nHepatic Impairment Severe: Contraindicated.\r\n\r\n",
    "child_dose": "",
    "renal_dose": "Renal Impairment \r\nCrCl Dosage\r\n<25 Contraindicated.",
    "administration": "Should be taken with food. Take w\/ 1st bite of each main meal.",
    "packssize": "30.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "4352",
    "generic_id": "6",
    "company_id": "2",
    "aky": "celofen",
    "brand_name": "Celofen",
    "form": "Tablet",
    "strength": "100mg",
    "price": "4.00",
    "packsize": "50's pack",
    "company_name": "ACI Limited",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "1779",
    "generic_id": "6",
    "company_id": "3",
    "aky": "apitac",
    "brand_name": "Apitac",
    "form": "Tablet",
    "strength": "100mg",
    "price": "4.00",
    "packsize": "100's pack",
    "company_name": "Acme Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "286",
    "generic_id": "6",
    "company_id": "8",
    "aky": "aclovix",
    "brand_name": "Aclovix",
    "form": "Tablet",
    "strength": "100mg",
    "price": "250",
    "packsize": "100's pack",
    "company_name": "Aexim Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "277",
    "generic_id": "6",
    "company_id": "13",
    "aky": "aclo",
    "brand_name": "Aclo",
    "form": "Tablet",
    "strength": "100mg",
    "price": "3.00",
    "packsize": "100's pack",
    "company_name": "Alco Pharma Limited",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "1748",
    "generic_id": "6",
    "company_id": "20",
    "aky": "apeclo",
    "brand_name": "Apeclo",
    "form": "Tablet",
    "strength": "100mg",
    "price": "3.00",
    "packsize": "100's pack",
    "company_name": "Apex Pharma Limited.",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "173",
    "generic_id": "6",
    "company_id": "24",
    "aky": "aceclofen",
    "brand_name": "Aceclofen",
    "form": "Tablet",
    "strength": "100mg",
    "price": "90",
    "packsize": "30's pack",
    "company_name": "Astra Biopharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "30.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "166",
    "generic_id": "6",
    "company_id": "31",
    "aky": "acebid",
    "brand_name": "Acebid",
    "form": "Tablet",
    "strength": "100mg",
    "price": "4.00",
    "packsize": "50's pack",
    "company_name": "Beacon Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "171",
    "generic_id": "6",
    "company_id": "36",
    "aky": "acecloben",
    "brand_name": "Acecloben",
    "form": "Tablet",
    "strength": "100mg",
    "price": "150",
    "packsize": "50's pack",
    "company_name": "Benham Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "5059",
    "generic_id": "6",
    "company_id": "40",
    "aky": "clof",
    "brand_name": "Clof",
    "form": "Tablet",
    "strength": "100mg",
    "price": "4.00",
    "packsize": "100's pack",
    "company_name": "Bio Pharma Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "189",
    "generic_id": "6",
    "company_id": "47",
    "aky": "acelock",
    "brand_name": "Acelock",
    "form": "Tablet",
    "strength": "100mg",
    "price": "300",
    "packsize": "100's pack",
    "company_name": "Bristol Pharma Ltd.",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "178",
    "generic_id": "6",
    "company_id": "57",
    "aky": "acedol",
    "brand_name": "Acedol",
    "form": "Tablet",
    "strength": "100mg",
    "price": "4.01",
    "packsize": "100's pack",
    "company_name": "Concord Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "1384",
    "generic_id": "6",
    "company_id": "59",
    "aky": "analgen",
    "brand_name": "Analgen",
    "form": "Tablet",
    "strength": "100mg",
    "price": "150",
    "packsize": "50's pack",
    "company_name": "Cosmo Pharma Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "214",
    "generic_id": "6",
    "company_id": "62",
    "aky": "acf",
    "brand_name": "ACF",
    "form": "Tablet",
    "strength": "100mg",
    "price": "4.00",
    "packsize": "100's pack",
    "company_name": "Decent Pharma Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "182",
    "generic_id": "6",
    "company_id": "91",
    "aky": "acefenac",
    "brand_name": "Acefenac",
    "form": "Tablet",
    "strength": "100mg",
    "price": "4.01",
    "packsize": "50's pack",
    "company_name": "General Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "1981",
    "generic_id": "6",
    "company_id": "99",
    "aky": "aros",
    "brand_name": "Aros",
    "form": "Tablet",
    "strength": "100mg",
    "price": "4.00",
    "packsize": "50's pack",
    "company_name": "Globe Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "4000",
    "generic_id": "6",
    "company_id": "112",
    "aky": "ceconac",
    "brand_name": "Ceconac",
    "form": "Tablet",
    "strength": "100mg",
    "price": "3.00",
    "packsize": "100's pack",
    "company_name": "Hudson Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "852",
    "generic_id": "6",
    "company_id": "133",
    "aky": "alona",
    "brand_name": "Alona",
    "form": "Tablet",
    "strength": "100mg",
    "price": "4.01",
    "packsize": "50's pack",
    "company_name": "Kemiko Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "176",
    "generic_id": "6",
    "company_id": "143",
    "aky": "aceclora",
    "brand_name": "Aceclora",
    "form": "Tablet",
    "strength": "100mg",
    "price": "3.02",
    "packsize": "50's pack",
    "company_name": "Marksman Pharmaceutical Ltd.",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "193",
    "generic_id": "6",
    "company_id": "146",
    "aky": "acenac",
    "brand_name": "Acenac",
    "form": "Tablet",
    "strength": "100mg",
    "price": null,
    "packsize": "50's pack",
    "company_name": "Medicon Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "294",
    "generic_id": "6",
    "company_id": "151",
    "aky": "acn",
    "brand_name": "ACN",
    "form": "Tablet",
    "strength": "100mg",
    "price": "300",
    "packsize": "100's pack",
    "company_name": "Modern Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "283",
    "generic_id": "6",
    "company_id": "191",
    "aky": "aclonac",
    "brand_name": "Aclonac",
    "form": "Tablet",
    "strength": "100mg",
    "price": "150",
    "packsize": "50's pack",
    "company_name": "Pharmasia Ltd.",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "2290",
    "generic_id": "6",
    "company_id": "205",
    "aky": "avenac",
    "brand_name": "Avenac",
    "form": "Tablet",
    "strength": "100mg",
    "price": "5.01",
    "packsize": "50's pack",
    "company_name": "Radiant Pharmaceutical Ltd.",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "284",
    "generic_id": "6",
    "company_id": "207",
    "aky": "aclopain",
    "brand_name": "Aclopain",
    "form": "Tablet",
    "strength": "100mg",
    "price": null,
    "packsize": "100's pack",
    "company_name": "Julphar Bangladesh Ltd.",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "3995",
    "generic_id": "6",
    "company_id": "219",
    "aky": "ceclofen",
    "brand_name": "Ceclofen",
    "form": "Tablet",
    "strength": "100mg",
    "price": "4.00",
    "packsize": "50's pack",
    "company_name": "Renata Limited",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "177",
    "generic_id": "6",
    "company_id": "279",
    "aky": "acecol100",
    "brand_name": "Acecol 100",
    "form": "Tablet",
    "strength": "100mg",
    "price": "2.00",
    "packsize": "50's pack",
    "company_name": "Ziska Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aceclofenac",
    "precaution": "Cautiously administer to patients with GI disease, ulcerative colitis, Crohn's disease, haematological abnormalities, hepatic porphyria; history of bronchial asthma; history of heart failure or hypertension; mild renal, hepatic or cardiac impairment. May impair ability to drive or operate machinery. Elderly. Patients suffering from severe hepatic impairment must be monitored.",
    "indication": "Indicated for the relief of pain and inflammation in both acute and chronic pain like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-traumatic pain, low back pain, gynaecological pain etc.",
    "contra_indication": "Hypersensitivity to aspirin or NSAIDs; moderate to severe renal impairment; pregnancy (3rd trimester); history of peptic ulceration or GI bleed; patients with infections.",
    "side_effect": "Gastrointestinal disorders (dyspepsia, abdominal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects including pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.\r\n\r\nPotentially Fatal: Severe GI bleeding; nephrotoxicity; blood dyscrasias.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Aceclofenac, a phenylacetic acid derivative, has antiinflammatory and analgesic properties. It is a potent inhibitor of cyclo-oxygenase which is involved in the production of prostaglandins.",
    "interaction": "May increase plasma concentrations of lithium and digoxin. Increased nephrotoxicity when used with diuretics or ciclosporin. Monitor serum potassium when used with potassium-sparing diuretics and ACE inhibitors. May enhance activity of anticoagulants. May increase risk of methotrexate toxicity when administered within 24 hr of methotrexate admin. Increased risk of GI bleed with other NSAIDs. Increased risk of convulsion with quinolones.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis \r\n100 mg twice daily.\r\n\r\nSR Tablet : The recommended dose is 200 mg, once daily.\r\n\r\nElderly: The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose and dose frequency. \r\n\r\nHepatic Impairment Reduce initial dose to 100 mg daily .",
    "child_dose": "Safety & Efficacy not established.",
    "renal_dose": "No dose adjustment needed.",
    "administration": "Should be taken with food. Take w\/ or immediately after meals.\r\n",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "191",
    "generic_id": "8",
    "company_id": "3",
    "aky": "acemox",
    "brand_name": "Acemox",
    "form": "Tablet",
    "strength": "250mg",
    "price": "2.00",
    "packsize": "100's pack",
    "company_name": "Acme Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Acetazolamide",
    "precaution": "Potassium supplements may be required. Impaired hepatic or renal function; diabetes. Monitor plasma electrolytes and blood count regularly. IM route is not recommended. Caution when driving or operating machinery. Elderly.\r\n\r\nLactation: Enters breast milk; not recommended",
    "indication": "Glaucoma,Epilepsy,Idiopathic intracranial hypertension,Altitude sickness",
    "contra_indication": "Hypersensitivity to sulphonamides; sodium or potassium depletion, hepatic insufficiency; hepatic cirrhosis; hyperchloraemic acidosis; severe renal impairment; severe pulmonary obstruction; chronic noncongestive angle-closure glaucoma; adrenocortical insufficiency. Pregnancy, lactation.",
    "side_effect": "Drowsiness, paraesthesia, ataxia, dizziness, thirst, anorexia, headache; confusion, malaise, depression; GI distress, metabolic acidosis, polyuria, hyperuricaemia, renal calculi, nephrotoxicity, hepatic dysfunction.\r\n\r\nPotentially Fatal: Rarely, skin reactions or blood dyscrasias.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Acetazolamide specifically inhibits the enzyme carbonic anhydrase which catalyses the reversible reaction involving the hydration of CO2 and dehydration of carbonic acid. It increases the excretion of HCO3 ions and as well as Na and K leading to alkaline diuresis. Carbonic anhydrase is also inhibited in the CNS to retard abnormal and excessive discharge from neurons.",
    "interaction": "Concomitant use w\/ high-dose aspirin may cause anorexia, tachypnoea, lethargy, metabolic acidosis, coma and death. May increase serum levels of phenytoin, resulting to increased risk of osteomalacia. May decrease serum concentrations of primidone. Additive effects w\/ other carbonic anhydrase inhibitors. May increase the effects of folic acid antagonists. May decrease urinary excretion of amphetamine and quinidine. May prevent the urinary antiseptic effect of methenamine. May increase lithium excretion. Increased risk of renal calculus formation w\/ Na bicarbonate. May increase ciclosporin levels.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Diuresis 250-375 mg\/day. \r\nGlaucoma; Epilepsy 250-1,000 mg\/day. \r\nProphylaxis of high altitude sickness 500-1,000 mg\/day. \r\n\r\nEpilepsy\r\n>12 years\r\nTablet: 8-30 mg\/kg\/day PO qDay or divided q6-12 hr; not to exceed 30 mg\/kg\/day or 1 g\/day\r\n\r\nAcute Altitude Sickness >12 years\r\nImmediate release: 500-1000 mg\/day PO divided q8-12hr\r\n\r\nHepatic impairment: Contraindicated in marked hepatic impairment.",
    "child_dose": "<12 years: Safety and efficacy is not established\r\n",
    "renal_dose": "Renal impairment: Contraindicated in marked renal impairment.",
    "administration": "Should be taken with food.\r\n\r\n",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "5183",
    "generic_id": "14",
    "company_id": "115",
    "aky": "clovir",
    "brand_name": "Clovir",
    "form": "Tablet",
    "strength": "200mg",
    "price": "14.00",
    "packsize": "30's pack",
    "company_name": "Ibn Sina Pharmaceutical Ind. Ltd.",
    "company_order": "0",
    "generic_name": "Acyclovir",
    "precaution": "Renal impairment. Pregnancy, lactation. Neurological abnormalities with significant hypoxia, serious hepatic or electrolyte abnormalities. Maintain adequate hydration.\r\n\r\nLactation: Drug enters breast milk; use with caution.",
    "indication": "Herpes simplex infections,Varicella zoster (chickenpox),Herpes zoster (shingles),Genital herpes",
    "contra_indication": "Hypersensitivity.",
    "side_effect": ">10%\r\nOral\r\nMalaise (<12%)\r\n\r\n1-10%\r\nParenteral\r\nInflammation or phlebitis at injection site (9%),Nausea (7%),Vomiting (7%),Rash or hives (2%),Elevated transaminase levels (1-2%)\r\n\r\nOral\r\nNausea (2-5%),Vomiting (<3%),Diarrhea (2-3%),Headache (2%)\r\n\r\n<1%\r\nAbdominal pain,Aggression\/confusion,Agitation,Alopecia,Anaphylaxis,Anemia,Angioedema,Anorexia,Ataxia,Coma,Disseminated intravascular coagulation (DIC),Dizziness,Fatigue\r\n\r\nPotentially Fatal: Occasionally neurotoxicity after IV use: Lethargy, confusion, agitation, tremors, seizures, coma.",
    "pregnancy_category_id": "2",
    "mode_of_action": "Activity against HSV types I and II and varicella-zoster virus is due to intracellular conversion of aciclovir to the monophosphate by viral thymidine kinase with subsequent conversion to the diphosphate and active triphosphate by cellular enzymes. This active form inhibits viral DNA synthesis and replication by interfering with viral DNA polymerase enzyme and being incorporated into viral DNA.",
    "interaction": "Probenecid, cimetidine and mycophenolate mofetil may increase the plasma concentration of aciclovir. Increased nephrotoxic effects w\/ drugs that affect renal physiology (e.g. ciclosporin, tacrolimus).",
    "pregnancy_category_note": "",
    "adult_dose": "Oral\r\nPrimary herpes simplex infections\r\nAdult: 200 mg 5 times daily every 4 hr for 5-10 days; for severely immuno compromised patients and those with impaired absorption: 400 mg 5 times daily for 5 days.\r\n\r\nSuppression of recurrent herpes simplex\r\nAdult: 800 mg daily in 2-4 divided doses. May reduce to 400-600 mg daily if necessary. Reassess the condition every 6-12 mth. For mild or infrequent recurrences: Episodic treatment may be used: 200 mg 5 times daily for 5 days, preferably begun during the prodromal period.\r\n\r\nProphylaxis of herpes simplex in immunocompromised patients\r\nAdult: 200-400 mg 4 times daily.\r\n\r\nVaricella zoster 800 mg 5 times\/day for 5-7 days. \r\n\r\nHerpes zoster 800 mg 5 times\/day for 7-10 days. \r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 900 mg\/m2\/day q8h\r\n60â€“80 mg\/kg\/day (max 4 g\/day) q6â€“8h\r\n\r\nVaricella Zoster (Chickenpox)\r\n>2 years and <40 kg: 20 mg\/kg\/dose PO q6hr for 5 days; not to exceed 800 mg\/dose\r\n>10 mL\/min\/1.73 mÂ²: 200 mg q4hr (five times daily)\r\n\r\n400 mg every 12 hr\r\n0-10 mL\/min\/1.73 mÂ²: 200 mg q12hr\r\n>10 mL\/min\/1.73 mÂ²: 400 mg q12hr\r\n\r\n800 mg every 4 hr\r\n0-10 mL\/min\/1.73 mÂ²: 800 mg q12hr\r\n10-25 mL\/min\/1.73 mÂ²: 800 mg q8hr\r\n>25 mL\/min\/1.73 mÂ²: 800 mg q4hr (five times daily)",
    "renal_dose": "",
    "administration": "May be taken with or without food. May be taken w\/ meals to reduce GI discomfort.\r\n\r\nReconstitution: Add 10 mL or 20 mL of sterile water for inj to a vial labeled as containing 500 mg or 1,000 mg of aciclovir, respectively, to provide a soln containing 50 mg\/mL. The appropriate dose of reconstituted soln should then be withdrawn from the vial and diluted w\/ 50-125 mL of a compatible IV infusion soln.",
    "packssize": "30.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "5184",
    "generic_id": "14",
    "company_id": "115",
    "aky": "clovir",
    "brand_name": "Clovir",
    "form": "Tablet",
    "strength": "400mg",
    "price": "22.00",
    "packsize": "20's pack",
    "company_name": "Ibn Sina Pharmaceutical Ind. Ltd.",
    "company_order": "0",
    "generic_name": "Acyclovir",
    "precaution": "Renal impairment. Pregnancy, lactation. Neurological abnormalities with significant hypoxia, serious hepatic or electrolyte abnormalities. Maintain adequate hydration.\r\n\r\nLactation: Drug enters breast milk; use with caution.",
    "indication": "Herpes simplex infections,Varicella zoster (chickenpox),Herpes zoster (shingles),Genital herpes",
    "contra_indication": "Hypersensitivity.",
    "side_effect": ">10%\r\nOral\r\nMalaise (<12%)\r\n\r\n1-10%\r\nParenteral\r\nInflammation or phlebitis at injection site (9%),Nausea (7%),Vomiting (7%),Rash or hives (2%),Elevated transaminase levels (1-2%)\r\n\r\nOral\r\nNausea (2-5%),Vomiting (<3%),Diarrhea (2-3%),Headache (2%)\r\n\r\n<1%\r\nAbdominal pain,Aggression\/confusion,Agitation,Alopecia,Anaphylaxis,Anemia,Angioedema,Anorexia,Ataxia,Coma,Disseminated intravascular coagulation (DIC),Dizziness,Fatigue\r\n\r\nPotentially Fatal: Occasionally neurotoxicity after IV use: Lethargy, confusion, agitation, tremors, seizures, coma.",
    "pregnancy_category_id": "2",
    "mode_of_action": "Activity against HSV types I and II and varicella-zoster virus is due to intracellular conversion of aciclovir to the monophosphate by viral thymidine kinase with subsequent conversion to the diphosphate and active triphosphate by cellular enzymes. This active form inhibits viral DNA synthesis and replication by interfering with viral DNA polymerase enzyme and being incorporated into viral DNA.",
    "interaction": "Probenecid, cimetidine and mycophenolate mofetil may increase the plasma concentration of aciclovir. Increased nephrotoxic effects w\/ drugs that affect renal physiology (e.g. ciclosporin, tacrolimus).",
    "pregnancy_category_note": "",
    "adult_dose": "Oral\r\nPrimary herpes simplex infections\r\nAdult: 200 mg 5 times daily every 4 hr for 5-10 days; for severely immuno compromised patients and those with impaired absorption: 400 mg 5 times daily for 5 days.\r\n\r\nSuppression of recurrent herpes simplex\r\nAdult: 800 mg daily in 2-4 divided doses. May reduce to 400-600 mg daily if necessary. Reassess the condition every 6-12 mth. For mild or infrequent recurrences: Episodic treatment may be used: 200 mg 5 times daily for 5 days, preferably begun during the prodromal period.\r\n\r\nProphylaxis of herpes simplex in immunocompromised patients\r\nAdult: 200-400 mg 4 times daily.\r\n\r\nVaricella zoster 800 mg 5 times\/day for 5-7 days. \r\n\r\nHerpes zoster 800 mg 5 times\/day for 7-10 days. \r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 900 mg\/m2\/day q8h\r\n60â€“80 mg\/kg\/day (max 4 g\/day) q6â€“8h\r\n\r\nVaricella Zoster (Chickenpox)\r\n>2 years and <40 kg: 20 mg\/kg\/dose PO q6hr for 5 days; not to exceed 800 mg\/dose\r\n>10 mL\/min\/1.73 mÂ²: 200 mg q4hr (five times daily)\r\n\r\n400 mg every 12 hr\r\n0-10 mL\/min\/1.73 mÂ²: 200 mg q12hr\r\n>10 mL\/min\/1.73 mÂ²: 400 mg q12hr\r\n\r\n800 mg every 4 hr\r\n0-10 mL\/min\/1.73 mÂ²: 800 mg q12hr\r\n10-25 mL\/min\/1.73 mÂ²: 800 mg q8hr\r\n>25 mL\/min\/1.73 mÂ²: 800 mg q4hr (five times daily)",
    "renal_dose": "",
    "administration": "May be taken with or without food. May be taken w\/ meals to reduce GI discomfort.\r\n\r\nReconstitution: Add 10 mL or 20 mL of sterile water for inj to a vial labeled as containing 500 mg or 1,000 mg of aciclovir, respectively, to provide a soln containing 50 mg\/mL. The appropriate dose of reconstituted soln should then be withdrawn from the vial and diluted w\/ 50-125 mL of a compatible IV infusion soln.",
    "packssize": "20.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "355",
    "generic_id": "15",
    "company_id": "22",
    "aky": "acyvir",
    "brand_name": "Acyvir",
    "form": "Eye Ointment",
    "strength": " ",
    "price": "100.00",
    "packsize": "5 gm tube",
    "company_name": "Aristopharma Limited",
    "company_order": "0",
    "generic_name": "Acyclovir 3% Eye prep",
    "precaution": "Renal impairment. Pregnancy, lactation. Neurological abnormalities with significant hypoxia, serious hepatic or electrolyte abnormalities. Maintain adequate hydration.",
    "indication": "Herpes simplex keratitis",
    "contra_indication": "Hypersensitivity.",
    "side_effect": "Eye application may produce stinging, superficial punctate keratopathy, blepharitis or conjunctivitis.",
    "pregnancy_category_id": "2",
    "mode_of_action": "Activity against HSV types I and II and varicella-zoster virus is due to intracellular conversion of aciclovir to the monophosphate by viral thymidine kinase with subsequent conversion to the diphosphate and active triphosphate by cellular enzymes. This active form inhibits viral DNA synthesis and replication by interfering with viral DNA polymerase enzyme and being incorporated into viral DNA.",
    "interaction": "Probenecid, cimetidine and mycophenolate mofetil may increase the plasma concentration of aciclovir. Increased nephrotoxic effects w\/ drugs that affect renal physiology (e.g. ciclosporin, tacrolimus).",
    "pregnancy_category_note": "",
    "adult_dose": " As 3% Eye oint: Apply 5 times\/day until 3rd day of complete healing.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "",
    "packssize": "1.00",
    "ext": "5gm",
    "unite": "tube"
},
{
    "brand_id": "5676",
    "generic_id": "15",
    "company_id": "91",
    "aky": "cuvir",
    "brand_name": "Cuvir",
    "form": "Eye Ointment",
    "strength": " ",
    "price": "100.30",
    "packsize": "5gm tube",
    "company_name": "General Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Acyclovir 3% Eye prep",
    "precaution": "Renal impairment. Pregnancy, lactation. Neurological abnormalities with significant hypoxia, serious hepatic or electrolyte abnormalities. Maintain adequate hydration.",
    "indication": "Herpes simplex keratitis",
    "contra_indication": "Hypersensitivity.",
    "side_effect": "Eye application may produce stinging, superficial punctate keratopathy, blepharitis or conjunctivitis.",
    "pregnancy_category_id": "2",
    "mode_of_action": "Activity against HSV types I and II and varicella-zoster virus is due to intracellular conversion of aciclovir to the monophosphate by viral thymidine kinase with subsequent conversion to the diphosphate and active triphosphate by cellular enzymes. This active form inhibits viral DNA synthesis and replication by interfering with viral DNA polymerase enzyme and being incorporated into viral DNA.",
    "interaction": "Probenecid, cimetidine and mycophenolate mofetil may increase the plasma concentration of aciclovir. Increased nephrotoxic effects w\/ drugs that affect renal physiology (e.g. ciclosporin, tacrolimus).",
    "pregnancy_category_note": "",
    "adult_dose": " As 3% Eye oint: Apply 5 times\/day until 3rd day of complete healing.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "",
    "packssize": "1.00",
    "ext": "5gm",
    "unite": "tube"
},
{
    "brand_id": "5182",
    "generic_id": "15",
    "company_id": "115",
    "aky": "clovir",
    "brand_name": "Clovir",
    "form": "Eye Ointment",
    "strength": " ",
    "price": "100.00",
    "packsize": "",
    "company_name": "Ibn Sina Pharmaceutical Ind. Ltd.",
    "company_order": "0",
    "generic_name": "Acyclovir 3% Eye prep",
    "precaution": "Renal impairment. Pregnancy, lactation. Neurological abnormalities with significant hypoxia, serious hepatic or electrolyte abnormalities. Maintain adequate hydration.",
    "indication": "Herpes simplex keratitis",
    "contra_indication": "Hypersensitivity.",
    "side_effect": "Eye application may produce stinging, superficial punctate keratopathy, blepharitis or conjunctivitis.",
    "pregnancy_category_id": "2",
    "mode_of_action": "Activity against HSV types I and II and varicella-zoster virus is due to intracellular conversion of aciclovir to the monophosphate by viral thymidine kinase with subsequent conversion to the diphosphate and active triphosphate by cellular enzymes. This active form inhibits viral DNA synthesis and replication by interfering with viral DNA polymerase enzyme and being incorporated into viral DNA.",
    "interaction": "Probenecid, cimetidine and mycophenolate mofetil may increase the plasma concentration of aciclovir. Increased nephrotoxic effects w\/ drugs that affect renal physiology (e.g. ciclosporin, tacrolimus).",
    "pregnancy_category_note": "",
    "adult_dose": " As 3% Eye oint: Apply 5 times\/day until 3rd day of complete healing.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "",
    "packssize": null,
    "ext": null,
    "unite": null
},
{
    "brand_id": "5703",
    "generic_id": "15",
    "company_id": "176",
    "aky": "cylcovex",
    "brand_name": "Cylcovex",
    "form": "Eye Ointment",
    "strength": " ",
    "price": "45.17",
    "packsize": "3 gm tube",
    "company_name": "Opso Saline Ltd.",
    "company_order": "0",
    "generic_name": "Acyclovir 3% Eye prep",
    "precaution": "Renal impairment. Pregnancy, lactation. Neurological abnormalities with significant hypoxia, serious hepatic or electrolyte abnormalities. Maintain adequate hydration.",
    "indication": "Herpes simplex keratitis",
    "contra_indication": "Hypersensitivity.",
    "side_effect": "Eye application may produce stinging, superficial punctate keratopathy, blepharitis or conjunctivitis.",
    "pregnancy_category_id": "2",
    "mode_of_action": "Activity against HSV types I and II and varicella-zoster virus is due to intracellular conversion of aciclovir to the monophosphate by viral thymidine kinase with subsequent conversion to the diphosphate and active triphosphate by cellular enzymes. This active form inhibits viral DNA synthesis and replication by interfering with viral DNA polymerase enzyme and being incorporated into viral DNA.",
    "interaction": "Probenecid, cimetidine and mycophenolate mofetil may increase the plasma concentration of aciclovir. Increased nephrotoxic effects w\/ drugs that affect renal physiology (e.g. ciclosporin, tacrolimus).",
    "pregnancy_category_note": "",
    "adult_dose": " As 3% Eye oint: Apply 5 times\/day until 3rd day of complete healing.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "",
    "packssize": "1.00",
    "ext": "3gm",
    "unite": "tube"
},
{
    "brand_id": "224",
    "generic_id": "15",
    "company_id": "216",
    "aky": "aciclon",
    "brand_name": "Aciclon",
    "form": "Eye Ointment",
    "strength": " ",
    "price": "60.00,100.00",
    "packsize": "3gm,5gm tube",
    "company_name": "Reman Drug Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Acyclovir 3% Eye prep",
    "precaution": "Renal impairment. Pregnancy, lactation. Neurological abnormalities with significant hypoxia, serious hepatic or electrolyte abnormalities. Maintain adequate hydration.",
    "indication": "Herpes simplex keratitis",
    "contra_indication": "Hypersensitivity.",
    "side_effect": "Eye application may produce stinging, superficial punctate keratopathy, blepharitis or conjunctivitis.",
    "pregnancy_category_id": "2",
    "mode_of_action": "Activity against HSV types I and II and varicella-zoster virus is due to intracellular conversion of aciclovir to the monophosphate by viral thymidine kinase with subsequent conversion to the diphosphate and active triphosphate by cellular enzymes. This active form inhibits viral DNA synthesis and replication by interfering with viral DNA polymerase enzyme and being incorporated into viral DNA.",
    "interaction": "Probenecid, cimetidine and mycophenolate mofetil may increase the plasma concentration of aciclovir. Increased nephrotoxic effects w\/ drugs that affect renal physiology (e.g. ciclosporin, tacrolimus).",
    "pregnancy_category_note": "",
    "adult_dose": " As 3% Eye oint: Apply 5 times\/day until 3rd day of complete healing.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "",
    "packssize": "1.00",
    "ext": "3gm",
    "unite": "tube"
},
{
    "brand_id": "224",
    "generic_id": "15",
    "company_id": "216",
    "aky": "aciclon",
    "brand_name": "Aciclon",
    "form": "Eye Ointment",
    "strength": " ",
    "price": "60.00,100.00",
    "packsize": "3gm,5gm tube",
    "company_name": "Reman Drug Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Acyclovir 3% Eye prep",
    "precaution": "Renal impairment. Pregnancy, lactation. Neurological abnormalities with significant hypoxia, serious hepatic or electrolyte abnormalities. Maintain adequate hydration.",
    "indication": "Herpes simplex keratitis",
    "contra_indication": "Hypersensitivity.",
    "side_effect": "Eye application may produce stinging, superficial punctate keratopathy, blepharitis or conjunctivitis.",
    "pregnancy_category_id": "2",
    "mode_of_action": "Activity against HSV types I and II and varicella-zoster virus is due to intracellular conversion of aciclovir to the monophosphate by viral thymidine kinase with subsequent conversion to the diphosphate and active triphosphate by cellular enzymes. This active form inhibits viral DNA synthesis and replication by interfering with viral DNA polymerase enzyme and being incorporated into viral DNA.",
    "interaction": "Probenecid, cimetidine and mycophenolate mofetil may increase the plasma concentration of aciclovir. Increased nephrotoxic effects w\/ drugs that affect renal physiology (e.g. ciclosporin, tacrolimus).",
    "pregnancy_category_note": "",
    "adult_dose": " As 3% Eye oint: Apply 5 times\/day until 3rd day of complete healing.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "",
    "packssize": "1.00",
    "ext": "5gm",
    "unite": "tube"
},
{
    "brand_id": "407",
    "generic_id": "17",
    "company_id": "2",
    "aky": "adgar",
    "brand_name": "Adgar",
    "form": "Gel",
    "strength": " 0.1%",
    "price": "60.18",
    "packsize": "10gm",
    "company_name": "ACI Limited",
    "company_order": "0",
    "generic_name": "Adapalene 0.1% Topical",
    "precaution": "Patients with sunburn, eczema. Pregnancy, lactation. Avoid excessive exposure to sunlight or UV irradiation. Keep away from the eyes, lips, nostrils and mucous membranes. Do not apply to cuts, abrasions, scaly or flaky skin, or patches of sunburned skin. Use with caution with preparations containing sulfur, resorcinol, or salicylic acid.\r\n\r\nLactation: Excretion in milk unknown; use with caution.",
    "indication": "Acne, Keratosis pilaris",
    "contra_indication": "Hypersensitivity.",
    "side_effect": ">10%\r\nDryness (1-45%),Scaling (1-44%),Burning\/stinging (4-29%),Erythema (0.5-26%)\r\n\r\n1-10%\r\nSkin discomfort (6%),Pruritus (2%),Desquamation (2%),Sunburn (1%)\r\n\r\n<1%\r\nAcne flare,Conjunctivitis,Contact dermatitis,Eczema,Erythema,Eyelid edema,Rash,Skin discoloration",
    "pregnancy_category_id": "3",
    "mode_of_action": "Adapalene binds to specific retinoic acid nuclear receptors which normalises the differentiation of follicular epithelial cells resulting in decreased microcomedone formation.",
    "interaction": "Increased irritation may occur with medicated or abrasive soaps, products with a pronounced drying effect and those containing alcohol or astringents.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: Topical As 0.1% soln\/cream\/gel: Apply once daily at night after cleansing.\r\n\r\n",
    "child_dose": "",
    "renal_dose": "",
    "administration": "Apply small (pea-sized) amount sparingly to entire face after cleansing with nonmedicated cleanser.\r\n\r\nFor topical use only;",
    "packssize": "1.00",
    "ext": "10",
    "unite": null
},
{
    "brand_id": "274",
    "generic_id": "17",
    "company_id": "71",
    "aky": "aclene",
    "brand_name": "Aclene",
    "form": "Cream",
    "strength": "0.1%",
    "price": "60.00",
    "packsize": "10gm tubex 1's pack",
    "company_name": "Drug International Ltd.",
    "company_order": "0",
    "generic_name": "Adapalene 0.1% Topical",
    "precaution": "Patients with sunburn, eczema. Pregnancy, lactation. Avoid excessive exposure to sunlight or UV irradiation. Keep away from the eyes, lips, nostrils and mucous membranes. Do not apply to cuts, abrasions, scaly or flaky skin, or patches of sunburned skin. Use with caution with preparations containing sulfur, resorcinol, or salicylic acid.\r\n\r\nLactation: Excretion in milk unknown; use with caution.",
    "indication": "Acne, Keratosis pilaris",
    "contra_indication": "Hypersensitivity.",
    "side_effect": ">10%\r\nDryness (1-45%),Scaling (1-44%),Burning\/stinging (4-29%),Erythema (0.5-26%)\r\n\r\n1-10%\r\nSkin discomfort (6%),Pruritus (2%),Desquamation (2%),Sunburn (1%)\r\n\r\n<1%\r\nAcne flare,Conjunctivitis,Contact dermatitis,Eczema,Erythema,Eyelid edema,Rash,Skin discoloration",
    "pregnancy_category_id": "3",
    "mode_of_action": "Adapalene binds to specific retinoic acid nuclear receptors which normalises the differentiation of follicular epithelial cells resulting in decreased microcomedone formation.",
    "interaction": "Increased irritation may occur with medicated or abrasive soaps, products with a pronounced drying effect and those containing alcohol or astringents.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: Topical As 0.1% soln\/cream\/gel: Apply once daily at night after cleansing.\r\n\r\n",
    "child_dose": "",
    "renal_dose": "",
    "administration": "Apply small (pea-sized) amount sparingly to entire face after cleansing with nonmedicated cleanser.\r\n\r\nFor topical use only;",
    "packssize": null,
    "ext": null,
    "unite": null
},
{
    "brand_id": "1740",
    "generic_id": "17",
    "company_id": "116",
    "aky": "apalene",
    "brand_name": "Apalene",
    "form": "Cream",
    "strength": "0.1%",
    "price": "60.00",
    "packsize": "10gm",
    "company_name": "Incepta Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Adapalene 0.1% Topical",
    "precaution": "Patients with sunburn, eczema. Pregnancy, lactation. Avoid excessive exposure to sunlight or UV irradiation. Keep away from the eyes, lips, nostrils and mucous membranes. Do not apply to cuts, abrasions, scaly or flaky skin, or patches of sunburned skin. Use with caution with preparations containing sulfur, resorcinol, or salicylic acid.\r\n\r\nLactation: Excretion in milk unknown; use with caution.",
    "indication": "Acne, Keratosis pilaris",
    "contra_indication": "Hypersensitivity.",
    "side_effect": ">10%\r\nDryness (1-45%),Scaling (1-44%),Burning\/stinging (4-29%),Erythema (0.5-26%)\r\n\r\n1-10%\r\nSkin discomfort (6%),Pruritus (2%),Desquamation (2%),Sunburn (1%)\r\n\r\n<1%\r\nAcne flare,Conjunctivitis,Contact dermatitis,Eczema,Erythema,Eyelid edema,Rash,Skin discoloration",
    "pregnancy_category_id": "3",
    "mode_of_action": "Adapalene binds to specific retinoic acid nuclear receptors which normalises the differentiation of follicular epithelial cells resulting in decreased microcomedone formation.",
    "interaction": "Increased irritation may occur with medicated or abrasive soaps, products with a pronounced drying effect and those containing alcohol or astringents.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: Topical As 0.1% soln\/cream\/gel: Apply once daily at night after cleansing.\r\n\r\n",
    "child_dose": "",
    "renal_dose": "",
    "administration": "Apply small (pea-sized) amount sparingly to entire face after cleansing with nonmedicated cleanser.\r\n\r\nFor topical use only;",
    "packssize": "1.00",
    "ext": "10",
    "unite": null
},
{
    "brand_id": "408",
    "generic_id": "19",
    "company_id": "2",
    "aky": "adgar",
    "brand_name": "Adgar",
    "form": "Gel",
    "strength": "0.3%",
    "price": "80.24",
    "packsize": "10gm",
    "company_name": "ACI Limited",
    "company_order": "0",
    "generic_name": "Adapalene 0.3% Topical",
    "precaution": "Patients with sunburn, eczema. Pregnancy, lactation. Avoid excessive exposure to sunlight or UV irradiation. Keep away from the eyes, lips, nostrils and mucous membranes. Do not apply to cuts, abrasions, scaly or flaky skin, or patches of sunburned skin. Use with caution with preparations containing sulfur, resorcinol, or salicylic acid.",
    "indication": "Acne",
    "contra_indication": "Hypersensitivity.",
    "side_effect": "Mild skin irritation, scaling, erythema, cutaneous dryness, sensations of stinging and burning, pruritus.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Adapalene binds to specific retinoic acid nuclear receptors which normalises the differentiation of follicular epithelial cells resulting in decreased microcomedone formation.",
    "interaction": "Increased irritation may occur with medicated or abrasive soaps, products with a pronounced drying effect and those containing alcohol or astringents.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: Topical As 0.3% soln\/cream\/gel: Apply once daily at night.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "",
    "packssize": "1.00",
    "ext": "10",
    "unite": null
},
{
    "brand_id": "457",
    "generic_id": "20",
    "company_id": "219",
    "aky": "adovir",
    "brand_name": "Adovir",
    "form": "Tablet",
    "strength": "10mg",
    "price": "300",
    "packsize": "30's pack",
    "company_name": "Renata Limited",
    "company_order": "0",
    "generic_name": "Adefovir Dipivoxil",
    "precaution": "Pregnancy; elderly; child; renal or hepatic impairment. HIV antibody testing to be performed before initiation due to possible resistance development in untreated HIV infection. Increased risk of hepatotoxicity in females, obese patients and with prolonged treatment. Monitor renal function every 3 mth; hepatitis B biochemical, viral and serological markers every 6 mth and LFTs. Discontinue therapy if liver function worsens, severe hepatomegaly, steatosis or unexplained metabolic or lactic acidosis. Monitor hepatic function for several mth in patients whose antihepatitis therapy is discontinued as acute exacerbations of hepatitis may occur.\r\n\r\nLactation: Unknown if excreted in breast milk.",
    "indication": "Chronic hepatitis B",
    "contra_indication": "Adefovir Dipivoxil is contraindicated in patients with previously demonstrated hypersensitivity to any of the components of the product.",
    "side_effect": ">10%\r\nHematuria (11% vs 10% in placebo-treated),Asthenia (13% vs. 14% placebo),Hepatitis exacerbation (25%)\r\n\r\n1-10%\r\nNausea (5%),Flatulence (4%),Diarrhea (3%)Dyspepsia (3%),Headache (9%),Rash (1-10%),Pruritus (1-10%),Dyspepsia (5-9%),Cough (6-8%),Rhinitis (5%)\r\n\r\nIncreased AST\/ALT,Abnormal liver function,Renal failure,Renal insufficiency,Increased serum Cr (2-3%),Hypophosphatemia\r\n\r\n\r\nPotentially Fatal: Lactic acidosis, severe hepatomegaly with steatosis, hepatotoxicity, nephrotoxicity.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Adefovir dipivoxil is an acyclic nucleoside reverse transciptase inhibitor. The diester function is hydrolyzed and subsequently phosphorylated to the active adefovir diphosphate. The active metabolite inhibits HBV DNA polymerase (reverse transcriptase) and hence inhibits viral replication. It can be used in patients with lamivudine-resistant hepatitis B.",
    "interaction": "Increased risk of nephrotoxicity with nephrotoxic drugs e.g. aminoglycosides, ciclosporin, NSAIDs, vancomycin, tacrolimus. Ibuprofen increases bioavailability of adefovir.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO: (age > 12 year) 10 mg, once daily.\r\n",
    "child_dose": "",
    "renal_dose": "Renal impairment: Haemodialysis patients: 10 mg every 7 days after dialysis.\r\nCrCl (ml\/min) \r\n30-49 10 mg every 48 hr.\r\n10-29 10 mg every 72 hr.\r\n\r\n\r\n",
    "administration": "Taken orally, without regard to food. \r\n",
    "packssize": "30.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "1687",
    "generic_id": "20",
    "company_id": "250",
    "aky": "antiva",
    "brand_name": "Antiva",
    "form": "Tablet",
    "strength": "10mg",
    "price": "35.24",
    "packsize": "10's pack",
    "company_name": "Square Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Adefovir Dipivoxil",
    "precaution": "Pregnancy; elderly; child; renal or hepatic impairment. HIV antibody testing to be performed before initiation due to possible resistance development in untreated HIV infection. Increased risk of hepatotoxicity in females, obese patients and with prolonged treatment. Monitor renal function every 3 mth; hepatitis B biochemical, viral and serological markers every 6 mth and LFTs. Discontinue therapy if liver function worsens, severe hepatomegaly, steatosis or unexplained metabolic or lactic acidosis. Monitor hepatic function for several mth in patients whose antihepatitis therapy is discontinued as acute exacerbations of hepatitis may occur.\r\n\r\nLactation: Unknown if excreted in breast milk.",
    "indication": "Chronic hepatitis B",
    "contra_indication": "Adefovir Dipivoxil is contraindicated in patients with previously demonstrated hypersensitivity to any of the components of the product.",
    "side_effect": ">10%\r\nHematuria (11% vs 10% in placebo-treated),Asthenia (13% vs. 14% placebo),Hepatitis exacerbation (25%)\r\n\r\n1-10%\r\nNausea (5%),Flatulence (4%),Diarrhea (3%)Dyspepsia (3%),Headache (9%),Rash (1-10%),Pruritus (1-10%),Dyspepsia (5-9%),Cough (6-8%),Rhinitis (5%)\r\n\r\nIncreased AST\/ALT,Abnormal liver function,Renal failure,Renal insufficiency,Increased serum Cr (2-3%),Hypophosphatemia\r\n\r\n\r\nPotentially Fatal: Lactic acidosis, severe hepatomegaly with steatosis, hepatotoxicity, nephrotoxicity.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Adefovir dipivoxil is an acyclic nucleoside reverse transciptase inhibitor. The diester function is hydrolyzed and subsequently phosphorylated to the active adefovir diphosphate. The active metabolite inhibits HBV DNA polymerase (reverse transcriptase) and hence inhibits viral replication. It can be used in patients with lamivudine-resistant hepatitis B.",
    "interaction": "Increased risk of nephrotoxicity with nephrotoxic drugs e.g. aminoglycosides, ciclosporin, NSAIDs, vancomycin, tacrolimus. Ibuprofen increases bioavailability of adefovir.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO: (age > 12 year) 10 mg, once daily.\r\n",
    "child_dose": "",
    "renal_dose": "Renal impairment: Haemodialysis patients: 10 mg every 7 days after dialysis.\r\nCrCl (ml\/min) \r\n30-49 10 mg every 48 hr.\r\n10-29 10 mg every 72 hr.\r\n\r\n\r\n",
    "administration": "Taken orally, without regard to food. \r\n",
    "packssize": "10.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "406",
    "generic_id": "20",
    "company_id": "255",
    "aky": "adfovir",
    "brand_name": "Adfovir",
    "form": "Tablet",
    "strength": "10mg",
    "price": "25.17",
    "packsize": "10's pack",
    "company_name": "Sun Pharmaceutical (Bangladesh) Ltd.",
    "company_order": "0",
    "generic_name": "Adefovir Dipivoxil",
    "precaution": "Pregnancy; elderly; child; renal or hepatic impairment. HIV antibody testing to be performed before initiation due to possible resistance development in untreated HIV infection. Increased risk of hepatotoxicity in females, obese patients and with prolonged treatment. Monitor renal function every 3 mth; hepatitis B biochemical, viral and serological markers every 6 mth and LFTs. Discontinue therapy if liver function worsens, severe hepatomegaly, steatosis or unexplained metabolic or lactic acidosis. Monitor hepatic function for several mth in patients whose antihepatitis therapy is discontinued as acute exacerbations of hepatitis may occur.\r\n\r\nLactation: Unknown if excreted in breast milk.",
    "indication": "Chronic hepatitis B",
    "contra_indication": "Adefovir Dipivoxil is contraindicated in patients with previously demonstrated hypersensitivity to any of the components of the product.",
    "side_effect": ">10%\r\nHematuria (11% vs 10% in placebo-treated),Asthenia (13% vs. 14% placebo),Hepatitis exacerbation (25%)\r\n\r\n1-10%\r\nNausea (5%),Flatulence (4%),Diarrhea (3%)Dyspepsia (3%),Headache (9%),Rash (1-10%),Pruritus (1-10%),Dyspepsia (5-9%),Cough (6-8%),Rhinitis (5%)\r\n\r\nIncreased AST\/ALT,Abnormal liver function,Renal failure,Renal insufficiency,Increased serum Cr (2-3%),Hypophosphatemia\r\n\r\n\r\nPotentially Fatal: Lactic acidosis, severe hepatomegaly with steatosis, hepatotoxicity, nephrotoxicity.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Adefovir dipivoxil is an acyclic nucleoside reverse transciptase inhibitor. The diester function is hydrolyzed and subsequently phosphorylated to the active adefovir diphosphate. The active metabolite inhibits HBV DNA polymerase (reverse transcriptase) and hence inhibits viral replication. It can be used in patients with lamivudine-resistant hepatitis B.",
    "interaction": "Increased risk of nephrotoxicity with nephrotoxic drugs e.g. aminoglycosides, ciclosporin, NSAIDs, vancomycin, tacrolimus. Ibuprofen increases bioavailability of adefovir.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO: (age > 12 year) 10 mg, once daily.\r\n",
    "child_dose": "",
    "renal_dose": "Renal impairment: Haemodialysis patients: 10 mg every 7 days after dialysis.\r\nCrCl (ml\/min) \r\n30-49 10 mg every 48 hr.\r\n10-29 10 mg every 72 hr.\r\n\r\n\r\n",
    "administration": "Taken orally, without regard to food. \r\n",
    "packssize": "10.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "3955",
    "generic_id": "23",
    "company_id": "3",
    "aky": "catnil",
    "brand_name": "Catnil",
    "form": "Eye Drops",
    "strength": " 0.2% + 0.05%",
    "price": "125.37",
    "packsize": " 5  ml drop",
    "company_name": "Acme Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Adenosine 0.2% + Cytochrome C 0.05% + Nicotinamide eye prep",
    "precaution": "Only for topical ophthalmic use. Do not inject or swallow. In case of concomitant treatment with another ophthalmic solution, wait 15 minutes between each instillation.",
    "indication": "Lens opacification",
    "contra_indication": " Patients with known hypersensitivity to any ingredient of this product.",
    "side_effect": "It may cause more or less discomfort",
    "pregnancy_category_id": "3",
    "mode_of_action": "Cytochrome C helps in the oxidative phosphorylation for synthesizing ATP from ADP. Sodium Succinate (intermediate substance) promotes the production of ATP. Adenosine plays essential role in producing energy required for the vital function of the lens. Nicotinamide is involved in the process of creating ATP.",
    "interaction": "No specific drug interaction has been demonstrated.",
    "pregnancy_category_note": "",
    "adult_dose": "One drop into the affected eye twice daily.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "",
    "packssize": null,
    "ext": null,
    "unite": null
},
{
    "brand_id": "3954",
    "generic_id": "23",
    "company_id": "20",
    "aky": "catavit",
    "brand_name": "Catavit",
    "form": "Eye Drops",
    "strength": " ",
    "price": "120.00",
    "packsize": "5  ml drop",
    "company_name": "Apex Pharma Limited.",
    "company_order": "0",
    "generic_name": "Adenosine 0.2% + Cytochrome C 0.05% + Nicotinamide eye prep",
    "precaution": "Only for topical ophthalmic use. Do not inject or swallow. In case of concomitant treatment with another ophthalmic solution, wait 15 minutes between each instillation.",
    "indication": "Lens opacification",
    "contra_indication": " Patients with known hypersensitivity to any ingredient of this product.",
    "side_effect": "It may cause more or less discomfort",
    "pregnancy_category_id": "3",
    "mode_of_action": "Cytochrome C helps in the oxidative phosphorylation for synthesizing ATP from ADP. Sodium Succinate (intermediate substance) promotes the production of ATP. Adenosine plays essential role in producing energy required for the vital function of the lens. Nicotinamide is involved in the process of creating ATP.",
    "interaction": "No specific drug interaction has been demonstrated.",
    "pregnancy_category_note": "",
    "adult_dose": "One drop into the affected eye twice daily.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "",
    "packssize": "1.00",
    "ext": "5ml",
    "unite": "drop"
},
{
    "brand_id": "3960",
    "generic_id": "23",
    "company_id": "116",
    "aky": "catrix",
    "brand_name": "Catrix",
    "form": "Eye Drops",
    "strength": " ",
    "price": "125.00",
    "packsize": "5  ml drop",
    "company_name": "Incepta Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Adenosine 0.2% + Cytochrome C 0.05% + Nicotinamide eye prep",
    "precaution": "Only for topical ophthalmic use. Do not inject or swallow. In case of concomitant treatment with another ophthalmic solution, wait 15 minutes between each instillation.",
    "indication": "Lens opacification",
    "contra_indication": " Patients with known hypersensitivity to any ingredient of this product.",
    "side_effect": "It may cause more or less discomfort",
    "pregnancy_category_id": "3",
    "mode_of_action": "Cytochrome C helps in the oxidative phosphorylation for synthesizing ATP from ADP. Sodium Succinate (intermediate substance) promotes the production of ATP. Adenosine plays essential role in producing energy required for the vital function of the lens. Nicotinamide is involved in the process of creating ATP.",
    "interaction": "No specific drug interaction has been demonstrated.",
    "pregnancy_category_note": "",
    "adult_dose": "One drop into the affected eye twice daily.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "",
    "packssize": "1.00",
    "ext": "5ml",
    "unite": "drop"
},
{
    "brand_id": "466",
    "generic_id": "24",
    "company_id": "87",
    "aky": "adrin",
    "brand_name": "Adrin",
    "form": "Injection",
    "strength": "1mg\/ml",
    "price": "25.00",
    "packsize": "1 amps pack",
    "company_name": "G. A. Company Ltd.",
    "company_order": "0",
    "generic_name": "Adrenaline (Epinephrine)",
    "precaution": "CV diseases; hyperthyroidism; DM; Parkinson's disease; elderly; pregnancy, lactation.\r\n\r\nLactation: Unknown if excreted into breast milk; use caution.",
    "indication": "Cardiac arrest, Anaphylaxis, Superficial bleeding, Acute asthma",
    "contra_indication": "Preexisting hypertension; occlusive vascular disease; angle-closure glaucoma (eye drops); hypersensitivity; cardiac arrhythmias or tachycardia. When used in addition to local anaesthetics: Procedures involving digits, ears, nose, penis or scrotum.",
    "side_effect": "Angina,Anxiety,Apprehensiveness,Cardiac arrhythmias,Dizziness,Dyspnea,Flushing,Headache,Hypertension,Nausea,Nervousness,Pallor,Palpitations,Respiratory difficulties,Restlessness,Sweating,Tachycardia,Tremor,Vasoconstriction,Vomiting,Weakness",
    "pregnancy_category_id": "3",
    "mode_of_action": "Epinephrine, an active principle of the adrenal medulla, is a direct-acting sympathomimetic. It stimulates alpha- and beta-adrenergic receptors resulting in relaxation of smooth muscle of the bronchial tree, cardiac stimulation and dilation of skeletal muscle vasculature. It is frequently added to local anaesthetics to retard diffusion and limit absorption, to prolong the duration of effect and to lessen the danger of toxicity.",
    "interaction": "Halogenated inhalation anaesthetics; alpha- or beta-blocking agents; methyldopa, guanethidine; drugs with vasoconstrictor and pressor effects; antihypertensives; adrenergic neuron blockers; potassium-depleting drugs; cardiac glycosides; ephedra, yohimbe. TCAs may induce hypertension and arrhythmia.",
    "pregnancy_category_note": "",
    "adult_dose": "Parenteral\r\nAcute asthma\r\nAdult: 0.3-0.5 ml (300-500 mcg). Dose may be given via IM or SC inj. \r\n\r\nIntravenous\r\nAdvanced cardiac life support (Cardiac Arrest)\r\nAdult: \r\n1. Intravenous injection: 1 mg injection repeated every 2-3 minutes as necessary.\r\n2. Endotracheal: 2-3 mg via an endotracheal tube, repeated as necessary.\r\n3. Intracardiac injection: 0.1 to 1 mg, direct into the atrium of the heart.\r\n4. Intraspinal use: Usual dose is 0.2 to 0.4 mg added to anesthetic spinal fluid mixture (to prolong anesthetic action by limiting absorption).\r\n\r\n\r\nAnaphylactic shock\r\nAdult: 0.5 mg (5 mL) given at a slow rate of 100 mcg\/minute, stopping when a response is achieved. \r\n\r\nIntramuscular\r\nAnaphylactic shock\r\nAdult: 500 mcg (0.5 ml), repeat every 5 minutes as needed until improvement occurs. For emergency self-admin (e.g. via autoinjector): A dose of 300 mcg (0.3 ml) may be used.\r\n\r\n\r\n",
    "child_dose": "Parenteral\r\nAcute asthma\r\nChild: 0.01 ml\/kg (10 mcg\/kg). Max: 0.5 ml (500 mcg). Dose may be given via IM or SC inj. \r\n\r\nIntravenous\r\nAdvanced cardiac life support (Cardiac Arrest)\r\nChild: Initially, 10 mcg\/kg, may repeat as often as every 2-3 minutes throughout the resuscitation process. Endotracheal doses: 100 mcg\/kg. Intraosseous doses are the same as IV doses. \r\nMax Dosage: Intraosseous doses for adults and children are the same as IV doses. \r\n\r\nAnaphylactic shock\r\nChild: 10 mcg\/kg. If auto injectors are used, doses are based on body wt: 15-30 kg: 150 mcg and >30 kg: 300 mcg. \r\n\r\nIntramuscular\r\nAnaphylactic shock\r\nChild: Dose depends on age and weight. Usual dose: 10 mcg\/kg.\r\n\r\n",
    "renal_dose": "",
    "administration": "IV Administration\r\nCentral line; infusion pump required\r\n\r\nIV Preparation\r\nSolution: 1 mg in 250 mL D5W or NS (4 mcg\/mL) to make up concentration of 15-60 mL\/hr (1-4 mcg\/min)",
    "packssize": "1.00",
    "ext": null,
    "unite": "amps"
},
{
    "brand_id": "467",
    "generic_id": "24",
    "company_id": "116",
    "aky": "adrinor",
    "brand_name": "Adrinor",
    "form": "Injection",
    "strength": "1mg\/ml",
    "price": "25.00",
    "packsize": "5 amps pack",
    "company_name": "Incepta Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Adrenaline (Epinephrine)",
    "precaution": "CV diseases; hyperthyroidism; DM; Parkinson's disease; elderly; pregnancy, lactation.\r\n\r\nLactation: Unknown if excreted into breast milk; use caution.",
    "indication": "Cardiac arrest, Anaphylaxis, Superficial bleeding, Acute asthma",
    "contra_indication": "Preexisting hypertension; occlusive vascular disease; angle-closure glaucoma (eye drops); hypersensitivity; cardiac arrhythmias or tachycardia. When used in addition to local anaesthetics: Procedures involving digits, ears, nose, penis or scrotum.",
    "side_effect": "Angina,Anxiety,Apprehensiveness,Cardiac arrhythmias,Dizziness,Dyspnea,Flushing,Headache,Hypertension,Nausea,Nervousness,Pallor,Palpitations,Respiratory difficulties,Restlessness,Sweating,Tachycardia,Tremor,Vasoconstriction,Vomiting,Weakness",
    "pregnancy_category_id": "3",
    "mode_of_action": "Epinephrine, an active principle of the adrenal medulla, is a direct-acting sympathomimetic. It stimulates alpha- and beta-adrenergic receptors resulting in relaxation of smooth muscle of the bronchial tree, cardiac stimulation and dilation of skeletal muscle vasculature. It is frequently added to local anaesthetics to retard diffusion and limit absorption, to prolong the duration of effect and to lessen the danger of toxicity.",
    "interaction": "Halogenated inhalation anaesthetics; alpha- or beta-blocking agents; methyldopa, guanethidine; drugs with vasoconstrictor and pressor effects; antihypertensives; adrenergic neuron blockers; potassium-depleting drugs; cardiac glycosides; ephedra, yohimbe. TCAs may induce hypertension and arrhythmia.",
    "pregnancy_category_note": "",
    "adult_dose": "Parenteral\r\nAcute asthma\r\nAdult: 0.3-0.5 ml (300-500 mcg). Dose may be given via IM or SC inj. \r\n\r\nIntravenous\r\nAdvanced cardiac life support (Cardiac Arrest)\r\nAdult: \r\n1. Intravenous injection: 1 mg injection repeated every 2-3 minutes as necessary.\r\n2. Endotracheal: 2-3 mg via an endotracheal tube, repeated as necessary.\r\n3. Intracardiac injection: 0.1 to 1 mg, direct into the atrium of the heart.\r\n4. Intraspinal use: Usual dose is 0.2 to 0.4 mg added to anesthetic spinal fluid mixture (to prolong anesthetic action by limiting absorption).\r\n\r\n\r\nAnaphylactic shock\r\nAdult: 0.5 mg (5 mL) given at a slow rate of 100 mcg\/minute, stopping when a response is achieved. \r\n\r\nIntramuscular\r\nAnaphylactic shock\r\nAdult: 500 mcg (0.5 ml), repeat every 5 minutes as needed until improvement occurs. For emergency self-admin (e.g. via autoinjector): A dose of 300 mcg (0.3 ml) may be used.\r\n\r\n\r\n",
    "child_dose": "Parenteral\r\nAcute asthma\r\nChild: 0.01 ml\/kg (10 mcg\/kg). Max: 0.5 ml (500 mcg). Dose may be given via IM or SC inj. \r\n\r\nIntravenous\r\nAdvanced cardiac life support (Cardiac Arrest)\r\nChild: Initially, 10 mcg\/kg, may repeat as often as every 2-3 minutes throughout the resuscitation process. Endotracheal doses: 100 mcg\/kg. Intraosseous doses are the same as IV doses. \r\nMax Dosage: Intraosseous doses for adults and children are the same as IV doses. \r\n\r\nAnaphylactic shock\r\nChild: 10 mcg\/kg. If auto injectors are used, doses are based on body wt: 15-30 kg: 150 mcg and >30 kg: 300 mcg. \r\n\r\nIntramuscular\r\nAnaphylactic shock\r\nChild: Dose depends on age and weight. Usual dose: 10 mcg\/kg.\r\n\r\n",
    "renal_dose": "",
    "administration": "IV Administration\r\nCentral line; infusion pump required\r\n\r\nIV Preparation\r\nSolution: 1 mg in 250 mL D5W or NS (4 mcg\/mL) to make up concentration of 15-60 mL\/hr (1-4 mcg\/min)",
    "packssize": "5.00",
    "ext": null,
    "unite": "amps"
},
{
    "brand_id": "464",
    "generic_id": "24",
    "company_id": "260",
    "aky": "adrenaline",
    "brand_name": "Adrenaline",
    "form": "Injection",
    "strength": "1mg\/ml",
    "price": "250.00",
    "packsize": "10 amps pack",
    "company_name": "Techno Drugs Ltd.",
    "company_order": "0",
    "generic_name": "Adrenaline (Epinephrine)",
    "precaution": "CV diseases; hyperthyroidism; DM; Parkinson's disease; elderly; pregnancy, lactation.\r\n\r\nLactation: Unknown if excreted into breast milk; use caution.",
    "indication": "Cardiac arrest, Anaphylaxis, Superficial bleeding, Acute asthma",
    "contra_indication": "Preexisting hypertension; occlusive vascular disease; angle-closure glaucoma (eye drops); hypersensitivity; cardiac arrhythmias or tachycardia. When used in addition to local anaesthetics: Procedures involving digits, ears, nose, penis or scrotum.",
    "side_effect": "Angina,Anxiety,Apprehensiveness,Cardiac arrhythmias,Dizziness,Dyspnea,Flushing,Headache,Hypertension,Nausea,Nervousness,Pallor,Palpitations,Respiratory difficulties,Restlessness,Sweating,Tachycardia,Tremor,Vasoconstriction,Vomiting,Weakness",
    "pregnancy_category_id": "3",
    "mode_of_action": "Epinephrine, an active principle of the adrenal medulla, is a direct-acting sympathomimetic. It stimulates alpha- and beta-adrenergic receptors resulting in relaxation of smooth muscle of the bronchial tree, cardiac stimulation and dilation of skeletal muscle vasculature. It is frequently added to local anaesthetics to retard diffusion and limit absorption, to prolong the duration of effect and to lessen the danger of toxicity.",
    "interaction": "Halogenated inhalation anaesthetics; alpha- or beta-blocking agents; methyldopa, guanethidine; drugs with vasoconstrictor and pressor effects; antihypertensives; adrenergic neuron blockers; potassium-depleting drugs; cardiac glycosides; ephedra, yohimbe. TCAs may induce hypertension and arrhythmia.",
    "pregnancy_category_note": "",
    "adult_dose": "Parenteral\r\nAcute asthma\r\nAdult: 0.3-0.5 ml (300-500 mcg). Dose may be given via IM or SC inj. \r\n\r\nIntravenous\r\nAdvanced cardiac life support (Cardiac Arrest)\r\nAdult: \r\n1. Intravenous injection: 1 mg injection repeated every 2-3 minutes as necessary.\r\n2. Endotracheal: 2-3 mg via an endotracheal tube, repeated as necessary.\r\n3. Intracardiac injection: 0.1 to 1 mg, direct into the atrium of the heart.\r\n4. Intraspinal use: Usual dose is 0.2 to 0.4 mg added to anesthetic spinal fluid mixture (to prolong anesthetic action by limiting absorption).\r\n\r\n\r\nAnaphylactic shock\r\nAdult: 0.5 mg (5 mL) given at a slow rate of 100 mcg\/minute, stopping when a response is achieved. \r\n\r\nIntramuscular\r\nAnaphylactic shock\r\nAdult: 500 mcg (0.5 ml), repeat every 5 minutes as needed until improvement occurs. For emergency self-admin (e.g. via autoinjector): A dose of 300 mcg (0.3 ml) may be used.\r\n\r\n\r\n",
    "child_dose": "Parenteral\r\nAcute asthma\r\nChild: 0.01 ml\/kg (10 mcg\/kg). Max: 0.5 ml (500 mcg). Dose may be given via IM or SC inj. \r\n\r\nIntravenous\r\nAdvanced cardiac life support (Cardiac Arrest)\r\nChild: Initially, 10 mcg\/kg, may repeat as often as every 2-3 minutes throughout the resuscitation process. Endotracheal doses: 100 mcg\/kg. Intraosseous doses are the same as IV doses. \r\nMax Dosage: Intraosseous doses for adults and children are the same as IV doses. \r\n\r\nAnaphylactic shock\r\nChild: 10 mcg\/kg. If auto injectors are used, doses are based on body wt: 15-30 kg: 150 mcg and >30 kg: 300 mcg. \r\n\r\nIntramuscular\r\nAnaphylactic shock\r\nChild: Dose depends on age and weight. Usual dose: 10 mcg\/kg.\r\n\r\n",
    "renal_dose": "",
    "administration": "IV Administration\r\nCentral line; infusion pump required\r\n\r\nIV Preparation\r\nSolution: 1 mg in 250 mL D5W or NS (4 mcg\/mL) to make up concentration of 15-60 mL\/hr (1-4 mcg\/min)",
    "packssize": "10.00",
    "ext": null,
    "unite": "amps"
},
{
    "brand_id": "1402",
    "generic_id": "26",
    "company_id": "174",
    "aky": "anaroxyl",
    "brand_name": "Anaroxyl",
    "form": "Tablet",
    "strength": "2.5mg",
    "price": "19.75",
    "packsize": "30's pack",
    "company_name": "Nuvista Pharma Ltd",
    "company_order": "0",
    "generic_name": "Adrenochrome Monosemicarbazone",
    "precaution": "Because of the content of diprophylline (90 mg\/ml), the dosage to premature babies, infants and young children should not exceed 0.3 ml.",
    "indication": "Capillary bleeding, Haemoptysis, Haematuria, Retinal hemorrhage,Secondary hemorrhage, Menorrhagia.",
    "contra_indication": "Should not be administered to patients with hypersensitivity.",
    "side_effect": "Allergic reactions may occur like dyspnoea, bronchospasm, skin reaction etc",
    "pregnancy_category_id": "0",
    "mode_of_action": "Carbazochrome is an oxidation product of adrenaline (epinephrine). It has been used as a haemostatic agent.",
    "interaction": "No specific drug interaction has been demonstrated.",
    "pregnancy_category_note": "",
    "adult_dose": "Oral As a haemostatic \r\nAdult: 10-30 mg tid. \r\n\r\nInjection As a haemostatic Adult: 10 mg daily by SC\/IM inj. \r\nAlternatively, 25-100 mg daily by IV Inj or drip infusion.\r\n\r\nPre-operative: 2-6ml at suitable intervals. \r\nPost-operative: 1-2ml every 2hrs. \r\nNon-surgical: 2-4ml tid. ",
    "child_dose": "Child <6yrs: 1-2ml tid.",
    "renal_dose": "",
    "administration": "",
    "packssize": "30.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "1403",
    "generic_id": "26",
    "company_id": "174",
    "aky": "anaroxyl",
    "brand_name": "Anaroxyl",
    "form": "Injection",
    "strength": "5mg\/ml",
    "price": "66.90",
    "packsize": "5 amp's pack",
    "company_name": "Nuvista Pharma Ltd",
    "company_order": "0",
    "generic_name": "Adrenochrome Monosemicarbazone",
    "precaution": "Because of the content of diprophylline (90 mg\/ml), the dosage to premature babies, infants and young children should not exceed 0.3 ml.",
    "indication": "Capillary bleeding, Haemoptysis, Haematuria, Retinal hemorrhage,Secondary hemorrhage, Menorrhagia.",
    "contra_indication": "Should not be administered to patients with hypersensitivity.",
    "side_effect": "Allergic reactions may occur like dyspnoea, bronchospasm, skin reaction etc",
    "pregnancy_category_id": "0",
    "mode_of_action": "Carbazochrome is an oxidation product of adrenaline (epinephrine). It has been used as a haemostatic agent.",
    "interaction": "No specific drug interaction has been demonstrated.",
    "pregnancy_category_note": "",
    "adult_dose": "Oral As a haemostatic \r\nAdult: 10-30 mg tid. \r\n\r\nInjection As a haemostatic Adult: 10 mg daily by SC\/IM inj. \r\nAlternatively, 25-100 mg daily by IV Inj or drip infusion.\r\n\r\nPre-operative: 2-6ml at suitable intervals. \r\nPost-operative: 1-2ml every 2hrs. \r\nNon-surgical: 2-4ml tid. ",
    "child_dose": "Child <6yrs: 1-2ml tid.",
    "renal_dose": "",
    "administration": "",
    "packssize": "5.00",
    "ext": null,
    "unite": "amps"
},
{
    "brand_id": "2793",
    "generic_id": "28",
    "company_id": "3",
    "aky": "bena",
    "brand_name": "Ben A",
    "form": "Tablet",
    "strength": "400mg",
    "price": "5.00",
    "packsize": "25's pack",
    "company_name": "Acme Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "25.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "2794",
    "generic_id": "28",
    "company_id": "3",
    "aky": "ben-a",
    "brand_name": "Ben-A",
    "form": "Suspension",
    "strength": "200mg\/5ml",
    "price": "20.00",
    "packsize": "10 ml bot",
    "company_name": "Acme Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "1.00",
    "ext": "10ml",
    "unite": "bot"
},
{
    "brand_id": "668",
    "generic_id": "28",
    "company_id": "5",
    "aky": "aldaben",
    "brand_name": "Aldaben",
    "form": "Suspension",
    "strength": "200mg\/5ml",
    "price": "15",
    "packsize": "10ml bot",
    "company_name": "Ad-din Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "1.00",
    "ext": "10ml",
    "unite": "bot"
},
{
    "brand_id": "670",
    "generic_id": "28",
    "company_id": "5",
    "aky": "aldabends",
    "brand_name": "Aldaben DS",
    "form": "Tablet",
    "strength": "400mg",
    "price": "100",
    "packsize": "25's pack",
    "company_name": "Ad-din Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "25.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "613",
    "generic_id": "28",
    "company_id": "8",
    "aky": "albendads",
    "brand_name": "Albenda DS",
    "form": "Tablet",
    "strength": "400mg",
    "price": "68",
    "packsize": "20's pack",
    "company_name": "Aexim Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "20.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "4648",
    "generic_id": "28",
    "company_id": "13",
    "aky": "chubends",
    "brand_name": "Chuben DS",
    "form": "Tablet",
    "strength": "400mg",
    "price": "3.85",
    "packsize": "50's pack",
    "company_name": "Alco Pharma Limited",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "116",
    "generic_id": "28",
    "company_id": "22",
    "aky": "abentel",
    "brand_name": "Abentel",
    "form": "Tablet",
    "strength": "400mg",
    "price": "5.00",
    "packsize": "50's pack",
    "company_name": "Aristopharma Limited",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "2054",
    "generic_id": "28",
    "company_id": "23",
    "aky": "asiben",
    "brand_name": "Asiben",
    "form": "Suspension",
    "strength": "200mg\/5ml",
    "price": "14.00",
    "packsize": "10 ml bot",
    "company_name": "Asiatic Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "1.00",
    "ext": "10ml",
    "unite": "bot"
},
{
    "brand_id": "2055",
    "generic_id": "28",
    "company_id": "23",
    "aky": "asiben",
    "brand_name": "Asiben",
    "form": "Tablet",
    "strength": "400mg",
    "price": null,
    "packsize": "10's pack",
    "company_name": "Asiatic Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "10.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "869",
    "generic_id": "28",
    "company_id": "37",
    "aky": "alphinds",
    "brand_name": "Alphin DS",
    "form": "Tablet",
    "strength": "400mg",
    "price": "5.00",
    "packsize": "50's pack",
    "company_name": "Beximco Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "2534",
    "generic_id": "28",
    "company_id": "40",
    "aky": "azole",
    "brand_name": "Azole",
    "form": "Suspension",
    "strength": "200mg\/5ml",
    "price": "18.00",
    "packsize": "10 ml bot",
    "company_name": "Bio Pharma Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "1.00",
    "ext": "10ml",
    "unite": "bot"
},
{
    "brand_id": "2535",
    "generic_id": "28",
    "company_id": "40",
    "aky": "azole",
    "brand_name": "Azole",
    "form": "Tablet",
    "strength": "400mg",
    "price": "5.00",
    "packsize": "30's pack",
    "company_name": "Bio Pharma Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "30.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "2813",
    "generic_id": "28",
    "company_id": "47",
    "aky": "bendads",
    "brand_name": "Benda DS",
    "form": "Tablet",
    "strength": "400mg",
    "price": "175",
    "packsize": "50's pack",
    "company_name": "Bristol Pharma Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "606",
    "generic_id": "28",
    "company_id": "51",
    "aky": "albazolds",
    "brand_name": "Albazol DS",
    "form": "Tablet",
    "strength": "400mg",
    "price": null,
    "packsize": "50's pack",
    "company_name": "Central Pharmaceutical Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "5298",
    "generic_id": "28",
    "company_id": "58",
    "aky": "colaz",
    "brand_name": "Colaz",
    "form": "Suspension",
    "strength": "200mg\/5ml",
    "price": "18.00",
    "packsize": "10 ml bot",
    "company_name": "Cosmic Chemical Industries Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "1.00",
    "ext": "10ml",
    "unite": "bot"
},
{
    "brand_id": "5299",
    "generic_id": "28",
    "company_id": "58",
    "aky": "colaz",
    "brand_name": "Colaz",
    "form": "Tablet",
    "strength": "400mg",
    "price": "5.00",
    "packsize": "30's pack",
    "company_name": "Cosmic Chemical Industries Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "30.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "5492",
    "generic_id": "28",
    "company_id": "59",
    "aky": "cosben",
    "brand_name": "Cosben",
    "form": "Tablet",
    "strength": "400mg",
    "price": "150",
    "packsize": "50's pack",
    "company_name": "Cosmo Pharma Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "688",
    "generic_id": "28",
    "company_id": "64",
    "aky": "aldes",
    "brand_name": "Aldes",
    "form": "Suspension",
    "strength": "200mg\/5ml",
    "price": "15",
    "packsize": "10ml bot",
    "company_name": "Desh Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "1.00",
    "ext": "10ml",
    "unite": "bot"
},
{
    "brand_id": "689",
    "generic_id": "28",
    "company_id": "64",
    "aky": "aldes-ds",
    "brand_name": "Aldes-DS",
    "form": "Tablet",
    "strength": "400mg",
    "price": "4.00",
    "packsize": "100's pack",
    "company_name": "Desh Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "690",
    "generic_id": "28",
    "company_id": "66",
    "aky": "aldew",
    "brand_name": "Aldew",
    "form": "Tablet",
    "strength": "400mg",
    "price": "4.00",
    "packsize": "50's pack",
    "company_name": "Doctor's Chemicals Works Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "607",
    "generic_id": "28",
    "company_id": "81",
    "aky": "alben",
    "brand_name": "Alben",
    "form": "Suspension",
    "strength": "200mg\/5ml",
    "price": "20.00",
    "packsize": "10ml",
    "company_name": "Eskayef Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "1.00",
    "ext": "10ml",
    "unite": null
},
{
    "brand_id": "610",
    "generic_id": "28",
    "company_id": "81",
    "aky": "albends",
    "brand_name": "Alben DS",
    "form": "Tablet",
    "strength": "400mg",
    "price": "5.00",
    "packsize": "100's, 48 's pack",
    "company_name": "Eskayef Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "610",
    "generic_id": "28",
    "company_id": "81",
    "aky": "albends",
    "brand_name": "Alben DS",
    "form": "Tablet",
    "strength": "400mg",
    "price": "5.00",
    "packsize": "100's, 48 's pack",
    "company_name": "Eskayef Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "48.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "553",
    "generic_id": "28",
    "company_id": "85",
    "aky": "al",
    "brand_name": "AL",
    "form": "Suspension",
    "strength": "200mg\/5ml",
    "price": "15",
    "packsize": "10 ml bot",
    "company_name": "Everest Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "1.00",
    "ext": "10ml",
    "unite": "bot"
},
{
    "brand_id": "555",
    "generic_id": "28",
    "company_id": "85",
    "aky": "al",
    "brand_name": "Al",
    "form": "Tablet",
    "strength": "400mg",
    "price": "114",
    "packsize": "30's pack",
    "company_name": "Everest Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "30.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "691",
    "generic_id": "28",
    "company_id": "87",
    "aky": "aldex",
    "brand_name": "Aldex",
    "form": "Suspension",
    "strength": "200mg\/5ml",
    "price": "15.00",
    "packsize": "10 ml bot",
    "company_name": "G. A. Company Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "1.00",
    "ext": "10ml",
    "unite": "bot"
},
{
    "brand_id": "692",
    "generic_id": "28",
    "company_id": "87",
    "aky": "aldexds",
    "brand_name": "Aldex DS",
    "form": "Tablet",
    "strength": "400mg",
    "price": "4.00",
    "packsize": "20's pack",
    "company_name": "G. A. Company Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "20.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "929",
    "generic_id": "28",
    "company_id": "91",
    "aky": "alzed",
    "brand_name": "Alzed",
    "form": "Tablet",
    "strength": "400mg",
    "price": "3.30",
    "packsize": "20's pack",
    "company_name": "General Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "20.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "556",
    "generic_id": "28",
    "company_id": "99",
    "aky": "alds",
    "brand_name": "Al DS",
    "form": "Tablet",
    "strength": "400mg",
    "price": "5.00",
    "packsize": "40's pack",
    "company_name": "Globe Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "40.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "621",
    "generic_id": "28",
    "company_id": "119",
    "aky": "albendox",
    "brand_name": "Albendox",
    "form": "Tablet",
    "strength": "400mg",
    "price": "200",
    "packsize": "50's pack",
    "company_name": "Indobangla Pharmaceuticals",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "490",
    "generic_id": "28",
    "company_id": "133",
    "aky": "adze",
    "brand_name": "Adze",
    "form": "Tablet",
    "strength": "400mg",
    "price": "2.00",
    "packsize": "50's pack",
    "company_name": "Kemiko Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "838",
    "generic_id": "28",
    "company_id": "134",
    "aky": "almin",
    "brand_name": "Almin",
    "form": "Suspension",
    "strength": "200mg\/5ml",
    "price": "15.00",
    "packsize": "10 ml bot",
    "company_name": "Kumudini Pharma Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "1.00",
    "ext": "10ml",
    "unite": "bot"
},
{
    "brand_id": "839",
    "generic_id": "28",
    "company_id": "134",
    "aky": "almin",
    "brand_name": "Almin",
    "form": "Tablet",
    "strength": "400mg",
    "price": "4.00",
    "packsize": "50's pack",
    "company_name": "Kumudini Pharma Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "645",
    "generic_id": "28",
    "company_id": "147",
    "aky": "albrex",
    "brand_name": "Albrex",
    "form": "Tablet",
    "strength": "400mg",
    "price": "175",
    "packsize": "50's pack",
    "company_name": "Medimet Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "601",
    "generic_id": "28",
    "company_id": "163",
    "aky": "alba",
    "brand_name": "Alba",
    "form": "Tablet",
    "strength": "400mg",
    "price": "4.00",
    "packsize": "50's pack",
    "company_name": "Navana Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "2826",
    "generic_id": "28",
    "company_id": "171",
    "aky": "benfast",
    "brand_name": "Benfast",
    "form": "Tablet",
    "strength": "400mg",
    "price": "200",
    "packsize": "50's pack",
    "company_name": "Novo Healthcare and Pharma Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "876",
    "generic_id": "28",
    "company_id": "190",
    "aky": "alpro",
    "brand_name": "Alpro",
    "form": "Tablet",
    "strength": "400mg",
    "price": "120",
    "packsize": "30's pack",
    "company_name": "Pharmadesh Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "30.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "4615",
    "generic_id": "28",
    "company_id": "215",
    "aky": "chir-ds",
    "brand_name": "Chir-DS",
    "form": "Tablet",
    "strength": "400mg",
    "price": "5.14",
    "packsize": "10's pack",
    "company_name": "Reliance Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "10.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "708",
    "generic_id": "28",
    "company_id": "219",
    "aky": "alentin",
    "brand_name": "Alentin",
    "form": "Tablet",
    "strength": "200mg",
    "price": null,
    "packsize": "80's pack",
    "company_name": "Renata Limited",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "80.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "709",
    "generic_id": "28",
    "company_id": "219",
    "aky": "alentinds",
    "brand_name": "Alentin DS",
    "form": "Tablet",
    "strength": "400mg",
    "price": "3.35",
    "packsize": "25's pack",
    "company_name": "Renata Limited",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "25.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "1632",
    "generic_id": "28",
    "company_id": "233",
    "aky": "anthel",
    "brand_name": "Anthel",
    "form": "Tablet",
    "strength": "400mg",
    "price": "210",
    "packsize": "50's pack",
    "company_name": "Seema Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "833",
    "generic_id": "28",
    "company_id": "250",
    "aky": "almex",
    "brand_name": "Almex",
    "form": "Suspension",
    "strength": "200mg\/5ml",
    "price": "20.00",
    "packsize": "6's ",
    "company_name": "Square Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "6.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "837",
    "generic_id": "28",
    "company_id": "250",
    "aky": "almex",
    "brand_name": "Almex",
    "form": "Tablet",
    "strength": "400mg",
    "price": "5.02",
    "packsize": "48's pack",
    "company_name": "Square Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "48.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "666",
    "generic_id": "28",
    "company_id": "258",
    "aky": "alda",
    "brand_name": "Alda",
    "form": "Suspension",
    "strength": "200mg\/5ml",
    "price": "15",
    "packsize": "10ml bot",
    "company_name": "Supreme Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "1.00",
    "ext": "10ml",
    "unite": "bot"
},
{
    "brand_id": "667",
    "generic_id": "28",
    "company_id": "258",
    "aky": "aldads",
    "brand_name": "Alda DS",
    "form": "Tablet",
    "strength": "400mg",
    "price": "100",
    "packsize": "25's pack",
    "company_name": "Supreme Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "25.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "694",
    "generic_id": "28",
    "company_id": "260",
    "aky": "aldinds",
    "brand_name": "Aldin DS",
    "form": "Tablet",
    "strength": "400mg",
    "price": "4.00",
    "packsize": "60's pack",
    "company_name": "Techno Drugs Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "60.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "632",
    "generic_id": "28",
    "company_id": "276",
    "aky": "albiconds",
    "brand_name": "Albicon DS",
    "form": "Tablet",
    "strength": "400mg",
    "price": "4.00",
    "packsize": "100's pack",
    "company_name": "White Horse Pharma",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "631",
    "generic_id": "28",
    "company_id": "278",
    "aky": "albezen",
    "brand_name": "Albezen",
    "form": "Tablet",
    "strength": "400mg",
    "price": "180",
    "packsize": "60's pack",
    "company_name": "Zenith Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "60.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "602",
    "generic_id": "28",
    "company_id": "279",
    "aky": "albamaxds",
    "brand_name": "Albamax DS",
    "form": "Tablet",
    "strength": "400mg",
    "price": "4.56",
    "packsize": "100's pack",
    "company_name": "Ziska Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Albendazole",
    "precaution": "Monitor blood counts and liver function. Administer within 7 days of start of normal menstruation in women of childbearing age. Adequate nonhormonal contraceptive measures must be taken during and for 1 mth after therapy. Perform liver function tests and blood counts before and every 2 wk during high dose therapy of hydatid disease.\r\n\r\nLactation: unknown, use caution.",
    "indication": "Helminthiasis, Echinococcosis, Neurocysticercosis, Enterobiasis, Ascariasis, Hookworm infections, Strongyloidiasis, Giardiasis, Filariasis",
    "contra_indication": "Pregnancy and lactation. Neonates. Hypersensitivity, liver impairment.",
    "side_effect": ">10%\r\nHeadache,Neurocysticercosis (11%),Hydatid disease (1.3%),Abnormal LFT,Hydatid disease (15.6%),Neurocysticercosis (<1%)\r\n\r\n1-10%\r\nAbdominal pain,Hydatid disease (6%),Nausea\/vomiting,Hydatid disease (3.7%),Neurocysticercosis (6.2%),Dizziness\/vertigo,Hydatid disease (1.2%),Neurocysticercosis (<1%),Increased intracranial pressure,Neurocysticercosis (1%),Meningeal signs,Neurocysticercosis (1%),Alopecia (reversible),Hydatid disease (1.6%),Neurocysticercosis (<1%),Fever,Hydatid disease (1%)\r\n\r\n<1% (selected)\r\nRash,Urticaria,Agranulocytosis,Aplastic anemia,Bone marrow suppression,Granulocytopenia,Pancytopenia,Thrombocytopenia,Hepatitis,Acute liver failure,Acute renal failure\r\n\r\nPotentially Fatal: Bone marrow depression.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecratory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.",
    "interaction": "Increased serum concentrations w\/ dexamethasone, praziquantel and cimetidine. Decreased serum concentrations w\/ aminoquinoline (antimalarials), carbamazepine, phenobarbital, and phenytoin.",
    "pregnancy_category_note": "",
    "adult_dose": "Echinococcosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses. Max: 800 mg\/day. ?60 kg: 400 mg bid. Admin dose for three 28-day cycles w\/ a 14-day drug-free interval in between each cycle.\r\n\r\nNeurocysticercosis\r\nAdult: <60 kg: 15 mg\/kg daily in 2 divided doses (max: 800 mg\/day) for 8-30 days. ?60 kg: 400 mg bid for 8-30 days.\r\n\r\nAncylostoma, Ascariasis, Hookworm, Trichostrongylus\r\n400 mg PO once\r\n\r\n\r\n\r\n",
    "child_dose": "Child: PO 15 mg\/kg\/day (max 800 mg\/day) q12h",
    "renal_dose": "",
    "administration": "Should be taken with food.",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "702",
    "generic_id": "29",
    "company_id": "37",
    "aky": "alendon",
    "brand_name": "Alendon",
    "form": "Tablet",
    "strength": "10mg",
    "price": "5.00",
    "packsize": "30's pack",
    "company_name": "Beximco Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Alendronic Acid (Alendronate)",
    "precaution": "Upper GI disorders (discontinue if symptoms worsen); history of ulcers, active GI bleeding. Correct vitamin D and calcium deficiency before starting therapy. To be taken half an hr before breakfast and remain upright for at least 30 minutes after admin. Not recommended for use in patients with CrCl <35 ml\/min.\r\n\r\nLactation: Unknown whether drug is excreted in milk; use with caution.",
    "indication": "Osteopetrosis, postmenopausal osteoporosis, Paget's disease of bone.",
    "contra_indication": "Hypocalcaemia; oesophageal abnormalities and factors which delay oesophageal emptying; severe renal impairment; hypersensitivity; inability to stand or sit upright for ?30 min. Pregnancy, lactation.",
    "side_effect": ">10%\r\nHypocalcemia, transient and mild (18%)\r\n\r\n1-10%\r\nHypophosphatemia, transient and mild (10%),Abdominal pain (7%),Musculoskeletal pain (4.1%),Dyspepsia (3.6%),Nausea (3.6%),Constipation (3.1%),Diarrhea (3.1%),Flatulence (2.6%),Headache (2.6%),Acid regurgitation (2%),Esophagitis (1.5%),Abdominal distention (1%)\r\n\r\n<1%\r\nAlopecia,Diaphyseal femur fracture,Esophageal cancer,Flu like syndrome,Gastritis,Myalgia,Oropharyngeal ulceration,Pruritus,Rash,Taste perversion,Toxic epidermal necrolysis,Uveitis,Vertigo,Weakness",
    "pregnancy_category_id": "3",
    "mode_of_action": "Alendronic acid reduces bone resorption by inhibiting the action of osteoclasts.",
    "interaction": "Concomitant iron, calcium supplements and antacids hinder alendronate absorption. Concomitant aspirin or NSAIDs may increase the incidence of adverse GI effects.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Osteoporosis 10 mg\/day or 70 mg once wkly. \r\nPrevention of postmenopausal osteoporosis 5 mg\/day or 35 mg once wkly. \r\nCorticosteroid-induced osteoporosis 5 mg\/day; up to 10 mg\/day in women not on HRT treatment. \r\nPaget's disease of bone 40 mg\/day for 6 mth. May repeat after an interval of 6 mth if needed.\r\n\r\n\r\n",
    "child_dose": "",
    "renal_dose": "Renal impairment:\r\nCrCl (ml\/min) \r\n<35         Not recommended.\r\n\r\n",
    "administration": "Administration\r\nTake only in morning, not at bedtime or before arising\r\n\r\nTake tablet with full glass of water (6-8 oz) at least 30 minutes before first food or drink of day, in upright position\r\n\r\nAdminister oral solution with at least 2 ounces of water\r\n\r\nSwallow with plain water only; mineral water, coffee, juice or other beverages severely reduces bioavailability\r\n\r\nSwallow tablet whole; do not suck or chew\r\n\r\nDo not lie down for 30 minutes after taking drug; sit or stand upright\r\n",
    "packssize": "30.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "703",
    "generic_id": "29",
    "company_id": "37",
    "aky": "alendon70",
    "brand_name": "Alendon 70",
    "form": "Tablet",
    "strength": "70mg",
    "price": "25.00",
    "packsize": "30's pack",
    "company_name": "Beximco Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Alendronic Acid (Alendronate)",
    "precaution": "Upper GI disorders (discontinue if symptoms worsen); history of ulcers, active GI bleeding. Correct vitamin D and calcium deficiency before starting therapy. To be taken half an hr before breakfast and remain upright for at least 30 minutes after admin. Not recommended for use in patients with CrCl <35 ml\/min.\r\n\r\nLactation: Unknown whether drug is excreted in milk; use with caution.",
    "indication": "Osteopetrosis, postmenopausal osteoporosis, Paget's disease of bone.",
    "contra_indication": "Hypocalcaemia; oesophageal abnormalities and factors which delay oesophageal emptying; severe renal impairment; hypersensitivity; inability to stand or sit upright for ?30 min. Pregnancy, lactation.",
    "side_effect": ">10%\r\nHypocalcemia, transient and mild (18%)\r\n\r\n1-10%\r\nHypophosphatemia, transient and mild (10%),Abdominal pain (7%),Musculoskeletal pain (4.1%),Dyspepsia (3.6%),Nausea (3.6%),Constipation (3.1%),Diarrhea (3.1%),Flatulence (2.6%),Headache (2.6%),Acid regurgitation (2%),Esophagitis (1.5%),Abdominal distention (1%)\r\n\r\n<1%\r\nAlopecia,Diaphyseal femur fracture,Esophageal cancer,Flu like syndrome,Gastritis,Myalgia,Oropharyngeal ulceration,Pruritus,Rash,Taste perversion,Toxic epidermal necrolysis,Uveitis,Vertigo,Weakness",
    "pregnancy_category_id": "3",
    "mode_of_action": "Alendronic acid reduces bone resorption by inhibiting the action of osteoclasts.",
    "interaction": "Concomitant iron, calcium supplements and antacids hinder alendronate absorption. Concomitant aspirin or NSAIDs may increase the incidence of adverse GI effects.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Osteoporosis 10 mg\/day or 70 mg once wkly. \r\nPrevention of postmenopausal osteoporosis 5 mg\/day or 35 mg once wkly. \r\nCorticosteroid-induced osteoporosis 5 mg\/day; up to 10 mg\/day in women not on HRT treatment. \r\nPaget's disease of bone 40 mg\/day for 6 mth. May repeat after an interval of 6 mth if needed.\r\n\r\n\r\n",
    "child_dose": "",
    "renal_dose": "Renal impairment:\r\nCrCl (ml\/min) \r\n<35         Not recommended.\r\n\r\n",
    "administration": "Administration\r\nTake only in morning, not at bedtime or before arising\r\n\r\nTake tablet with full glass of water (6-8 oz) at least 30 minutes before first food or drink of day, in upright position\r\n\r\nAdminister oral solution with at least 2 ounces of water\r\n\r\nSwallow with plain water only; mineral water, coffee, juice or other beverages severely reduces bioavailability\r\n\r\nSwallow tablet whole; do not suck or chew\r\n\r\nDo not lie down for 30 minutes after taking drug; sit or stand upright\r\n",
    "packssize": "30.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "3214",
    "generic_id": "29",
    "company_id": "116",
    "aky": "bonemas",
    "brand_name": "Bonemas",
    "form": "Tablet",
    "strength": "70mg",
    "price": "30.00",
    "packsize": "10's pack",
    "company_name": "Incepta Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Alendronic Acid (Alendronate)",
    "precaution": "Upper GI disorders (discontinue if symptoms worsen); history of ulcers, active GI bleeding. Correct vitamin D and calcium deficiency before starting therapy. To be taken half an hr before breakfast and remain upright for at least 30 minutes after admin. Not recommended for use in patients with CrCl <35 ml\/min.\r\n\r\nLactation: Unknown whether drug is excreted in milk; use with caution.",
    "indication": "Osteopetrosis, postmenopausal osteoporosis, Paget's disease of bone.",
    "contra_indication": "Hypocalcaemia; oesophageal abnormalities and factors which delay oesophageal emptying; severe renal impairment; hypersensitivity; inability to stand or sit upright for ?30 min. Pregnancy, lactation.",
    "side_effect": ">10%\r\nHypocalcemia, transient and mild (18%)\r\n\r\n1-10%\r\nHypophosphatemia, transient and mild (10%),Abdominal pain (7%),Musculoskeletal pain (4.1%),Dyspepsia (3.6%),Nausea (3.6%),Constipation (3.1%),Diarrhea (3.1%),Flatulence (2.6%),Headache (2.6%),Acid regurgitation (2%),Esophagitis (1.5%),Abdominal distention (1%)\r\n\r\n<1%\r\nAlopecia,Diaphyseal femur fracture,Esophageal cancer,Flu like syndrome,Gastritis,Myalgia,Oropharyngeal ulceration,Pruritus,Rash,Taste perversion,Toxic epidermal necrolysis,Uveitis,Vertigo,Weakness",
    "pregnancy_category_id": "3",
    "mode_of_action": "Alendronic acid reduces bone resorption by inhibiting the action of osteoclasts.",
    "interaction": "Concomitant iron, calcium supplements and antacids hinder alendronate absorption. Concomitant aspirin or NSAIDs may increase the incidence of adverse GI effects.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Osteoporosis 10 mg\/day or 70 mg once wkly. \r\nPrevention of postmenopausal osteoporosis 5 mg\/day or 35 mg once wkly. \r\nCorticosteroid-induced osteoporosis 5 mg\/day; up to 10 mg\/day in women not on HRT treatment. \r\nPaget's disease of bone 40 mg\/day for 6 mth. May repeat after an interval of 6 mth if needed.\r\n\r\n\r\n",
    "child_dose": "",
    "renal_dose": "Renal impairment:\r\nCrCl (ml\/min) \r\n<35         Not recommended.\r\n\r\n",
    "administration": "Administration\r\nTake only in morning, not at bedtime or before arising\r\n\r\nTake tablet with full glass of water (6-8 oz) at least 30 minutes before first food or drink of day, in upright position\r\n\r\nAdminister oral solution with at least 2 ounces of water\r\n\r\nSwallow with plain water only; mineral water, coffee, juice or other beverages severely reduces bioavailability\r\n\r\nSwallow tablet whole; do not suck or chew\r\n\r\nDo not lie down for 30 minutes after taking drug; sit or stand upright\r\n",
    "packssize": "10.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "3215",
    "generic_id": "30",
    "company_id": "116",
    "aky": "bonemassd",
    "brand_name": "Bonemass D",
    "form": "Tablet",
    "strength": " ",
    "price": "30.00",
    "packsize": " 10's pack",
    "company_name": "Incepta Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Alendronic Acid + Vitamin D3",
    "precaution": "Upper GI disorders (discontinue if symptoms worsen); history of ulcers, active GI bleeding. Correct vitamin D and calcium deficiency before starting therapy. To be taken half an hr before breakfast and remain upright for at least 30 minutes after admin. Not recommended for use in patients with CrCl <35 ml\/min.",
    "indication": "Osteopetrosis, postmenopausal osteoporosis, Paget's disease of bone       \r\n",
    "contra_indication": "Hypocalcaemia; oesophageal abnormalities and factors which delay oesophageal emptying; severe renal impairment; hypersensitivity; inability to stand or sit upright for <30 min. Pregnancy, lactation.",
    "side_effect": "The most common side-effect is digestive reactions. These reactions include irritation, inflammation, or ulcers of the esophagus, which may sometimes bleed. This may occur especially if patients do not drink a full glass of water or if they lie down in less than 30 minutes or before their first food of the day. \r\n\r\nLess common side-effects are nausea, vomiting, a full or bloated feeling in the stomach, constipation, diarrhea, black or bloody stools, gas, headache, a changed sense of taste, and bone, muscle, or joint pain.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Alendronic acid reduces bone resorption by inhibiting the action of osteoclasts.",
    "interaction": "Concomitant iron, calcium supplements and antacids hinder alendronate absorption. Concomitant aspirin or NSAIDs may increase the incidence of adverse GI effects.",
    "pregnancy_category_note": "",
    "adult_dose": "Treatment of osteoporosis in postmenopausal women: One tablet once weekly.\r\nTreatment to increase bonemass in men with osteoporosis: One tablet once weekly.\r\n\r\nHepatic Impairment No dosage adjustment needed.",
    "child_dose": "",
    "renal_dose": "Dosing in elderly and renal insufficiency: No dosage adjustment is necessary for the elderly or for patients with mild-to-moderate renal insufficiency (creatinine clearance 35 to 60 mL\/min).  \r\nCrCl (ml\/min) \r\n<35          Not recommended.",
    "administration": "",
    "packssize": "10.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "911",
    "generic_id": "34",
    "company_id": "116",
    "aky": "alurol",
    "brand_name": "Alurol",
    "form": "Tablet",
    "strength": "100mg",
    "price": "4.00",
    "packsize": "100's pack",
    "company_name": "Incepta Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Allopurinol",
    "precaution": "Ensure adequate fluid intake. Prophylactically with an anti-inflammatory or colchicine for at least 1 mth. Withdraw immediately when sensitivity (skin rash, etc) appears. Pregnancy, lactation. Hepatic and renal impairment.\r\n\r\nLactation: Agent is distributed into breast milk; use with caution.",
    "indication": "Hyperuricaemia, Uric acid nephropathy, Cancer therapy-induced hyperuricaemia, Gout, Recurrent renal stones",
    "contra_indication": "Hypersensitivity; acute attack of gout.",
    "side_effect": "1-10%\r\nRash (1.5%),Nausea (1.3%),Renal failure (1.2%),Vomiting (1.2%)\r\n\r\nFrequency Not Defined\r\nAmblyopia,Arthralgias,Blood dyscrasias,Bronchospasm,Cardiovascular abnormalities,Cataracts,Confusion,Decrease in libido,Dizziness,Ecchymosis,Electrolyte abnormalities,Epistaxis,Foot drop,Hematuria,Hepatotoxicity,Hypotonia,Iritis,Kidney function abnormality,Macular retinitis,Malaise,Neuritis,Pharyngitis,Pruritus,Skin edema,Stevens-Johnson syndrome,Sweating,Tinnitus\r\n\r\nPotentially Fatal: Stevens-Jonhson and\/or Lyell's Syndrome (urticaria, fever, lymphadenopathy, arthralgia). Occasionally, thrombocytopaenia, agranulocytosis and aplastic anaemia.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Allopurinol is an inhibitor of the enzyme xanthine oxidase which converts hypoxanthine to xanthine then uric acid. The reduced production of uric acid relieves all symptoms associated with hyperuricaemia and gout. Inhibition of xanthine oxidase leads to accumulation of its substrates hypoxanthine and xanthine but since their renal clearance is more than 10 times that of uric acid, there is no risk of nephrolithiasis.",
    "interaction": "May inhibit the metabolism of mercaptopurine and azathioprine; reduce dose of mercaptopurine and azathioprine when given w\/ allopurinol. May increase effect of warfarin and other coumarin anticoagulants. Increased excretion of the oxipurinol (metabolite) w\/ salicylates or uricosuric agents. Increased toxicity w\/ thiazide diuretics, some antibacterials, other antineoplastics, ciclosporin, some sulfonylurea antidiabetics, theophylline and vidarabine.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Gout; Hyperuricaemia \r\nMild: 100 mg\/day PO initially; increased weekly to 200-300 mg\/day\r\n\r\nModerate to severe: 100 mg\/day PO initially; increased weekly to 400-600 mg\/day\r\n\r\nPrevention of hyperuricaemia associated w\/ chemotherapy treatment or enzyme disorders 600-800 mg\/day, starting 2-3 days before cancer treatment. \r\n\r\nHepatic impairment: Dose reduction may be needed. Monitor liver function regularly.\r\n\r\n",
    "child_dose": "",
    "renal_dose": "Renal impairment: Haemodialysis: Administer dose after session or administer 50% supplemental dose.\r\n\r\nCrCl (ml\/min) \r\n10-20 200 mg daily.\r\n<3 100 mg daily at extended intervals.\r\n3-10  100 mg daily.",
    "administration": "Administration Should be taken with food. Take immediately after meals.\r\n",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "910",
    "generic_id": "34",
    "company_id": "244",
    "aky": "aluric",
    "brand_name": "Aluric",
    "form": "Tablet",
    "strength": "100mg",
    "price": "410",
    "packsize": "100's pack",
    "company_name": "Sonear Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Allopurinol",
    "precaution": "Ensure adequate fluid intake. Prophylactically with an anti-inflammatory or colchicine for at least 1 mth. Withdraw immediately when sensitivity (skin rash, etc) appears. Pregnancy, lactation. Hepatic and renal impairment.\r\n\r\nLactation: Agent is distributed into breast milk; use with caution.",
    "indication": "Hyperuricaemia, Uric acid nephropathy, Cancer therapy-induced hyperuricaemia, Gout, Recurrent renal stones",
    "contra_indication": "Hypersensitivity; acute attack of gout.",
    "side_effect": "1-10%\r\nRash (1.5%),Nausea (1.3%),Renal failure (1.2%),Vomiting (1.2%)\r\n\r\nFrequency Not Defined\r\nAmblyopia,Arthralgias,Blood dyscrasias,Bronchospasm,Cardiovascular abnormalities,Cataracts,Confusion,Decrease in libido,Dizziness,Ecchymosis,Electrolyte abnormalities,Epistaxis,Foot drop,Hematuria,Hepatotoxicity,Hypotonia,Iritis,Kidney function abnormality,Macular retinitis,Malaise,Neuritis,Pharyngitis,Pruritus,Skin edema,Stevens-Johnson syndrome,Sweating,Tinnitus\r\n\r\nPotentially Fatal: Stevens-Jonhson and\/or Lyell's Syndrome (urticaria, fever, lymphadenopathy, arthralgia). Occasionally, thrombocytopaenia, agranulocytosis and aplastic anaemia.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Allopurinol is an inhibitor of the enzyme xanthine oxidase which converts hypoxanthine to xanthine then uric acid. The reduced production of uric acid relieves all symptoms associated with hyperuricaemia and gout. Inhibition of xanthine oxidase leads to accumulation of its substrates hypoxanthine and xanthine but since their renal clearance is more than 10 times that of uric acid, there is no risk of nephrolithiasis.",
    "interaction": "May inhibit the metabolism of mercaptopurine and azathioprine; reduce dose of mercaptopurine and azathioprine when given w\/ allopurinol. May increase effect of warfarin and other coumarin anticoagulants. Increased excretion of the oxipurinol (metabolite) w\/ salicylates or uricosuric agents. Increased toxicity w\/ thiazide diuretics, some antibacterials, other antineoplastics, ciclosporin, some sulfonylurea antidiabetics, theophylline and vidarabine.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Gout; Hyperuricaemia \r\nMild: 100 mg\/day PO initially; increased weekly to 200-300 mg\/day\r\n\r\nModerate to severe: 100 mg\/day PO initially; increased weekly to 400-600 mg\/day\r\n\r\nPrevention of hyperuricaemia associated w\/ chemotherapy treatment or enzyme disorders 600-800 mg\/day, starting 2-3 days before cancer treatment. \r\n\r\nHepatic impairment: Dose reduction may be needed. Monitor liver function regularly.\r\n\r\n",
    "child_dose": "",
    "renal_dose": "Renal impairment: Haemodialysis: Administer dose after session or administer 50% supplemental dose.\r\n\r\nCrCl (ml\/min) \r\n10-20 200 mg daily.\r\n<3 100 mg daily at extended intervals.\r\n3-10  100 mg daily.",
    "administration": "Administration Should be taken with food. Take immediately after meals.\r\n",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "812",
    "generic_id": "35",
    "company_id": "174",
    "aky": "allygest",
    "brand_name": "Allygest",
    "form": "Tablet",
    "strength": "5mg",
    "price": "7.72",
    "packsize": "30's pack",
    "company_name": "Nuvista Pharma Ltd",
    "company_order": "0",
    "generic_name": "Allystrenol",
    "precaution": "Discontinue medications if there is sudden partial or complete loss of vision, proptosis or diplopia; migraine and embolic disorders; epilepsy, migraine, asthma, cardiac or renal dysfunction. History of depression, glucose tolerance and diabetic patients. My impair ability to drive operate machinery. Sudden withdrawal of allyloestrenol should be avoided as it leads to intermittent breakthrough bleeding; lactation.\r\n\r\nPregnancy category: Not classified but clinically it is proven that Allylestrenol is safe during pregnancy & has no teratogenic effect on fetus in any trimester.",
    "indication": "Threatened miscarriage, Premature labor",
    "contra_indication": "Hypersensitivity; thrombophleobitis; undiagnosed vag bleeding, incomplete abortion, hormone-dependent carcinoma, cerebral apoplexy, as a diagnostic test for pregnancy; severe hepatic impairment.",
    "side_effect": "GI disturbances, appetite\/weight change; fluid retention, oedema; acnes, skin rash, urticaria; depression, headache, fever, fatigue; breast changes, hirsutism, changes in libido, altered menstrual cycles or irregular menstrual bleeding (rare).",
    "pregnancy_category_id": "0",
    "mode_of_action": "Allylestrenol is similar to that of natural progesterone. It prepares the uterus for receiving the fertilised ovum and suppresses uterine motility.",
    "interaction": "Enhanced clearance with enzyme-inducing drugs eg, carbamazepine, griseofulvin, phenobarbital, phenytoin and rifampicin. Ketoconazole may increase bioavailability of progesterone.\r\n\r\nPotentially Fatal: Increased ciclosporin concentration.",
    "pregnancy_category_note": "clinically it is proven that Allylestrenol is safe during pregnancy & has no teratogenic effect on fetus in any trimester.",
    "adult_dose": "Adult: PO 5 mg 3 times\/day for 5-7 days.\r\n\r\n",
    "child_dose": "",
    "renal_dose": "",
    "administration": "Administration May be taken with or without food. May be taken w\/ meals if GI upset occurs.",
    "packssize": "30.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "813",
    "generic_id": "35",
    "company_id": "198",
    "aky": "allynol",
    "brand_name": "Allynol",
    "form": "Tablet",
    "strength": "5mg",
    "price": "8.00",
    "packsize": "45's pack",
    "company_name": "Popular Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Allystrenol",
    "precaution": "Discontinue medications if there is sudden partial or complete loss of vision, proptosis or diplopia; migraine and embolic disorders; epilepsy, migraine, asthma, cardiac or renal dysfunction. History of depression, glucose tolerance and diabetic patients. My impair ability to drive operate machinery. Sudden withdrawal of allyloestrenol should be avoided as it leads to intermittent breakthrough bleeding; lactation.\r\n\r\nPregnancy category: Not classified but clinically it is proven that Allylestrenol is safe during pregnancy & has no teratogenic effect on fetus in any trimester.",
    "indication": "Threatened miscarriage, Premature labor",
    "contra_indication": "Hypersensitivity; thrombophleobitis; undiagnosed vag bleeding, incomplete abortion, hormone-dependent carcinoma, cerebral apoplexy, as a diagnostic test for pregnancy; severe hepatic impairment.",
    "side_effect": "GI disturbances, appetite\/weight change; fluid retention, oedema; acnes, skin rash, urticaria; depression, headache, fever, fatigue; breast changes, hirsutism, changes in libido, altered menstrual cycles or irregular menstrual bleeding (rare).",
    "pregnancy_category_id": "0",
    "mode_of_action": "Allylestrenol is similar to that of natural progesterone. It prepares the uterus for receiving the fertilised ovum and suppresses uterine motility.",
    "interaction": "Enhanced clearance with enzyme-inducing drugs eg, carbamazepine, griseofulvin, phenobarbital, phenytoin and rifampicin. Ketoconazole may increase bioavailability of progesterone.\r\n\r\nPotentially Fatal: Increased ciclosporin concentration.",
    "pregnancy_category_note": "clinically it is proven that Allylestrenol is safe during pregnancy & has no teratogenic effect on fetus in any trimester.",
    "adult_dose": "Adult: PO 5 mg 3 times\/day for 5-7 days.\r\n\r\n",
    "child_dose": "",
    "renal_dose": "",
    "administration": "Administration May be taken with or without food. May be taken w\/ meals if GI upset occurs.",
    "packssize": "45.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "604",
    "generic_id": "36",
    "company_id": "71",
    "aky": "albasine",
    "brand_name": "Albasine",
    "form": "Tablet",
    "strength": "30 mg + 10 mg",
    "price": "12.05",
    "packsize": "28's pack",
    "company_name": "Drug International Ltd.",
    "company_order": "0",
    "generic_name": "Almitrine Bismesylate + Raubasine",
    "precaution": "Pregnancy. Long term treatment may result in numbness, prickling or formication effects in the lower limbs which may, in rare cases, lead to treatment withdrawal.",
    "indication": "Cerebrovascular insufficiency, Functional rehabilitation after cerebrovascular accidents, Auditory, Vestibular and visual disorders of ischaemic aetiology, Stroke",
    "contra_indication": "Concurrent usage with MAOIs.",
    "side_effect": "Mild GI disorders, sleep disturbances, palpitations, anxiety, dizziness. \r\n\r\nRarely, wt loss, peripheral neuropathy with abnormal sensations in the lower limbs.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Almitrine and raubasine work together to increase the amount of oxygen brought to the brain and neurosensory tissue, by increasing the oxygen content of arterial blood.",
    "interaction": "Not to be used concurrently with other almitrine-containing preparations.\r\n\r\nPotentially Fatal: MAOIs.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO \r\nAuditory, vestibular and visual disorders of ischaemic aetiology; Cerebrovascular insufficiency; Functional rehabilitation after cerebrovascular accidents \r\nPer tab contains almitrine 30 mg and raubasine 10 mg: \r\n1 tab twice daily.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "",
    "packssize": "28.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "898",
    "generic_id": "37",
    "company_id": "167",
    "aky": "altrip",
    "brand_name": "Altrip",
    "form": "Tablet",
    "strength": "6.25mg",
    "price": "25.08",
    "packsize": "10's pack",
    "company_name": "NIPRO JMI Pharma Limited",
    "company_order": "0",
    "generic_name": "Almotriptan",
    "precaution": "Hypersensitivity to sulfonamides. Hepatic or moderate-severe renal impairment. Caution when used in patients with a history of seizures. May significantly increase BP. May cause drowsiness. Children <18 yr. Pregnancy, lactation.\r\n\r\nLactation: excretion in milk unknown; use with caution",
    "indication": "Migraine headache, Acute migraine attacks",
    "contra_indication": "Underlying CV disease e.g. ischaemic heart disease or coronary artery vasospasm. Uncontrolled hypertension. Severe hepatic or renal impairment. Prophylaxis of migraine, hemiplegic or basilar migraine; cluster headache. Use within 24 hr of another 5-HT1 agonist; use within 24 hr of ergotamine derivative; concurrent use or within 2 wk of discontinuing an MAOI.",
    "side_effect": "1-10%\r\nSomnolence (1-5%),Dizziness (3-4%),Nausea (1-3%),Vomiting (2%),Dry mouth (1-2%),Headache (1-2%),Nausea (1-2%),Paresthesia (1-2%),Paresthesia (1%),Somnolence (>1%)\r\n\r\n<1%\r\nInfrequent (0.01-0.001%)\r\nAnxiety, asthenia, chills, CNS stimulation, fatigue, hypesthesia, tremor, Pruitus, rash, Diaphoresis, dysmenorrhea, hyperglycemia, increased thirst, Abdominal cramp, gastroenteritis\r\nBack pain, myalgia, neck pain, rigid neck, Increased CPK, Bronchitis, chest pain, dyspnea, pharyngitis, rhinitis, sinusitis, Conjunctivitis, tinnitis, vertigo\r\n\r\nPotentially Fatal: Serious cardiac events.",
    "pregnancy_category_id": "3",
    "mode_of_action": "Almotriptan is a selective serotonin agonist which acts mainly on the 5-HT1 receptors and produces cranial vasodilation. It is used for the acute treatment of migraine.",
    "interaction": "Increased risk of serotonin syndrome when used with SSRIs or serotonin norepinephrine reuptake inhibitors. Increased plasma concentrations when used with verapamil, ketoconazole or other potent CYP450 inhibitors.\r\n\r\nPotentially Fatal: Severe vasospastic reactions may occur when given within 24 hr of treatment with another 5-HT1 agonist, or an ergotamine-containing or ergot-like medication. Avoid usage with or within 2 wk of stopping treatment with a MAOI.",
    "pregnancy_category_note": "",
    "adult_dose": "Oral\r\nAcute migraine attacks\r\nAdult: Initially, 6.25-12.5 mg. May repeat 2 hr later if needed. Max: 2 doses\/24 hr.\r\n\r\nHepatic Impairment Initially, 6.25 mg as a single dose. Max: 12.5 mg\/24 hr. Avoid in severe impairment.\r\n\r\n",
    "child_dose": "Oral\r\nChild: Migraine\r\nIndicated for acute treatment of migraine headache pain in adolescents with a history of migraine attacks with or without aura usually lasting >4 hr (when untreated)\r\n\r\n<12 years: Safety and efficacy not established\r\n>12 years: 6.25-12.5 mg PO at onset of headache; may repeat once after 2 hr\r\n\r\nNot to exceed 25 mg\/day\r\n",
    "renal_dose": "Renal Impairment Initially, 6.25 mg as a single dose. Max: 12.5 mg\/24 hr.",
    "administration": "May be taken with or without food.",
    "packssize": "10.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "864",
    "generic_id": "38",
    "company_id": "23",
    "aky": "alpam",
    "brand_name": "Alpam",
    "form": "Tablet",
    "strength": "0.25mg",
    "price": "1.00",
    "packsize": "100's pack",
    "company_name": "Asiatic Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Alprazolam",
    "precaution": "Dosage reduction or gradual withdrawal. Dependence. Geriatric or debilitated patients. Muscle weakness, impaired hepatic or renal function; arteriosclerosis; obesity; depression particularly suicidal tendency; chronic pulmonary insufficiency. May impair ability to drive or operate machinery. Children <18 yr.\r\n\r\nLactation: Enters breast milk\/not recommended",
    "indication": "Anxiety disorders, Panic disorders, Nausea due to chemotherapy",
    "contra_indication": "Acute narrow-angle glaucoma, preexisting CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; pregnancy, lactation.",
    "side_effect": ">10% (4 mg dose)\r\nDrowsiness (41%),Depression (10-15%),Headache (10-15%),Constipation (10-15%),Diarrhea (10-15%),Dry mouth (10-15%)\r\n\r\n>10% (10 mg dose)\r\nDrowsiness (77%),Impaired coordination (40-50%),Increased appetite (30-35%),Fatigue (30-35%),Memory impairment (30-35%),Irritability (30-35%),Decreased salivation (30-35%),Cognitive disorders (20-30%),Insomnia (20-30%),Dcreased appetite (20-30%),Headache (20-30%),Lightheadedness (20-30%),Dysarthria (20-30%),Diarrhea, constipation, and nausea\/vomiting (20-30%),Weight change (20-30%),Nasal congestion (15-20%),Decreased or increased libido (10-15%),Menstrual disorder (10-15%),Difficult micturition (10-15%)\r\n\r\n1-10% (4 mg dose)\r\nTachycardia (5-10%),Confusion (5-10%),Insomnia (5-10%),Nausea\/vomiting (5-10%),Blurred vision (5-10%),Nasal congestion (5-10%),Hypotension (1-5%),Syncope (1-5%),Akathisia (1-5%),Dizziness (1-5%),Increased salivation (1-5%),Nervousness (1-5%),Tremor (1-5%),Weight change (1-5%)\r\n\r\n1-10% (10 mg dose)\r\nIncreased salivation (5-10%),Talkativeness (1-5%),Incontinence (1-5%)\r\n\r\nPotentially Fatal: Blood dyscrasias.",
    "pregnancy_category_id": "4",
    "mode_of_action": "Alprazolam has anxiolytic, muscle-relaxant, anticonvulsant, antidepressant and sleep-modifying effects. It binds to the ? aminobutyric acid (GABA)-specific sites throughout the CNS, leading to an increase in the inhibitory effect of GABA on neuronal excitability. Increased neuronal permeability to chloride ions thus results in hyperpolarisation and stabilisation.",
    "interaction": "Potentiates action of alcohol and CNS depressants. Reduced conc with cigarette smoking by 50%.\r\n\r\nPotentially Fatal: Cimetidine and fluoxetine reduce the clearance of alprazolam. Alprazolam enhances activity of imipramine and desipramine. ",
    "pregnancy_category_note": "",
    "adult_dose": "Oral\r\nShort-term management of anxiety\r\nAdult: 0.25-0.5 mg tid, increased to 3-4 mg daily if necessary.\r\nElderly: Initially, 0.25 mg bid\/tid.\r\n\r\nPanic attacks\r\nAdult\r\nImmediate-release\r\n0.5 mg PO q8hr; may increase q3-4Days by ?1 mg\/day\r\nAverage dose: 5-6 mg\/day PO\r\nMay require up to 10 mg\/day PO divided q8hr \r\n\r\nExtended-release\r\n0.5-1 mg PO qDay; may increase q3-4Days by <1 mg\/day\r\nAverage dose: 3-6 mg PO qDay\r\n\r\nAnxiety Associated With Depression\r\n1-4 mg\/day PO divided q8hr\r\n\r\nHepatic impairment: Avoid in severe impairment.",
    "child_dose": "<18 years old: Not recommended",
    "renal_dose": "Renal impairment: Use caution; not studied\r\n\r\n\r\n",
    "administration": "Administration May be taken with or without food. Side effects eg sleepiness\/drowsiness may be reduced if taken immediately after meals.",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "865",
    "generic_id": "38",
    "company_id": "23",
    "aky": "alpam",
    "brand_name": "Alpam",
    "form": "Tablet",
    "strength": "0.5mg",
    "price": "2.00",
    "packsize": "50's pack",
    "company_name": "Asiatic Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Alprazolam",
    "precaution": "Dosage reduction or gradual withdrawal. Dependence. Geriatric or debilitated patients. Muscle weakness, impaired hepatic or renal function; arteriosclerosis; obesity; depression particularly suicidal tendency; chronic pulmonary insufficiency. May impair ability to drive or operate machinery. Children <18 yr.\r\n\r\nLactation: Enters breast milk\/not recommended",
    "indication": "Anxiety disorders, Panic disorders, Nausea due to chemotherapy",
    "contra_indication": "Acute narrow-angle glaucoma, preexisting CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; pregnancy, lactation.",
    "side_effect": ">10% (4 mg dose)\r\nDrowsiness (41%),Depression (10-15%),Headache (10-15%),Constipation (10-15%),Diarrhea (10-15%),Dry mouth (10-15%)\r\n\r\n>10% (10 mg dose)\r\nDrowsiness (77%),Impaired coordination (40-50%),Increased appetite (30-35%),Fatigue (30-35%),Memory impairment (30-35%),Irritability (30-35%),Decreased salivation (30-35%),Cognitive disorders (20-30%),Insomnia (20-30%),Dcreased appetite (20-30%),Headache (20-30%),Lightheadedness (20-30%),Dysarthria (20-30%),Diarrhea, constipation, and nausea\/vomiting (20-30%),Weight change (20-30%),Nasal congestion (15-20%),Decreased or increased libido (10-15%),Menstrual disorder (10-15%),Difficult micturition (10-15%)\r\n\r\n1-10% (4 mg dose)\r\nTachycardia (5-10%),Confusion (5-10%),Insomnia (5-10%),Nausea\/vomiting (5-10%),Blurred vision (5-10%),Nasal congestion (5-10%),Hypotension (1-5%),Syncope (1-5%),Akathisia (1-5%),Dizziness (1-5%),Increased salivation (1-5%),Nervousness (1-5%),Tremor (1-5%),Weight change (1-5%)\r\n\r\n1-10% (10 mg dose)\r\nIncreased salivation (5-10%),Talkativeness (1-5%),Incontinence (1-5%)\r\n\r\nPotentially Fatal: Blood dyscrasias.",
    "pregnancy_category_id": "4",
    "mode_of_action": "Alprazolam has anxiolytic, muscle-relaxant, anticonvulsant, antidepressant and sleep-modifying effects. It binds to the ? aminobutyric acid (GABA)-specific sites throughout the CNS, leading to an increase in the inhibitory effect of GABA on neuronal excitability. Increased neuronal permeability to chloride ions thus results in hyperpolarisation and stabilisation.",
    "interaction": "Potentiates action of alcohol and CNS depressants. Reduced conc with cigarette smoking by 50%.\r\n\r\nPotentially Fatal: Cimetidine and fluoxetine reduce the clearance of alprazolam. Alprazolam enhances activity of imipramine and desipramine. ",
    "pregnancy_category_note": "",
    "adult_dose": "Oral\r\nShort-term management of anxiety\r\nAdult: 0.25-0.5 mg tid, increased to 3-4 mg daily if necessary.\r\nElderly: Initially, 0.25 mg bid\/tid.\r\n\r\nPanic attacks\r\nAdult\r\nImmediate-release\r\n0.5 mg PO q8hr; may increase q3-4Days by ?1 mg\/day\r\nAverage dose: 5-6 mg\/day PO\r\nMay require up to 10 mg\/day PO divided q8hr \r\n\r\nExtended-release\r\n0.5-1 mg PO qDay; may increase q3-4Days by <1 mg\/day\r\nAverage dose: 3-6 mg PO qDay\r\n\r\nAnxiety Associated With Depression\r\n1-4 mg\/day PO divided q8hr\r\n\r\nHepatic impairment: Avoid in severe impairment.",
    "child_dose": "<18 years old: Not recommended",
    "renal_dose": "Renal impairment: Use caution; not studied\r\n\r\n\r\n",
    "administration": "Administration May be taken with or without food. Side effects eg sleepiness\/drowsiness may be reduced if taken immediately after meals.",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "871",
    "generic_id": "38",
    "company_id": "178",
    "aky": "alprax",
    "brand_name": "Alprax",
    "form": "Tablet",
    "strength": "0.25mg",
    "price": "1.00",
    "packsize": "50's pack",
    "company_name": "Opsonin Pharma Limited",
    "company_order": "0",
    "generic_name": "Alprazolam",
    "precaution": "Dosage reduction or gradual withdrawal. Dependence. Geriatric or debilitated patients. Muscle weakness, impaired hepatic or renal function; arteriosclerosis; obesity; depression particularly suicidal tendency; chronic pulmonary insufficiency. May impair ability to drive or operate machinery. Children <18 yr.\r\n\r\nLactation: Enters breast milk\/not recommended",
    "indication": "Anxiety disorders, Panic disorders, Nausea due to chemotherapy",
    "contra_indication": "Acute narrow-angle glaucoma, preexisting CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; pregnancy, lactation.",
    "side_effect": ">10% (4 mg dose)\r\nDrowsiness (41%),Depression (10-15%),Headache (10-15%),Constipation (10-15%),Diarrhea (10-15%),Dry mouth (10-15%)\r\n\r\n>10% (10 mg dose)\r\nDrowsiness (77%),Impaired coordination (40-50%),Increased appetite (30-35%),Fatigue (30-35%),Memory impairment (30-35%),Irritability (30-35%),Decreased salivation (30-35%),Cognitive disorders (20-30%),Insomnia (20-30%),Dcreased appetite (20-30%),Headache (20-30%),Lightheadedness (20-30%),Dysarthria (20-30%),Diarrhea, constipation, and nausea\/vomiting (20-30%),Weight change (20-30%),Nasal congestion (15-20%),Decreased or increased libido (10-15%),Menstrual disorder (10-15%),Difficult micturition (10-15%)\r\n\r\n1-10% (4 mg dose)\r\nTachycardia (5-10%),Confusion (5-10%),Insomnia (5-10%),Nausea\/vomiting (5-10%),Blurred vision (5-10%),Nasal congestion (5-10%),Hypotension (1-5%),Syncope (1-5%),Akathisia (1-5%),Dizziness (1-5%),Increased salivation (1-5%),Nervousness (1-5%),Tremor (1-5%),Weight change (1-5%)\r\n\r\n1-10% (10 mg dose)\r\nIncreased salivation (5-10%),Talkativeness (1-5%),Incontinence (1-5%)\r\n\r\nPotentially Fatal: Blood dyscrasias.",
    "pregnancy_category_id": "4",
    "mode_of_action": "Alprazolam has anxiolytic, muscle-relaxant, anticonvulsant, antidepressant and sleep-modifying effects. It binds to the ? aminobutyric acid (GABA)-specific sites throughout the CNS, leading to an increase in the inhibitory effect of GABA on neuronal excitability. Increased neuronal permeability to chloride ions thus results in hyperpolarisation and stabilisation.",
    "interaction": "Potentiates action of alcohol and CNS depressants. Reduced conc with cigarette smoking by 50%.\r\n\r\nPotentially Fatal: Cimetidine and fluoxetine reduce the clearance of alprazolam. Alprazolam enhances activity of imipramine and desipramine. ",
    "pregnancy_category_note": "",
    "adult_dose": "Oral\r\nShort-term management of anxiety\r\nAdult: 0.25-0.5 mg tid, increased to 3-4 mg daily if necessary.\r\nElderly: Initially, 0.25 mg bid\/tid.\r\n\r\nPanic attacks\r\nAdult\r\nImmediate-release\r\n0.5 mg PO q8hr; may increase q3-4Days by ?1 mg\/day\r\nAverage dose: 5-6 mg\/day PO\r\nMay require up to 10 mg\/day PO divided q8hr \r\n\r\nExtended-release\r\n0.5-1 mg PO qDay; may increase q3-4Days by <1 mg\/day\r\nAverage dose: 3-6 mg PO qDay\r\n\r\nAnxiety Associated With Depression\r\n1-4 mg\/day PO divided q8hr\r\n\r\nHepatic impairment: Avoid in severe impairment.",
    "child_dose": "<18 years old: Not recommended",
    "renal_dose": "Renal impairment: Use caution; not studied\r\n\r\n\r\n",
    "administration": "Administration May be taken with or without food. Side effects eg sleepiness\/drowsiness may be reduced if taken immediately after meals.",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "872",
    "generic_id": "38",
    "company_id": "178",
    "aky": "alprax",
    "brand_name": "Alprax",
    "form": "Tablet",
    "strength": "0.5mg",
    "price": "2.01",
    "packsize": "50's pack",
    "company_name": "Opsonin Pharma Limited",
    "company_order": "0",
    "generic_name": "Alprazolam",
    "precaution": "Dosage reduction or gradual withdrawal. Dependence. Geriatric or debilitated patients. Muscle weakness, impaired hepatic or renal function; arteriosclerosis; obesity; depression particularly suicidal tendency; chronic pulmonary insufficiency. May impair ability to drive or operate machinery. Children <18 yr.\r\n\r\nLactation: Enters breast milk\/not recommended",
    "indication": "Anxiety disorders, Panic disorders, Nausea due to chemotherapy",
    "contra_indication": "Acute narrow-angle glaucoma, preexisting CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; pregnancy, lactation.",
    "side_effect": ">10% (4 mg dose)\r\nDrowsiness (41%),Depression (10-15%),Headache (10-15%),Constipation (10-15%),Diarrhea (10-15%),Dry mouth (10-15%)\r\n\r\n>10% (10 mg dose)\r\nDrowsiness (77%),Impaired coordination (40-50%),Increased appetite (30-35%),Fatigue (30-35%),Memory impairment (30-35%),Irritability (30-35%),Decreased salivation (30-35%),Cognitive disorders (20-30%),Insomnia (20-30%),Dcreased appetite (20-30%),Headache (20-30%),Lightheadedness (20-30%),Dysarthria (20-30%),Diarrhea, constipation, and nausea\/vomiting (20-30%),Weight change (20-30%),Nasal congestion (15-20%),Decreased or increased libido (10-15%),Menstrual disorder (10-15%),Difficult micturition (10-15%)\r\n\r\n1-10% (4 mg dose)\r\nTachycardia (5-10%),Confusion (5-10%),Insomnia (5-10%),Nausea\/vomiting (5-10%),Blurred vision (5-10%),Nasal congestion (5-10%),Hypotension (1-5%),Syncope (1-5%),Akathisia (1-5%),Dizziness (1-5%),Increased salivation (1-5%),Nervousness (1-5%),Tremor (1-5%),Weight change (1-5%)\r\n\r\n1-10% (10 mg dose)\r\nIncreased salivation (5-10%),Talkativeness (1-5%),Incontinence (1-5%)\r\n\r\nPotentially Fatal: Blood dyscrasias.",
    "pregnancy_category_id": "4",
    "mode_of_action": "Alprazolam has anxiolytic, muscle-relaxant, anticonvulsant, antidepressant and sleep-modifying effects. It binds to the ? aminobutyric acid (GABA)-specific sites throughout the CNS, leading to an increase in the inhibitory effect of GABA on neuronal excitability. Increased neuronal permeability to chloride ions thus results in hyperpolarisation and stabilisation.",
    "interaction": "Potentiates action of alcohol and CNS depressants. Reduced conc with cigarette smoking by 50%.\r\n\r\nPotentially Fatal: Cimetidine and fluoxetine reduce the clearance of alprazolam. Alprazolam enhances activity of imipramine and desipramine. ",
    "pregnancy_category_note": "",
    "adult_dose": "Oral\r\nShort-term management of anxiety\r\nAdult: 0.25-0.5 mg tid, increased to 3-4 mg daily if necessary.\r\nElderly: Initially, 0.25 mg bid\/tid.\r\n\r\nPanic attacks\r\nAdult\r\nImmediate-release\r\n0.5 mg PO q8hr; may increase q3-4Days by ?1 mg\/day\r\nAverage dose: 5-6 mg\/day PO\r\nMay require up to 10 mg\/day PO divided q8hr \r\n\r\nExtended-release\r\n0.5-1 mg PO qDay; may increase q3-4Days by <1 mg\/day\r\nAverage dose: 3-6 mg PO qDay\r\n\r\nAnxiety Associated With Depression\r\n1-4 mg\/day PO divided q8hr\r\n\r\nHepatic impairment: Avoid in severe impairment.",
    "child_dose": "<18 years old: Not recommended",
    "renal_dose": "Renal impairment: Use caution; not studied\r\n\r\n\r\n",
    "administration": "Administration May be taken with or without food. Side effects eg sleepiness\/drowsiness may be reduced if taken immediately after meals.",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "934",
    "generic_id": "38",
    "company_id": "255",
    "aky": "alzolam0.25",
    "brand_name": "Alzolam 0.25",
    "form": "Tablet",
    "strength": "0.25mg",
    "price": "112",
    "packsize": "100's pack",
    "company_name": "Sun Pharmaceutical (Bangladesh) Ltd.",
    "company_order": "0",
    "generic_name": "Alprazolam",
    "precaution": "Dosage reduction or gradual withdrawal. Dependence. Geriatric or debilitated patients. Muscle weakness, impaired hepatic or renal function; arteriosclerosis; obesity; depression particularly suicidal tendency; chronic pulmonary insufficiency. May impair ability to drive or operate machinery. Children <18 yr.\r\n\r\nLactation: Enters breast milk\/not recommended",
    "indication": "Anxiety disorders, Panic disorders, Nausea due to chemotherapy",
    "contra_indication": "Acute narrow-angle glaucoma, preexisting CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; pregnancy, lactation.",
    "side_effect": ">10% (4 mg dose)\r\nDrowsiness (41%),Depression (10-15%),Headache (10-15%),Constipation (10-15%),Diarrhea (10-15%),Dry mouth (10-15%)\r\n\r\n>10% (10 mg dose)\r\nDrowsiness (77%),Impaired coordination (40-50%),Increased appetite (30-35%),Fatigue (30-35%),Memory impairment (30-35%),Irritability (30-35%),Decreased salivation (30-35%),Cognitive disorders (20-30%),Insomnia (20-30%),Dcreased appetite (20-30%),Headache (20-30%),Lightheadedness (20-30%),Dysarthria (20-30%),Diarrhea, constipation, and nausea\/vomiting (20-30%),Weight change (20-30%),Nasal congestion (15-20%),Decreased or increased libido (10-15%),Menstrual disorder (10-15%),Difficult micturition (10-15%)\r\n\r\n1-10% (4 mg dose)\r\nTachycardia (5-10%),Confusion (5-10%),Insomnia (5-10%),Nausea\/vomiting (5-10%),Blurred vision (5-10%),Nasal congestion (5-10%),Hypotension (1-5%),Syncope (1-5%),Akathisia (1-5%),Dizziness (1-5%),Increased salivation (1-5%),Nervousness (1-5%),Tremor (1-5%),Weight change (1-5%)\r\n\r\n1-10% (10 mg dose)\r\nIncreased salivation (5-10%),Talkativeness (1-5%),Incontinence (1-5%)\r\n\r\nPotentially Fatal: Blood dyscrasias.",
    "pregnancy_category_id": "4",
    "mode_of_action": "Alprazolam has anxiolytic, muscle-relaxant, anticonvulsant, antidepressant and sleep-modifying effects. It binds to the ? aminobutyric acid (GABA)-specific sites throughout the CNS, leading to an increase in the inhibitory effect of GABA on neuronal excitability. Increased neuronal permeability to chloride ions thus results in hyperpolarisation and stabilisation.",
    "interaction": "Potentiates action of alcohol and CNS depressants. Reduced conc with cigarette smoking by 50%.\r\n\r\nPotentially Fatal: Cimetidine and fluoxetine reduce the clearance of alprazolam. Alprazolam enhances activity of imipramine and desipramine. ",
    "pregnancy_category_note": "",
    "adult_dose": "Oral\r\nShort-term management of anxiety\r\nAdult: 0.25-0.5 mg tid, increased to 3-4 mg daily if necessary.\r\nElderly: Initially, 0.25 mg bid\/tid.\r\n\r\nPanic attacks\r\nAdult\r\nImmediate-release\r\n0.5 mg PO q8hr; may increase q3-4Days by ?1 mg\/day\r\nAverage dose: 5-6 mg\/day PO\r\nMay require up to 10 mg\/day PO divided q8hr \r\n\r\nExtended-release\r\n0.5-1 mg PO qDay; may increase q3-4Days by <1 mg\/day\r\nAverage dose: 3-6 mg PO qDay\r\n\r\nAnxiety Associated With Depression\r\n1-4 mg\/day PO divided q8hr\r\n\r\nHepatic impairment: Avoid in severe impairment.",
    "child_dose": "<18 years old: Not recommended",
    "renal_dose": "Renal impairment: Use caution; not studied\r\n\r\n\r\n",
    "administration": "Administration May be taken with or without food. Side effects eg sleepiness\/drowsiness may be reduced if taken immediately after meals.",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "935",
    "generic_id": "38",
    "company_id": "255",
    "aky": "alzolam0.5",
    "brand_name": "Alzolam 0.5",
    "form": "Tablet",
    "strength": "0.5mg",
    "price": "203",
    "packsize": "100's pack",
    "company_name": "Sun Pharmaceutical (Bangladesh) Ltd.",
    "company_order": "0",
    "generic_name": "Alprazolam",
    "precaution": "Dosage reduction or gradual withdrawal. Dependence. Geriatric or debilitated patients. Muscle weakness, impaired hepatic or renal function; arteriosclerosis; obesity; depression particularly suicidal tendency; chronic pulmonary insufficiency. May impair ability to drive or operate machinery. Children <18 yr.\r\n\r\nLactation: Enters breast milk\/not recommended",
    "indication": "Anxiety disorders, Panic disorders, Nausea due to chemotherapy",
    "contra_indication": "Acute narrow-angle glaucoma, preexisting CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; pregnancy, lactation.",
    "side_effect": ">10% (4 mg dose)\r\nDrowsiness (41%),Depression (10-15%),Headache (10-15%),Constipation (10-15%),Diarrhea (10-15%),Dry mouth (10-15%)\r\n\r\n>10% (10 mg dose)\r\nDrowsiness (77%),Impaired coordination (40-50%),Increased appetite (30-35%),Fatigue (30-35%),Memory impairment (30-35%),Irritability (30-35%),Decreased salivation (30-35%),Cognitive disorders (20-30%),Insomnia (20-30%),Dcreased appetite (20-30%),Headache (20-30%),Lightheadedness (20-30%),Dysarthria (20-30%),Diarrhea, constipation, and nausea\/vomiting (20-30%),Weight change (20-30%),Nasal congestion (15-20%),Decreased or increased libido (10-15%),Menstrual disorder (10-15%),Difficult micturition (10-15%)\r\n\r\n1-10% (4 mg dose)\r\nTachycardia (5-10%),Confusion (5-10%),Insomnia (5-10%),Nausea\/vomiting (5-10%),Blurred vision (5-10%),Nasal congestion (5-10%),Hypotension (1-5%),Syncope (1-5%),Akathisia (1-5%),Dizziness (1-5%),Increased salivation (1-5%),Nervousness (1-5%),Tremor (1-5%),Weight change (1-5%)\r\n\r\n1-10% (10 mg dose)\r\nIncreased salivation (5-10%),Talkativeness (1-5%),Incontinence (1-5%)\r\n\r\nPotentially Fatal: Blood dyscrasias.",
    "pregnancy_category_id": "4",
    "mode_of_action": "Alprazolam has anxiolytic, muscle-relaxant, anticonvulsant, antidepressant and sleep-modifying effects. It binds to the ? aminobutyric acid (GABA)-specific sites throughout the CNS, leading to an increase in the inhibitory effect of GABA on neuronal excitability. Increased neuronal permeability to chloride ions thus results in hyperpolarisation and stabilisation.",
    "interaction": "Potentiates action of alcohol and CNS depressants. Reduced conc with cigarette smoking by 50%.\r\n\r\nPotentially Fatal: Cimetidine and fluoxetine reduce the clearance of alprazolam. Alprazolam enhances activity of imipramine and desipramine. ",
    "pregnancy_category_note": "",
    "adult_dose": "Oral\r\nShort-term management of anxiety\r\nAdult: 0.25-0.5 mg tid, increased to 3-4 mg daily if necessary.\r\nElderly: Initially, 0.25 mg bid\/tid.\r\n\r\nPanic attacks\r\nAdult\r\nImmediate-release\r\n0.5 mg PO q8hr; may increase q3-4Days by ?1 mg\/day\r\nAverage dose: 5-6 mg\/day PO\r\nMay require up to 10 mg\/day PO divided q8hr \r\n\r\nExtended-release\r\n0.5-1 mg PO qDay; may increase q3-4Days by <1 mg\/day\r\nAverage dose: 3-6 mg PO qDay\r\n\r\nAnxiety Associated With Depression\r\n1-4 mg\/day PO divided q8hr\r\n\r\nHepatic impairment: Avoid in severe impairment.",
    "child_dose": "<18 years old: Not recommended",
    "renal_dose": "Renal impairment: Use caution; not studied\r\n\r\n\r\n",
    "administration": "Administration May be taken with or without food. Side effects eg sleepiness\/drowsiness may be reduced if taken immediately after meals.",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "936",
    "generic_id": "38",
    "company_id": "255",
    "aky": "alzolamsr1",
    "brand_name": "Alzolam SR 1",
    "form": "Tablet",
    "strength": "1mg",
    "price": "4.02",
    "packsize": "100's pack",
    "company_name": "Sun Pharmaceutical (Bangladesh) Ltd.",
    "company_order": "0",
    "generic_name": "Alprazolam",
    "precaution": "Dosage reduction or gradual withdrawal. Dependence. Geriatric or debilitated patients. Muscle weakness, impaired hepatic or renal function; arteriosclerosis; obesity; depression particularly suicidal tendency; chronic pulmonary insufficiency. May impair ability to drive or operate machinery. Children <18 yr.\r\n\r\nLactation: Enters breast milk\/not recommended",
    "indication": "Anxiety disorders, Panic disorders, Nausea due to chemotherapy",
    "contra_indication": "Acute narrow-angle glaucoma, preexisting CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; pregnancy, lactation.",
    "side_effect": ">10% (4 mg dose)\r\nDrowsiness (41%),Depression (10-15%),Headache (10-15%),Constipation (10-15%),Diarrhea (10-15%),Dry mouth (10-15%)\r\n\r\n>10% (10 mg dose)\r\nDrowsiness (77%),Impaired coordination (40-50%),Increased appetite (30-35%),Fatigue (30-35%),Memory impairment (30-35%),Irritability (30-35%),Decreased salivation (30-35%),Cognitive disorders (20-30%),Insomnia (20-30%),Dcreased appetite (20-30%),Headache (20-30%),Lightheadedness (20-30%),Dysarthria (20-30%),Diarrhea, constipation, and nausea\/vomiting (20-30%),Weight change (20-30%),Nasal congestion (15-20%),Decreased or increased libido (10-15%),Menstrual disorder (10-15%),Difficult micturition (10-15%)\r\n\r\n1-10% (4 mg dose)\r\nTachycardia (5-10%),Confusion (5-10%),Insomnia (5-10%),Nausea\/vomiting (5-10%),Blurred vision (5-10%),Nasal congestion (5-10%),Hypotension (1-5%),Syncope (1-5%),Akathisia (1-5%),Dizziness (1-5%),Increased salivation (1-5%),Nervousness (1-5%),Tremor (1-5%),Weight change (1-5%)\r\n\r\n1-10% (10 mg dose)\r\nIncreased salivation (5-10%),Talkativeness (1-5%),Incontinence (1-5%)\r\n\r\nPotentially Fatal: Blood dyscrasias.",
    "pregnancy_category_id": "4",
    "mode_of_action": "Alprazolam has anxiolytic, muscle-relaxant, anticonvulsant, antidepressant and sleep-modifying effects. It binds to the ? aminobutyric acid (GABA)-specific sites throughout the CNS, leading to an increase in the inhibitory effect of GABA on neuronal excitability. Increased neuronal permeability to chloride ions thus results in hyperpolarisation and stabilisation.",
    "interaction": "Potentiates action of alcohol and CNS depressants. Reduced conc with cigarette smoking by 50%.\r\n\r\nPotentially Fatal: Cimetidine and fluoxetine reduce the clearance of alprazolam. Alprazolam enhances activity of imipramine and desipramine. ",
    "pregnancy_category_note": "",
    "adult_dose": "Oral\r\nShort-term management of anxiety\r\nAdult: 0.25-0.5 mg tid, increased to 3-4 mg daily if necessary.\r\nElderly: Initially, 0.25 mg bid\/tid.\r\n\r\nPanic attacks\r\nAdult\r\nImmediate-release\r\n0.5 mg PO q8hr; may increase q3-4Days by ?1 mg\/day\r\nAverage dose: 5-6 mg\/day PO\r\nMay require up to 10 mg\/day PO divided q8hr \r\n\r\nExtended-release\r\n0.5-1 mg PO qDay; may increase q3-4Days by <1 mg\/day\r\nAverage dose: 3-6 mg PO qDay\r\n\r\nAnxiety Associated With Depression\r\n1-4 mg\/day PO divided q8hr\r\n\r\nHepatic impairment: Avoid in severe impairment.",
    "child_dose": "<18 years old: Not recommended",
    "renal_dose": "Renal impairment: Use caution; not studied\r\n\r\n\r\n",
    "administration": "Administration May be taken with or without food. Side effects eg sleepiness\/drowsiness may be reduced if taken immediately after meals.",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "7068",
    "generic_id": "40",
    "company_id": "5",
    "aky": "duomeal",
    "brand_name": "Duomeal",
    "form": "Tablet",
    "strength": " ",
    "price": "106",
    "packsize": "200's pack",
    "company_name": "Ad-din Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown; use caution",
    "indication": "Heartburn, Reflux oesophagitis, Hyperacidity, Peptic ulcer, Constipation, Indigestion",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": ">10%\r\nAluminum oxide,Chalky taste,Constipation,Fecal impaction,Stomach cramps\r\n\r\nFrequency Not Defined\r\nAluminum oxide,Nausea,Vomiting,Aluminum intoxication,Hypophosphatemia,Osteomalacia,Magnesium oxide,Diarrhea,Hypermagnesemia",
    "pregnancy_category_id": "3",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Gastric Hyperacidity, Heartburn: Up to 1 g\/day. \r\n\r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.\r\n\r\n10-20 mL PO between meals & qHS",
    "child_dose": "",
    "renal_dose": "",
    "administration": "May be taken with or without food.",
    "packssize": "200.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "6818",
    "generic_id": "40",
    "company_id": "8",
    "aky": "dolocid",
    "brand_name": "Dolocid",
    "form": "Tablet",
    "strength": " ",
    "price": "120",
    "packsize": "200's pack",
    "company_name": "Aexim Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown; use caution",
    "indication": "Heartburn, Reflux oesophagitis, Hyperacidity, Peptic ulcer, Constipation, Indigestion",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": ">10%\r\nAluminum oxide,Chalky taste,Constipation,Fecal impaction,Stomach cramps\r\n\r\nFrequency Not Defined\r\nAluminum oxide,Nausea,Vomiting,Aluminum intoxication,Hypophosphatemia,Osteomalacia,Magnesium oxide,Diarrhea,Hypermagnesemia",
    "pregnancy_category_id": "3",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Gastric Hyperacidity, Heartburn: Up to 1 g\/day. \r\n\r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.\r\n\r\n10-20 mL PO between meals & qHS",
    "child_dose": "",
    "renal_dose": "",
    "administration": "May be taken with or without food.",
    "packssize": "200.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "1614",
    "generic_id": "40",
    "company_id": "13",
    "aky": "antameal",
    "brand_name": "Antameal",
    "form": "Tablet",
    "strength": "250mg + 400mg",
    "price": "0.50",
    "packsize": "200's pack",
    "company_name": "Alco Pharma Limited",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown; use caution",
    "indication": "Heartburn, Reflux oesophagitis, Hyperacidity, Peptic ulcer, Constipation, Indigestion",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": ">10%\r\nAluminum oxide,Chalky taste,Constipation,Fecal impaction,Stomach cramps\r\n\r\nFrequency Not Defined\r\nAluminum oxide,Nausea,Vomiting,Aluminum intoxication,Hypophosphatemia,Osteomalacia,Magnesium oxide,Diarrhea,Hypermagnesemia",
    "pregnancy_category_id": "3",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Gastric Hyperacidity, Heartburn: Up to 1 g\/day. \r\n\r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.\r\n\r\n10-20 mL PO between meals & qHS",
    "child_dose": "",
    "renal_dose": "",
    "administration": "May be taken with or without food.",
    "packssize": "200.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "6556",
    "generic_id": "40",
    "company_id": "22",
    "aky": "digel",
    "brand_name": "Digel",
    "form": "Tablet",
    "strength": " 250mg + 400mg",
    "price": "0.50",
    "packsize": "200's pack",
    "company_name": "Aristopharma Limited",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown; use caution",
    "indication": "Heartburn, Reflux oesophagitis, Hyperacidity, Peptic ulcer, Constipation, Indigestion",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": ">10%\r\nAluminum oxide,Chalky taste,Constipation,Fecal impaction,Stomach cramps\r\n\r\nFrequency Not Defined\r\nAluminum oxide,Nausea,Vomiting,Aluminum intoxication,Hypophosphatemia,Osteomalacia,Magnesium oxide,Diarrhea,Hypermagnesemia",
    "pregnancy_category_id": "3",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Gastric Hyperacidity, Heartburn: Up to 1 g\/day. \r\n\r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.\r\n\r\n10-20 mL PO between meals & qHS",
    "child_dose": "",
    "renal_dose": "",
    "administration": "May be taken with or without food.",
    "packssize": "200.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "3082",
    "generic_id": "40",
    "company_id": "40",
    "aky": "biocid",
    "brand_name": "Biocid",
    "form": "Tablet",
    "strength": " 250mg + 500mg",
    "price": "0.72",
    "packsize": "200's pack",
    "company_name": "Bio Pharma Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown; use caution",
    "indication": "Heartburn, Reflux oesophagitis, Hyperacidity, Peptic ulcer, Constipation, Indigestion",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": ">10%\r\nAluminum oxide,Chalky taste,Constipation,Fecal impaction,Stomach cramps\r\n\r\nFrequency Not Defined\r\nAluminum oxide,Nausea,Vomiting,Aluminum intoxication,Hypophosphatemia,Osteomalacia,Magnesium oxide,Diarrhea,Hypermagnesemia",
    "pregnancy_category_id": "3",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Gastric Hyperacidity, Heartburn: Up to 1 g\/day. \r\n\r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.\r\n\r\n10-20 mL PO between meals & qHS",
    "child_dose": "",
    "renal_dose": "",
    "administration": "May be taken with or without food.",
    "packssize": "200.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "5736",
    "generic_id": "40",
    "company_id": "51",
    "aky": "cytocid",
    "brand_name": "Cytocid",
    "form": "Tablet",
    "strength": " ",
    "price": "100",
    "packsize": "200's pack",
    "company_name": "Central Pharmaceutical Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown; use caution",
    "indication": "Heartburn, Reflux oesophagitis, Hyperacidity, Peptic ulcer, Constipation, Indigestion",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": ">10%\r\nAluminum oxide,Chalky taste,Constipation,Fecal impaction,Stomach cramps\r\n\r\nFrequency Not Defined\r\nAluminum oxide,Nausea,Vomiting,Aluminum intoxication,Hypophosphatemia,Osteomalacia,Magnesium oxide,Diarrhea,Hypermagnesemia",
    "pregnancy_category_id": "3",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Gastric Hyperacidity, Heartburn: Up to 1 g\/day. \r\n\r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.\r\n\r\n10-20 mL PO between meals & qHS",
    "child_dose": "",
    "renal_dose": "",
    "administration": "May be taken with or without food.",
    "packssize": "200.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "908",
    "generic_id": "40",
    "company_id": "58",
    "aky": "alugel",
    "brand_name": "Alugel",
    "form": "Tablet",
    "strength": " ",
    "price": "100",
    "packsize": "200's pack",
    "company_name": "Cosmic Chemical Industries Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown; use caution",
    "indication": "Heartburn, Reflux oesophagitis, Hyperacidity, Peptic ulcer, Constipation, Indigestion",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": ">10%\r\nAluminum oxide,Chalky taste,Constipation,Fecal impaction,Stomach cramps\r\n\r\nFrequency Not Defined\r\nAluminum oxide,Nausea,Vomiting,Aluminum intoxication,Hypophosphatemia,Osteomalacia,Magnesium oxide,Diarrhea,Hypermagnesemia",
    "pregnancy_category_id": "3",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Gastric Hyperacidity, Heartburn: Up to 1 g\/day. \r\n\r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.\r\n\r\n10-20 mL PO between meals & qHS",
    "child_dose": "",
    "renal_dose": "",
    "administration": "May be taken with or without food.",
    "packssize": "200.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "5632",
    "generic_id": "40",
    "company_id": "61",
    "aky": "crystacid",
    "brand_name": "Crystacid",
    "form": "Tablet",
    "strength": " ",
    "price": "32",
    "packsize": "200ml bot",
    "company_name": "Crystal Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown; use caution",
    "indication": "Heartburn, Reflux oesophagitis, Hyperacidity, Peptic ulcer, Constipation, Indigestion",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": ">10%\r\nAluminum oxide,Chalky taste,Constipation,Fecal impaction,Stomach cramps\r\n\r\nFrequency Not Defined\r\nAluminum oxide,Nausea,Vomiting,Aluminum intoxication,Hypophosphatemia,Osteomalacia,Magnesium oxide,Diarrhea,Hypermagnesemia",
    "pregnancy_category_id": "3",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Gastric Hyperacidity, Heartburn: Up to 1 g\/day. \r\n\r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.\r\n\r\n10-20 mL PO between meals & qHS",
    "child_dose": "",
    "renal_dose": "",
    "administration": "May be taken with or without food.",
    "packssize": "1.00",
    "ext": "200ml",
    "unite": "bot"
},
{
    "brand_id": "744",
    "generic_id": "40",
    "company_id": "66",
    "aky": "algex",
    "brand_name": "Algex",
    "form": "Tablet",
    "strength": " 250mg + 400mg",
    "price": "0.50",
    "packsize": "200's pack",
    "company_name": "Doctor's Chemicals Works Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown; use caution",
    "indication": "Heartburn, Reflux oesophagitis, Hyperacidity, Peptic ulcer, Constipation, Indigestion",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": ">10%\r\nAluminum oxide,Chalky taste,Constipation,Fecal impaction,Stomach cramps\r\n\r\nFrequency Not Defined\r\nAluminum oxide,Nausea,Vomiting,Aluminum intoxication,Hypophosphatemia,Osteomalacia,Magnesium oxide,Diarrhea,Hypermagnesemia",
    "pregnancy_category_id": "3",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Gastric Hyperacidity, Heartburn: Up to 1 g\/day. \r\n\r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.\r\n\r\n10-20 mL PO between meals & qHS",
    "child_dose": "",
    "renal_dose": "",
    "administration": "May be taken with or without food.",
    "packssize": "200.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "1617",
    "generic_id": "40",
    "company_id": "115",
    "aky": "antanil",
    "brand_name": "Antanil",
    "form": "Tablet",
    "strength": " 250mg + 400mg",
    "price": "0.64",
    "packsize": "200's pack",
    "company_name": "Ibn Sina Pharmaceutical Ind. Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown; use caution",
    "indication": "Heartburn, Reflux oesophagitis, Hyperacidity, Peptic ulcer, Constipation, Indigestion",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": ">10%\r\nAluminum oxide,Chalky taste,Constipation,Fecal impaction,Stomach cramps\r\n\r\nFrequency Not Defined\r\nAluminum oxide,Nausea,Vomiting,Aluminum intoxication,Hypophosphatemia,Osteomalacia,Magnesium oxide,Diarrhea,Hypermagnesemia",
    "pregnancy_category_id": "3",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Gastric Hyperacidity, Heartburn: Up to 1 g\/day. \r\n\r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.\r\n\r\n10-20 mL PO between meals & qHS",
    "child_dose": "",
    "renal_dose": "",
    "administration": "May be taken with or without food.",
    "packssize": "200.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "901",
    "generic_id": "40",
    "company_id": "178",
    "aky": "alucil",
    "brand_name": "Alucil",
    "form": "Suspension",
    "strength": "175 mg + 225 mg\/ 5ml",
    "price": "55.32",
    "packsize": "200ml bot",
    "company_name": "Opsonin Pharma Limited",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown; use caution",
    "indication": "Heartburn, Reflux oesophagitis, Hyperacidity, Peptic ulcer, Constipation, Indigestion",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": ">10%\r\nAluminum oxide,Chalky taste,Constipation,Fecal impaction,Stomach cramps\r\n\r\nFrequency Not Defined\r\nAluminum oxide,Nausea,Vomiting,Aluminum intoxication,Hypophosphatemia,Osteomalacia,Magnesium oxide,Diarrhea,Hypermagnesemia",
    "pregnancy_category_id": "3",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Gastric Hyperacidity, Heartburn: Up to 1 g\/day. \r\n\r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.\r\n\r\n10-20 mL PO between meals & qHS",
    "child_dose": "",
    "renal_dose": "",
    "administration": "May be taken with or without food.",
    "packssize": "1.00",
    "ext": "200ml",
    "unite": "bot"
},
{
    "brand_id": "1430",
    "generic_id": "40",
    "company_id": "219",
    "aky": "ancidplus",
    "brand_name": "Ancid Plus",
    "form": "Suspension",
    "strength": " ",
    "price": "46",
    "packsize": "200ml bot",
    "company_name": "Renata Limited",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown; use caution",
    "indication": "Heartburn, Reflux oesophagitis, Hyperacidity, Peptic ulcer, Constipation, Indigestion",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": ">10%\r\nAluminum oxide,Chalky taste,Constipation,Fecal impaction,Stomach cramps\r\n\r\nFrequency Not Defined\r\nAluminum oxide,Nausea,Vomiting,Aluminum intoxication,Hypophosphatemia,Osteomalacia,Magnesium oxide,Diarrhea,Hypermagnesemia",
    "pregnancy_category_id": "3",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Gastric Hyperacidity, Heartburn: Up to 1 g\/day. \r\n\r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.\r\n\r\n10-20 mL PO between meals & qHS",
    "child_dose": "",
    "renal_dose": "",
    "administration": "May be taken with or without food.",
    "packssize": "1.00",
    "ext": "200ml",
    "unite": "bot"
},
{
    "brand_id": "1745",
    "generic_id": "40",
    "company_id": "258",
    "aky": "apcocid",
    "brand_name": "Apcocid",
    "form": "Tablet",
    "strength": " ",
    "price": "50",
    "packsize": "100's pack",
    "company_name": "Supreme Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown; use caution",
    "indication": "Heartburn, Reflux oesophagitis, Hyperacidity, Peptic ulcer, Constipation, Indigestion",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": ">10%\r\nAluminum oxide,Chalky taste,Constipation,Fecal impaction,Stomach cramps\r\n\r\nFrequency Not Defined\r\nAluminum oxide,Nausea,Vomiting,Aluminum intoxication,Hypophosphatemia,Osteomalacia,Magnesium oxide,Diarrhea,Hypermagnesemia",
    "pregnancy_category_id": "3",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: PO Gastric Hyperacidity, Heartburn: Up to 1 g\/day. \r\n\r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.\r\n\r\n10-20 mL PO between meals & qHS",
    "child_dose": "",
    "renal_dose": "",
    "administration": "May be taken with or without food.",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "2321",
    "generic_id": "41",
    "company_id": "2",
    "aky": "avlocidplus",
    "brand_name": "Avlocid Plus",
    "form": "Suspension",
    "strength": "400mg + 400mg + 30mg\/5ml",
    "price": "75.23",
    "packsize": "200ml",
    "company_name": "ACI Limited",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide + Simethicon",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown",
    "indication": "Dyspepsia, Flatulence",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": "Aluminum hydroxide\r\nChalky taste,Constipation,Fecal impaction,Stomach cramps,Nausea,Vomiting,Rebound hyperacidity,Aluminum intoxication,Hypophosphatemia,Milk-alkali syndrome,Osteomalacia\r\n\r\nMagnesium hydroxide\r\nDiarrhea,Hypermagnesemia\r\n\r\nSimethicone\r\nLoose stools",
    "pregnancy_category_id": "3",
    "mode_of_action": "Aluminum hydroxide: Neutralizes stomach hydrocloride to form AlCl3 salt plus water; increases gastric pH.\r\nMagnesium hydroxide: Promotes bowel evacuation by causing osmotic retention of fluid, which causes the colon to distend with increased peristaltic activity; forms magnesium chloride when reacts with hydrochloric acid.\r\nSimethicone: Disperses and prevents gas pockets in the GI system by decreasing surface tension of gas bubles.\r\n\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.\r\n\r\nSimethicon: None well documented.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: Dyspepsia, Abdominal Bloating\r\n10-20 mL PO q4-6hr taken 1 hour before or 3 hours after meals, OR\r\n\r\nChew 2-4 tablets q4-6hr; not to exceed 12 tablets\/24 hr\r\n\r\nPO Antacid Up to 1 g\/day. \r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "Administration Should be taken on an empty stomach.",
    "packssize": "1.00",
    "ext": "200ml",
    "unite": null
},
{
    "brand_id": "1609",
    "generic_id": "41",
    "company_id": "37",
    "aky": "antacidmax",
    "brand_name": "Antacid Max",
    "form": "Tablet",
    "strength": " 400mg + 400mg + 30mg",
    "price": "2.00",
    "packsize": "200's pack",
    "company_name": "Beximco Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide + Simethicon",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown",
    "indication": "Dyspepsia, Flatulence",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": "Aluminum hydroxide\r\nChalky taste,Constipation,Fecal impaction,Stomach cramps,Nausea,Vomiting,Rebound hyperacidity,Aluminum intoxication,Hypophosphatemia,Milk-alkali syndrome,Osteomalacia\r\n\r\nMagnesium hydroxide\r\nDiarrhea,Hypermagnesemia\r\n\r\nSimethicone\r\nLoose stools",
    "pregnancy_category_id": "3",
    "mode_of_action": "Aluminum hydroxide: Neutralizes stomach hydrocloride to form AlCl3 salt plus water; increases gastric pH.\r\nMagnesium hydroxide: Promotes bowel evacuation by causing osmotic retention of fluid, which causes the colon to distend with increased peristaltic activity; forms magnesium chloride when reacts with hydrochloric acid.\r\nSimethicone: Disperses and prevents gas pockets in the GI system by decreasing surface tension of gas bubles.\r\n\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.\r\n\r\nSimethicon: None well documented.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: Dyspepsia, Abdominal Bloating\r\n10-20 mL PO q4-6hr taken 1 hour before or 3 hours after meals, OR\r\n\r\nChew 2-4 tablets q4-6hr; not to exceed 12 tablets\/24 hr\r\n\r\nPO Antacid Up to 1 g\/day. \r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "Administration Should be taken on an empty stomach.",
    "packssize": "200.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "3084",
    "generic_id": "41",
    "company_id": "40",
    "aky": "biocidplus",
    "brand_name": "Biocid PLUS",
    "form": "Tablet",
    "strength": " 400mg + 400mg + 30mg",
    "price": "2.00",
    "packsize": "200's pack",
    "company_name": "Bio Pharma Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide + Simethicon",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown",
    "indication": "Dyspepsia, Flatulence",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": "Aluminum hydroxide\r\nChalky taste,Constipation,Fecal impaction,Stomach cramps,Nausea,Vomiting,Rebound hyperacidity,Aluminum intoxication,Hypophosphatemia,Milk-alkali syndrome,Osteomalacia\r\n\r\nMagnesium hydroxide\r\nDiarrhea,Hypermagnesemia\r\n\r\nSimethicone\r\nLoose stools",
    "pregnancy_category_id": "3",
    "mode_of_action": "Aluminum hydroxide: Neutralizes stomach hydrocloride to form AlCl3 salt plus water; increases gastric pH.\r\nMagnesium hydroxide: Promotes bowel evacuation by causing osmotic retention of fluid, which causes the colon to distend with increased peristaltic activity; forms magnesium chloride when reacts with hydrochloric acid.\r\nSimethicone: Disperses and prevents gas pockets in the GI system by decreasing surface tension of gas bubles.\r\n\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.\r\n\r\nSimethicon: None well documented.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: Dyspepsia, Abdominal Bloating\r\n10-20 mL PO q4-6hr taken 1 hour before or 3 hours after meals, OR\r\n\r\nChew 2-4 tablets q4-6hr; not to exceed 12 tablets\/24 hr\r\n\r\nPO Antacid Up to 1 g\/day. \r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "Administration Should be taken on an empty stomach.",
    "packssize": "200.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "3085",
    "generic_id": "41",
    "company_id": "40",
    "aky": "biocidplus",
    "brand_name": "Biocid Plus",
    "form": "Suspension",
    "strength": " 400mg + 400mg + 30mg",
    "price": "75.00",
    "packsize": "200ml bot",
    "company_name": "Bio Pharma Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide + Simethicon",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown",
    "indication": "Dyspepsia, Flatulence",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": "Aluminum hydroxide\r\nChalky taste,Constipation,Fecal impaction,Stomach cramps,Nausea,Vomiting,Rebound hyperacidity,Aluminum intoxication,Hypophosphatemia,Milk-alkali syndrome,Osteomalacia\r\n\r\nMagnesium hydroxide\r\nDiarrhea,Hypermagnesemia\r\n\r\nSimethicone\r\nLoose stools",
    "pregnancy_category_id": "3",
    "mode_of_action": "Aluminum hydroxide: Neutralizes stomach hydrocloride to form AlCl3 salt plus water; increases gastric pH.\r\nMagnesium hydroxide: Promotes bowel evacuation by causing osmotic retention of fluid, which causes the colon to distend with increased peristaltic activity; forms magnesium chloride when reacts with hydrochloric acid.\r\nSimethicone: Disperses and prevents gas pockets in the GI system by decreasing surface tension of gas bubles.\r\n\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.\r\n\r\nSimethicon: None well documented.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: Dyspepsia, Abdominal Bloating\r\n10-20 mL PO q4-6hr taken 1 hour before or 3 hours after meals, OR\r\n\r\nChew 2-4 tablets q4-6hr; not to exceed 12 tablets\/24 hr\r\n\r\nPO Antacid Up to 1 g\/day. \r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "Administration Should be taken on an empty stomach.",
    "packssize": "1.00",
    "ext": "200ml",
    "unite": "bot"
},
{
    "brand_id": "1620",
    "generic_id": "41",
    "company_id": "115",
    "aky": "antanilplus",
    "brand_name": "Antanil PLUS",
    "form": "Tablet",
    "strength": "400 mg + 400 mg + 30 mg",
    "price": "1.50",
    "packsize": "100's pack",
    "company_name": "Ibn Sina Pharmaceutical Ind. Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide + Simethicon",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown",
    "indication": "Dyspepsia, Flatulence",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": "Aluminum hydroxide\r\nChalky taste,Constipation,Fecal impaction,Stomach cramps,Nausea,Vomiting,Rebound hyperacidity,Aluminum intoxication,Hypophosphatemia,Milk-alkali syndrome,Osteomalacia\r\n\r\nMagnesium hydroxide\r\nDiarrhea,Hypermagnesemia\r\n\r\nSimethicone\r\nLoose stools",
    "pregnancy_category_id": "3",
    "mode_of_action": "Aluminum hydroxide: Neutralizes stomach hydrocloride to form AlCl3 salt plus water; increases gastric pH.\r\nMagnesium hydroxide: Promotes bowel evacuation by causing osmotic retention of fluid, which causes the colon to distend with increased peristaltic activity; forms magnesium chloride when reacts with hydrochloric acid.\r\nSimethicone: Disperses and prevents gas pockets in the GI system by decreasing surface tension of gas bubles.\r\n\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.\r\n\r\nSimethicon: None well documented.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: Dyspepsia, Abdominal Bloating\r\n10-20 mL PO q4-6hr taken 1 hour before or 3 hours after meals, OR\r\n\r\nChew 2-4 tablets q4-6hr; not to exceed 12 tablets\/24 hr\r\n\r\nPO Antacid Up to 1 g\/day. \r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "Administration Should be taken on an empty stomach.",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "941",
    "generic_id": "41",
    "company_id": "116",
    "aky": "amacidplus",
    "brand_name": "Amacid Plus",
    "form": "Tablet",
    "strength": " 425.53mg + 400mg + 30mg ",
    "price": "1.20",
    "packsize": "200's pack",
    "company_name": "Incepta Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide + Simethicon",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown",
    "indication": "Dyspepsia, Flatulence",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": "Aluminum hydroxide\r\nChalky taste,Constipation,Fecal impaction,Stomach cramps,Nausea,Vomiting,Rebound hyperacidity,Aluminum intoxication,Hypophosphatemia,Milk-alkali syndrome,Osteomalacia\r\n\r\nMagnesium hydroxide\r\nDiarrhea,Hypermagnesemia\r\n\r\nSimethicone\r\nLoose stools",
    "pregnancy_category_id": "3",
    "mode_of_action": "Aluminum hydroxide: Neutralizes stomach hydrocloride to form AlCl3 salt plus water; increases gastric pH.\r\nMagnesium hydroxide: Promotes bowel evacuation by causing osmotic retention of fluid, which causes the colon to distend with increased peristaltic activity; forms magnesium chloride when reacts with hydrochloric acid.\r\nSimethicone: Disperses and prevents gas pockets in the GI system by decreasing surface tension of gas bubles.\r\n\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.\r\n\r\nSimethicon: None well documented.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: Dyspepsia, Abdominal Bloating\r\n10-20 mL PO q4-6hr taken 1 hour before or 3 hours after meals, OR\r\n\r\nChew 2-4 tablets q4-6hr; not to exceed 12 tablets\/24 hr\r\n\r\nPO Antacid Up to 1 g\/day. \r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "Administration Should be taken on an empty stomach.",
    "packssize": "200.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "942",
    "generic_id": "41",
    "company_id": "116",
    "aky": "amacidplussusp",
    "brand_name": "Amacid Plus Susp",
    "form": "Suspension",
    "strength": " 200mg + 400mg + 30mg",
    "price": "55.00",
    "packsize": "200ml",
    "company_name": "Incepta Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide + Simethicon",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown",
    "indication": "Dyspepsia, Flatulence",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": "Aluminum hydroxide\r\nChalky taste,Constipation,Fecal impaction,Stomach cramps,Nausea,Vomiting,Rebound hyperacidity,Aluminum intoxication,Hypophosphatemia,Milk-alkali syndrome,Osteomalacia\r\n\r\nMagnesium hydroxide\r\nDiarrhea,Hypermagnesemia\r\n\r\nSimethicone\r\nLoose stools",
    "pregnancy_category_id": "3",
    "mode_of_action": "Aluminum hydroxide: Neutralizes stomach hydrocloride to form AlCl3 salt plus water; increases gastric pH.\r\nMagnesium hydroxide: Promotes bowel evacuation by causing osmotic retention of fluid, which causes the colon to distend with increased peristaltic activity; forms magnesium chloride when reacts with hydrochloric acid.\r\nSimethicone: Disperses and prevents gas pockets in the GI system by decreasing surface tension of gas bubles.\r\n\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.\r\n\r\nSimethicon: None well documented.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: Dyspepsia, Abdominal Bloating\r\n10-20 mL PO q4-6hr taken 1 hour before or 3 hours after meals, OR\r\n\r\nChew 2-4 tablets q4-6hr; not to exceed 12 tablets\/24 hr\r\n\r\nPO Antacid Up to 1 g\/day. \r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "Administration Should be taken on an empty stomach.",
    "packssize": "1.00",
    "ext": "200ml",
    "unite": null
},
{
    "brand_id": "7032",
    "generic_id": "41",
    "company_id": "151",
    "aky": "droxigelplus",
    "brand_name": "Droxigel PLUS",
    "form": "Tablet",
    "strength": " ",
    "price": "180",
    "packsize": "200's pack",
    "company_name": "Modern Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide + Simethicon",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown",
    "indication": "Dyspepsia, Flatulence",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": "Aluminum hydroxide\r\nChalky taste,Constipation,Fecal impaction,Stomach cramps,Nausea,Vomiting,Rebound hyperacidity,Aluminum intoxication,Hypophosphatemia,Milk-alkali syndrome,Osteomalacia\r\n\r\nMagnesium hydroxide\r\nDiarrhea,Hypermagnesemia\r\n\r\nSimethicone\r\nLoose stools",
    "pregnancy_category_id": "3",
    "mode_of_action": "Aluminum hydroxide: Neutralizes stomach hydrocloride to form AlCl3 salt plus water; increases gastric pH.\r\nMagnesium hydroxide: Promotes bowel evacuation by causing osmotic retention of fluid, which causes the colon to distend with increased peristaltic activity; forms magnesium chloride when reacts with hydrochloric acid.\r\nSimethicone: Disperses and prevents gas pockets in the GI system by decreasing surface tension of gas bubles.\r\n\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.\r\n\r\nSimethicon: None well documented.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: Dyspepsia, Abdominal Bloating\r\n10-20 mL PO q4-6hr taken 1 hour before or 3 hours after meals, OR\r\n\r\nChew 2-4 tablets q4-6hr; not to exceed 12 tablets\/24 hr\r\n\r\nPO Antacid Up to 1 g\/day. \r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "Administration Should be taken on an empty stomach.",
    "packssize": "200.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "7033",
    "generic_id": "41",
    "company_id": "151",
    "aky": "droxigelplus",
    "brand_name": "Droxigel PLUS",
    "form": "Suspension",
    "strength": " ",
    "price": "65.00",
    "packsize": "200ml bot",
    "company_name": "Modern Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide + Simethicon",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown",
    "indication": "Dyspepsia, Flatulence",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": "Aluminum hydroxide\r\nChalky taste,Constipation,Fecal impaction,Stomach cramps,Nausea,Vomiting,Rebound hyperacidity,Aluminum intoxication,Hypophosphatemia,Milk-alkali syndrome,Osteomalacia\r\n\r\nMagnesium hydroxide\r\nDiarrhea,Hypermagnesemia\r\n\r\nSimethicone\r\nLoose stools",
    "pregnancy_category_id": "3",
    "mode_of_action": "Aluminum hydroxide: Neutralizes stomach hydrocloride to form AlCl3 salt plus water; increases gastric pH.\r\nMagnesium hydroxide: Promotes bowel evacuation by causing osmotic retention of fluid, which causes the colon to distend with increased peristaltic activity; forms magnesium chloride when reacts with hydrochloric acid.\r\nSimethicone: Disperses and prevents gas pockets in the GI system by decreasing surface tension of gas bubles.\r\n\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.\r\n\r\nSimethicon: None well documented.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: Dyspepsia, Abdominal Bloating\r\n10-20 mL PO q4-6hr taken 1 hour before or 3 hours after meals, OR\r\n\r\nChew 2-4 tablets q4-6hr; not to exceed 12 tablets\/24 hr\r\n\r\nPO Antacid Up to 1 g\/day. \r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "Administration Should be taken on an empty stomach.",
    "packssize": "1.00",
    "ext": "200ml",
    "unite": "bot"
},
{
    "brand_id": "904",
    "generic_id": "41",
    "company_id": "178",
    "aky": "alucils",
    "brand_name": "Alucil S",
    "form": "Tablet",
    "strength": "400 mg + 400 mg + 30 mg",
    "price": "2.00",
    "packsize": "100's Pack",
    "company_name": "Opsonin Pharma Limited",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide + Simethicon",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown",
    "indication": "Dyspepsia, Flatulence",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": "Aluminum hydroxide\r\nChalky taste,Constipation,Fecal impaction,Stomach cramps,Nausea,Vomiting,Rebound hyperacidity,Aluminum intoxication,Hypophosphatemia,Milk-alkali syndrome,Osteomalacia\r\n\r\nMagnesium hydroxide\r\nDiarrhea,Hypermagnesemia\r\n\r\nSimethicone\r\nLoose stools",
    "pregnancy_category_id": "3",
    "mode_of_action": "Aluminum hydroxide: Neutralizes stomach hydrocloride to form AlCl3 salt plus water; increases gastric pH.\r\nMagnesium hydroxide: Promotes bowel evacuation by causing osmotic retention of fluid, which causes the colon to distend with increased peristaltic activity; forms magnesium chloride when reacts with hydrochloric acid.\r\nSimethicone: Disperses and prevents gas pockets in the GI system by decreasing surface tension of gas bubles.\r\n\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.\r\n\r\nSimethicon: None well documented.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: Dyspepsia, Abdominal Bloating\r\n10-20 mL PO q4-6hr taken 1 hour before or 3 hours after meals, OR\r\n\r\nChew 2-4 tablets q4-6hr; not to exceed 12 tablets\/24 hr\r\n\r\nPO Antacid Up to 1 g\/day. \r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "Administration Should be taken on an empty stomach.",
    "packssize": "100.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "905",
    "generic_id": "41",
    "company_id": "178",
    "aky": "alucils",
    "brand_name": "Alucil S",
    "form": "Suspension",
    "strength": " ",
    "price": "80.00",
    "packsize": "200ml bot",
    "company_name": "Opsonin Pharma Limited",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide + Simethicon",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown",
    "indication": "Dyspepsia, Flatulence",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": "Aluminum hydroxide\r\nChalky taste,Constipation,Fecal impaction,Stomach cramps,Nausea,Vomiting,Rebound hyperacidity,Aluminum intoxication,Hypophosphatemia,Milk-alkali syndrome,Osteomalacia\r\n\r\nMagnesium hydroxide\r\nDiarrhea,Hypermagnesemia\r\n\r\nSimethicone\r\nLoose stools",
    "pregnancy_category_id": "3",
    "mode_of_action": "Aluminum hydroxide: Neutralizes stomach hydrocloride to form AlCl3 salt plus water; increases gastric pH.\r\nMagnesium hydroxide: Promotes bowel evacuation by causing osmotic retention of fluid, which causes the colon to distend with increased peristaltic activity; forms magnesium chloride when reacts with hydrochloric acid.\r\nSimethicone: Disperses and prevents gas pockets in the GI system by decreasing surface tension of gas bubles.\r\n\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.\r\n\r\nSimethicon: None well documented.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: Dyspepsia, Abdominal Bloating\r\n10-20 mL PO q4-6hr taken 1 hour before or 3 hours after meals, OR\r\n\r\nChew 2-4 tablets q4-6hr; not to exceed 12 tablets\/24 hr\r\n\r\nPO Antacid Up to 1 g\/day. \r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "Administration Should be taken on an empty stomach.",
    "packssize": "1.00",
    "ext": "200ml",
    "unite": "bot"
},
{
    "brand_id": "1431",
    "generic_id": "41",
    "company_id": "219",
    "aky": "anciddsplus",
    "brand_name": "Ancid DS Plus",
    "form": "Suspension",
    "strength": " 200mg + 400mg + 30mg",
    "price": "46.00",
    "packsize": "200ml bot",
    "company_name": "Renata Limited",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide + Simethicon",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown",
    "indication": "Dyspepsia, Flatulence",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": "Aluminum hydroxide\r\nChalky taste,Constipation,Fecal impaction,Stomach cramps,Nausea,Vomiting,Rebound hyperacidity,Aluminum intoxication,Hypophosphatemia,Milk-alkali syndrome,Osteomalacia\r\n\r\nMagnesium hydroxide\r\nDiarrhea,Hypermagnesemia\r\n\r\nSimethicone\r\nLoose stools",
    "pregnancy_category_id": "3",
    "mode_of_action": "Aluminum hydroxide: Neutralizes stomach hydrocloride to form AlCl3 salt plus water; increases gastric pH.\r\nMagnesium hydroxide: Promotes bowel evacuation by causing osmotic retention of fluid, which causes the colon to distend with increased peristaltic activity; forms magnesium chloride when reacts with hydrochloric acid.\r\nSimethicone: Disperses and prevents gas pockets in the GI system by decreasing surface tension of gas bubles.\r\n\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.\r\n\r\nSimethicon: None well documented.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: Dyspepsia, Abdominal Bloating\r\n10-20 mL PO q4-6hr taken 1 hour before or 3 hours after meals, OR\r\n\r\nChew 2-4 tablets q4-6hr; not to exceed 12 tablets\/24 hr\r\n\r\nPO Antacid Up to 1 g\/day. \r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "Administration Should be taken on an empty stomach.",
    "packssize": "1.00",
    "ext": "200ml",
    "unite": "bot"
},
{
    "brand_id": "181",
    "generic_id": "41",
    "company_id": "278",
    "aky": "acedone-zplus",
    "brand_name": "Acedone-Z Plus",
    "form": "Suspension",
    "strength": " 200 mg + 400 mg + 30 mg\/",
    "price": "55.00",
    "packsize": "200ml bot",
    "company_name": "Zenith Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Hydroxide + Magnesium Hydroxide + Simethicon",
    "precaution": "Chronic renal impairment; CHF; oedema; cirrhosis and low Na diets; patients with recent GI haemorrhage. Administer 2-3 hrs before\/after another medication to minimise drug interactions. Pregnancy and lactation.\r\n\r\nLactation: excretion in milk unknown",
    "indication": "Dyspepsia, Flatulence",
    "contra_indication": "Hypersensitivity to aluminium salts.",
    "side_effect": "Aluminum hydroxide\r\nChalky taste,Constipation,Fecal impaction,Stomach cramps,Nausea,Vomiting,Rebound hyperacidity,Aluminum intoxication,Hypophosphatemia,Milk-alkali syndrome,Osteomalacia\r\n\r\nMagnesium hydroxide\r\nDiarrhea,Hypermagnesemia\r\n\r\nSimethicone\r\nLoose stools",
    "pregnancy_category_id": "3",
    "mode_of_action": "Aluminum hydroxide: Neutralizes stomach hydrocloride to form AlCl3 salt plus water; increases gastric pH.\r\nMagnesium hydroxide: Promotes bowel evacuation by causing osmotic retention of fluid, which causes the colon to distend with increased peristaltic activity; forms magnesium chloride when reacts with hydrochloric acid.\r\nSimethicone: Disperses and prevents gas pockets in the GI system by decreasing surface tension of gas bubles.\r\n\r\n",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.\r\n\r\nSimethicon: None well documented.",
    "pregnancy_category_note": "",
    "adult_dose": "Adult: Dyspepsia, Abdominal Bloating\r\n10-20 mL PO q4-6hr taken 1 hour before or 3 hours after meals, OR\r\n\r\nChew 2-4 tablets q4-6hr; not to exceed 12 tablets\/24 hr\r\n\r\nPO Antacid Up to 1 g\/day. \r\nHyperphosphataemia in chronic renal failure Up to 10 g\/day in divided doses w\/ meals.",
    "child_dose": "",
    "renal_dose": "",
    "administration": "Administration Should be taken on an empty stomach.",
    "packssize": "1.00",
    "ext": "200ml",
    "unite": "bot"
},
{
    "brand_id": "7069",
    "generic_id": "43",
    "company_id": "5",
    "aky": "duomeal",
    "brand_name": "Duomeal",
    "form": "Suspension",
    "strength": " ",
    "price": "32",
    "packsize": "200ml bot",
    "company_name": "Ad-din Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Oxide + Magnesium Hydroxide",
    "precaution": "Renal dysfunction, low phosphate diet, prolonged use.",
    "indication": "Hyperacidity, Flatulence, Gastric ulcer, Duodenal ulcer, Gastritis, Stomach distension",
    "contra_indication": "Hypophosphataemia.",
    "side_effect": "Diarrhoea, constipation, nausea, vomiting.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Chew 1-2 tablets after meals and at bedtime as needed (up to 4 times a day).\r\nDo not take more than 16 tablets in 24 hours",
    "child_dose": "",
    "renal_dose": "",
    "administration": "After meals and at bedtime as needed. For best results, drink a half glass of water or other liquid after each dose. ",
    "packssize": "1.00",
    "ext": "200ml",
    "unite": "bot"
},
{
    "brand_id": "6819",
    "generic_id": "43",
    "company_id": "8",
    "aky": "dolocid",
    "brand_name": "Dolocid",
    "form": "Suspension",
    "strength": " ",
    "price": "32",
    "packsize": "200ml bot",
    "company_name": "Aexim Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Oxide + Magnesium Hydroxide",
    "precaution": "Renal dysfunction, low phosphate diet, prolonged use.",
    "indication": "Hyperacidity, Flatulence, Gastric ulcer, Duodenal ulcer, Gastritis, Stomach distension",
    "contra_indication": "Hypophosphataemia.",
    "side_effect": "Diarrhoea, constipation, nausea, vomiting.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Chew 1-2 tablets after meals and at bedtime as needed (up to 4 times a day).\r\nDo not take more than 16 tablets in 24 hours",
    "child_dose": "",
    "renal_dose": "",
    "administration": "After meals and at bedtime as needed. For best results, drink a half glass of water or other liquid after each dose. ",
    "packssize": "1.00",
    "ext": "200ml",
    "unite": "bot"
},
{
    "brand_id": "1749",
    "generic_id": "43",
    "company_id": "19",
    "aky": "apedrox",
    "brand_name": "Apedrox",
    "form": "Suspension",
    "strength": "175 mg + 225 mg\/5 ml",
    "price": null,
    "packsize": "200ml bot",
    "company_name": "APC Pharma Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Oxide + Magnesium Hydroxide",
    "precaution": "Renal dysfunction, low phosphate diet, prolonged use.",
    "indication": "Hyperacidity, Flatulence, Gastric ulcer, Duodenal ulcer, Gastritis, Stomach distension",
    "contra_indication": "Hypophosphataemia.",
    "side_effect": "Diarrhoea, constipation, nausea, vomiting.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Chew 1-2 tablets after meals and at bedtime as needed (up to 4 times a day).\r\nDo not take more than 16 tablets in 24 hours",
    "child_dose": "",
    "renal_dose": "",
    "administration": "After meals and at bedtime as needed. For best results, drink a half glass of water or other liquid after each dose. ",
    "packssize": "1.00",
    "ext": "200ml",
    "unite": "bot"
},
{
    "brand_id": "6557",
    "generic_id": "43",
    "company_id": "22",
    "aky": "digel",
    "brand_name": "Digel",
    "form": "Suspension",
    "strength": " 175mg + 225mg ",
    "price": "32.00",
    "packsize": "200ml bot",
    "company_name": "Aristopharma Limited",
    "company_order": "0",
    "generic_name": "Aluminium Oxide + Magnesium Hydroxide",
    "precaution": "Renal dysfunction, low phosphate diet, prolonged use.",
    "indication": "Hyperacidity, Flatulence, Gastric ulcer, Duodenal ulcer, Gastritis, Stomach distension",
    "contra_indication": "Hypophosphataemia.",
    "side_effect": "Diarrhoea, constipation, nausea, vomiting.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Chew 1-2 tablets after meals and at bedtime as needed (up to 4 times a day).\r\nDo not take more than 16 tablets in 24 hours",
    "child_dose": "",
    "renal_dose": "",
    "administration": "After meals and at bedtime as needed. For best results, drink a half glass of water or other liquid after each dose. ",
    "packssize": "1.00",
    "ext": "200ml",
    "unite": "bot"
},
{
    "brand_id": "3083",
    "generic_id": "43",
    "company_id": "40",
    "aky": "biocidmh",
    "brand_name": "Biocid MH",
    "form": "Suspension",
    "strength": " 175mg + 100mg ",
    "price": "32.00",
    "packsize": "200ml bot",
    "company_name": "Bio Pharma Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Oxide + Magnesium Hydroxide",
    "precaution": "Renal dysfunction, low phosphate diet, prolonged use.",
    "indication": "Hyperacidity, Flatulence, Gastric ulcer, Duodenal ulcer, Gastritis, Stomach distension",
    "contra_indication": "Hypophosphataemia.",
    "side_effect": "Diarrhoea, constipation, nausea, vomiting.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Chew 1-2 tablets after meals and at bedtime as needed (up to 4 times a day).\r\nDo not take more than 16 tablets in 24 hours",
    "child_dose": "",
    "renal_dose": "",
    "administration": "After meals and at bedtime as needed. For best results, drink a half glass of water or other liquid after each dose. ",
    "packssize": "1.00",
    "ext": "200ml",
    "unite": "bot"
},
{
    "brand_id": "5737",
    "generic_id": "43",
    "company_id": "51",
    "aky": "cytocid",
    "brand_name": "Cytocid",
    "form": "Suspension",
    "strength": "",
    "price": "32.00",
    "packsize": "200ml bot",
    "company_name": "Central Pharmaceutical Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Oxide + Magnesium Hydroxide",
    "precaution": "Renal dysfunction, low phosphate diet, prolonged use.",
    "indication": "Hyperacidity, Flatulence, Gastric ulcer, Duodenal ulcer, Gastritis, Stomach distension",
    "contra_indication": "Hypophosphataemia.",
    "side_effect": "Diarrhoea, constipation, nausea, vomiting.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Chew 1-2 tablets after meals and at bedtime as needed (up to 4 times a day).\r\nDo not take more than 16 tablets in 24 hours",
    "child_dose": "",
    "renal_dose": "",
    "administration": "After meals and at bedtime as needed. For best results, drink a half glass of water or other liquid after each dose. ",
    "packssize": "1.00",
    "ext": "200ml",
    "unite": "bot"
},
{
    "brand_id": "745",
    "generic_id": "43",
    "company_id": "66",
    "aky": "algex",
    "brand_name": "Algex",
    "form": "Suspension",
    "strength": " 178.5mg + 420mg\/ 5ml",
    "price": "33.00",
    "packsize": "200ml bot",
    "company_name": "Doctor's Chemicals Works Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Oxide + Magnesium Hydroxide",
    "precaution": "Renal dysfunction, low phosphate diet, prolonged use.",
    "indication": "Hyperacidity, Flatulence, Gastric ulcer, Duodenal ulcer, Gastritis, Stomach distension",
    "contra_indication": "Hypophosphataemia.",
    "side_effect": "Diarrhoea, constipation, nausea, vomiting.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Chew 1-2 tablets after meals and at bedtime as needed (up to 4 times a day).\r\nDo not take more than 16 tablets in 24 hours",
    "child_dose": "",
    "renal_dose": "",
    "administration": "After meals and at bedtime as needed. For best results, drink a half glass of water or other liquid after each dose. ",
    "packssize": "1.00",
    "ext": "200ml",
    "unite": "bot"
},
{
    "brand_id": "1618",
    "generic_id": "43",
    "company_id": "115",
    "aky": "antanil",
    "brand_name": "Antanil",
    "form": "Suspension",
    "strength": "200 mg + 125 mg\/5 ml",
    "price": "45.00",
    "packsize": "1's",
    "company_name": "Ibn Sina Pharmaceutical Ind. Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Oxide + Magnesium Hydroxide",
    "precaution": "Renal dysfunction, low phosphate diet, prolonged use.",
    "indication": "Hyperacidity, Flatulence, Gastric ulcer, Duodenal ulcer, Gastritis, Stomach distension",
    "contra_indication": "Hypophosphataemia.",
    "side_effect": "Diarrhoea, constipation, nausea, vomiting.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Chew 1-2 tablets after meals and at bedtime as needed (up to 4 times a day).\r\nDo not take more than 16 tablets in 24 hours",
    "child_dose": "",
    "renal_dose": "",
    "administration": "After meals and at bedtime as needed. For best results, drink a half glass of water or other liquid after each dose. ",
    "packssize": "1.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "7034",
    "generic_id": "43",
    "company_id": "151",
    "aky": "droxigels",
    "brand_name": "Droxigel S",
    "form": "Suspension",
    "strength": " ",
    "price": "32.88",
    "packsize": "200ml bot",
    "company_name": "Modern Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Oxide + Magnesium Hydroxide",
    "precaution": "Renal dysfunction, low phosphate diet, prolonged use.",
    "indication": "Hyperacidity, Flatulence, Gastric ulcer, Duodenal ulcer, Gastritis, Stomach distension",
    "contra_indication": "Hypophosphataemia.",
    "side_effect": "Diarrhoea, constipation, nausea, vomiting.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Chew 1-2 tablets after meals and at bedtime as needed (up to 4 times a day).\r\nDo not take more than 16 tablets in 24 hours",
    "child_dose": "",
    "renal_dose": "",
    "administration": "After meals and at bedtime as needed. For best results, drink a half glass of water or other liquid after each dose. ",
    "packssize": "1.00",
    "ext": "200ml",
    "unite": "bot"
},
{
    "brand_id": "180",
    "generic_id": "43",
    "company_id": "278",
    "aky": "acedonez",
    "brand_name": "Acedone Z",
    "form": "Suspension",
    "strength": " ",
    "price": "40",
    "packsize": "200ml bot",
    "company_name": "Zenith Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Oxide + Magnesium Hydroxide",
    "precaution": "Renal dysfunction, low phosphate diet, prolonged use.",
    "indication": "Hyperacidity, Flatulence, Gastric ulcer, Duodenal ulcer, Gastritis, Stomach distension",
    "contra_indication": "Hypophosphataemia.",
    "side_effect": "Diarrhoea, constipation, nausea, vomiting.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Chew 1-2 tablets after meals and at bedtime as needed (up to 4 times a day).\r\nDo not take more than 16 tablets in 24 hours",
    "child_dose": "",
    "renal_dose": "",
    "administration": "After meals and at bedtime as needed. For best results, drink a half glass of water or other liquid after each dose. ",
    "packssize": "1.00",
    "ext": "200ml",
    "unite": "bot"
},
{
    "brand_id": "231",
    "generic_id": "43",
    "company_id": "826",
    "aky": "acidrox",
    "brand_name": "Acidrox",
    "form": "Suspension",
    "strength": " ",
    "price": "32",
    "packsize": "200ml bot",
    "company_name": "MST Pharma and Healthcare Ltd.",
    "company_order": "0",
    "generic_name": "Aluminium Oxide + Magnesium Hydroxide",
    "precaution": "Renal dysfunction, low phosphate diet, prolonged use.",
    "indication": "Hyperacidity, Flatulence, Gastric ulcer, Duodenal ulcer, Gastritis, Stomach distension",
    "contra_indication": "Hypophosphataemia.",
    "side_effect": "Diarrhoea, constipation, nausea, vomiting.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Alumunium hydroxide acts on the HCl in the stomach by neutralization, forming aluminium chloride salt and water.\r\nMagnesium hydroxide increases peristaltic activity causing osmotic retention of fluids, thus resulting in bowel evacuation. It also reduces stomach acid by reacting with hydrochloric acid to form Mg chloride.",
    "interaction": "Aluminium Hydroxide: Enhanced absorption with citrates or ascorbic acid. Decreases absorption of allopurinol, tetracyclines, quinolones, cephalosporins, biphosphonate derivatives, corticosteroids, cyclosporin, delavirdine, Fe salts, imidazole antifungals, isoniazid, mycophenolate, penicillamine, phosphate supplements, phenytoin, phenothiazines, trientine.\r\n\r\nMagnesium Hydroxide: Decreases absorption of tetracyclines and biphosphonates. Separate administration of these and other drugs by around 2 hr.",
    "pregnancy_category_note": "",
    "adult_dose": "Chew 1-2 tablets after meals and at bedtime as needed (up to 4 times a day).\r\nDo not take more than 16 tablets in 24 hours",
    "child_dose": "",
    "renal_dose": "",
    "administration": "After meals and at bedtime as needed. For best results, drink a half glass of water or other liquid after each dose. ",
    "packssize": "1.00",
    "ext": "200ml",
    "unite": "bot"
},
{
    "brand_id": "6722",
    "generic_id": "46",
    "company_id": "178",
    "aky": "dismonal",
    "brand_name": "Dismonal",
    "form": "Tablet",
    "strength": "60mg",
    "price": "4.01",
    "packsize": "50's pack",
    "company_name": "Opsonin Pharma Limited",
    "company_order": "0",
    "generic_name": "Alverine Citrate",
    "precaution": "Pregnancy, lactation.",
    "indication": "Dysmenorrhoea, Gastrointestinal tract spasm, Irritable bowel syndrome, Diverticular disease",
    "contra_indication": "Hypersensitivity, intestinal obstruction, paralytic ileus; children <12 yr.",
    "side_effect": "Nausea, headache; pruritus, rash; dizziness; allergic reactions.\r\n\r\nPotentially Fatal: Anaphylaxis.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Alverine is a synthetic, non-narcotic, nonhabit-forming spasmolytic agent, which acts directly on intestinal and uterine smooth muscle.",
    "interaction": "",
    "pregnancy_category_note": "",
    "adult_dose": "Oral\r\nDysmenorrhoea, Gastrointestinal tract spasm\r\nAdult: 60-120 mg 1-3 times daily.\r\n",
    "child_dose": "Oral\r\nDysmenorrhoea, Gastrointestinal tract spasm\r\nChild: >12 yr: 60-120 mg 1-3 times daily.",
    "renal_dose": "",
    "administration": "",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "919",
    "generic_id": "46",
    "company_id": "182",
    "aky": "alve",
    "brand_name": "Alve",
    "form": "Tablet",
    "strength": "60mg",
    "price": "5.00",
    "packsize": "50's pack",
    "company_name": "Orion Pharma Ltd.",
    "company_order": "0",
    "generic_name": "Alverine Citrate",
    "precaution": "Pregnancy, lactation.",
    "indication": "Dysmenorrhoea, Gastrointestinal tract spasm, Irritable bowel syndrome, Diverticular disease",
    "contra_indication": "Hypersensitivity, intestinal obstruction, paralytic ileus; children <12 yr.",
    "side_effect": "Nausea, headache; pruritus, rash; dizziness; allergic reactions.\r\n\r\nPotentially Fatal: Anaphylaxis.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Alverine is a synthetic, non-narcotic, nonhabit-forming spasmolytic agent, which acts directly on intestinal and uterine smooth muscle.",
    "interaction": "",
    "pregnancy_category_note": "",
    "adult_dose": "Oral\r\nDysmenorrhoea, Gastrointestinal tract spasm\r\nAdult: 60-120 mg 1-3 times daily.\r\n",
    "child_dose": "Oral\r\nDysmenorrhoea, Gastrointestinal tract spasm\r\nChild: >12 yr: 60-120 mg 1-3 times daily.",
    "renal_dose": "",
    "administration": "",
    "packssize": "50.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "920",
    "generic_id": "46",
    "company_id": "210",
    "aky": "alverin",
    "brand_name": "Alverin",
    "form": "Tablet",
    "strength": "60mg",
    "price": "5.02",
    "packsize": "30's pack",
    "company_name": "Rangs Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Alverine Citrate",
    "precaution": "Pregnancy, lactation.",
    "indication": "Dysmenorrhoea, Gastrointestinal tract spasm, Irritable bowel syndrome, Diverticular disease",
    "contra_indication": "Hypersensitivity, intestinal obstruction, paralytic ileus; children <12 yr.",
    "side_effect": "Nausea, headache; pruritus, rash; dizziness; allergic reactions.\r\n\r\nPotentially Fatal: Anaphylaxis.",
    "pregnancy_category_id": "0",
    "mode_of_action": "Alverine is a synthetic, non-narcotic, nonhabit-forming spasmolytic agent, which acts directly on intestinal and uterine smooth muscle.",
    "interaction": "",
    "pregnancy_category_note": "",
    "adult_dose": "Oral\r\nDysmenorrhoea, Gastrointestinal tract spasm\r\nAdult: 60-120 mg 1-3 times daily.\r\n",
    "child_dose": "Oral\r\nDysmenorrhoea, Gastrointestinal tract spasm\r\nChild: >12 yr: 60-120 mg 1-3 times daily.",
    "renal_dose": "",
    "administration": "",
    "packssize": "30.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "983",
    "generic_id": "48",
    "company_id": "17",
    "aky": "ambrotil",
    "brand_name": "Ambrotil",
    "form": "Syrup",
    "strength": "15mg\/5ml",
    "price": "35",
    "packsize": "100ml bot",
    "company_name": "Amico Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "1.00",
    "ext": "100ml",
    "unite": "bot"
},
{
    "brand_id": "299",
    "generic_id": "48",
    "company_id": "20",
    "aky": "acorex",
    "brand_name": "Acorex",
    "form": "Syrup",
    "strength": "15mg\/5ml",
    "price": "40.00",
    "packsize": "100ml bot",
    "company_name": "Apex Pharma Limited.",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "1.00",
    "ext": "100ml",
    "unite": "bot"
},
{
    "brand_id": "3342",
    "generic_id": "48",
    "company_id": "21",
    "aky": "bronchosil",
    "brand_name": "Bronchosil",
    "form": "Syrup",
    "strength": "15mg\/5ml",
    "price": "38.00",
    "packsize": "100ml bot",
    "company_name": "Apollo Pharmaceutical Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "1.00",
    "ext": "100ml",
    "unite": "bot"
},
{
    "brand_id": "988",
    "generic_id": "48",
    "company_id": "40",
    "aky": "ambroxol",
    "brand_name": "Ambroxol",
    "form": "Syrup",
    "strength": "15mg\/5ml",
    "price": "40.00",
    "packsize": "100ml bot",
    "company_name": "Bio Pharma Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "1.00",
    "ext": "100ml",
    "unite": "bot"
},
{
    "brand_id": "993",
    "generic_id": "48",
    "company_id": "40",
    "aky": "ambroxolsr",
    "brand_name": "Ambroxol SR",
    "form": "Capsule",
    "strength": "75mg",
    "price": "5.03",
    "packsize": "30's pack",
    "company_name": "Bio Pharma Laboratories Ltd.",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "30.00",
    "ext": null,
    "unite": "pack"
},
{
    "brand_id": "1334",
    "generic_id": "48",
    "company_id": "63",
    "aky": "amsiv",
    "brand_name": "Amsiv",
    "form": "Syrup",
    "strength": "15mg\/5ml",
    "price": "45.00",
    "packsize": "100ml bot",
    "company_name": "Delta Pharma Limited",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "1.00",
    "ext": "100ml",
    "unite": "bot"
},
{
    "brand_id": "3067",
    "generic_id": "48",
    "company_id": "66",
    "aky": "bilco",
    "brand_name": "Bilco",
    "form": "Syrup",
    "strength": "15mg\/5ml",
    "price": "30.00",
    "packsize": "100ml bot",
    "company_name": "Doctor's Chemicals Works Ltd.",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "1.00",
    "ext": "100ml",
    "unite": "bot"
},
{
    "brand_id": "3068",
    "generic_id": "48",
    "company_id": "66",
    "aky": "bilco",
    "brand_name": "Bilco",
    "form": "Paediatric Drops",
    "strength": "6mg\/ml",
    "price": "20.00",
    "packsize": "15ml bot",
    "company_name": "Doctor's Chemicals Works Ltd.",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "1.00",
    "ext": "15ml",
    "unite": "bot"
},
{
    "brand_id": "972",
    "generic_id": "48",
    "company_id": "81",
    "aky": "amboten",
    "brand_name": "Amboten",
    "form": "Syrup",
    "strength": "15mg\/5ml",
    "price": "45.00",
    "packsize": "100ml bot",
    "company_name": "Eskayef Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "1.00",
    "ext": "100ml",
    "unite": "bot"
},
{
    "brand_id": "973",
    "generic_id": "48",
    "company_id": "81",
    "aky": "ambotenpd",
    "brand_name": "Amboten PD",
    "form": "Paediatric Drops",
    "strength": "6mg\/ml",
    "price": "35.00",
    "packsize": "15ml bot",
    "company_name": "Eskayef Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "1.00",
    "ext": "15ml",
    "unite": "bot"
},
{
    "brand_id": "1996",
    "generic_id": "48",
    "company_id": "110",
    "aky": "aroxolpd",
    "brand_name": "Aroxol PD",
    "form": "Paediatric Drops",
    "strength": "6mg\/ml",
    "price": "20.00",
    "packsize": "15ml bot",
    "company_name": "Healthcare Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "1.00",
    "ext": "15ml",
    "unite": "bot"
},
{
    "brand_id": "965",
    "generic_id": "48",
    "company_id": "116",
    "aky": "ambolyt",
    "brand_name": "Ambolyt",
    "form": "Syrup",
    "strength": "15mg\/5ml",
    "price": "40.00",
    "packsize": "100ml bot",
    "company_name": "Incepta Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "1.00",
    "ext": "100ml",
    "unite": "bot"
},
{
    "brand_id": "966",
    "generic_id": "48",
    "company_id": "116",
    "aky": "ambolyt",
    "brand_name": "Ambolyt",
    "form": "Paediatric Drops",
    "strength": "6mg\/ml",
    "price": "30.00",
    "packsize": "15ml bot",
    "company_name": "Incepta Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "1.00",
    "ext": "15ml",
    "unite": "bot"
},
{
    "brand_id": "3368",
    "generic_id": "48",
    "company_id": "128",
    "aky": "broxolin",
    "brand_name": "Broxolin",
    "form": "Syrup",
    "strength": "15mg\/5ml",
    "price": "40.12",
    "packsize": "100ml bot",
    "company_name": "Jayson Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "1.00",
    "ext": "100ml",
    "unite": "bot"
},
{
    "brand_id": "976",
    "generic_id": "48",
    "company_id": "134",
    "aky": "amboxol",
    "brand_name": "Amboxol",
    "form": "Syrup",
    "strength": "15mg\/5ml",
    "price": "40.00",
    "packsize": "100ml bot",
    "company_name": "Kumudini Pharma Ltd.",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "1.00",
    "ext": "100ml",
    "unite": "bot"
},
{
    "brand_id": "989",
    "generic_id": "48",
    "company_id": "134",
    "aky": "ambroxol",
    "brand_name": "Ambroxol",
    "form": "Paediatric Drops",
    "strength": "6mg\/ml",
    "price": "20.00",
    "packsize": "15ml bot",
    "company_name": "Kumudini Pharma Ltd.",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "1.00",
    "ext": "15ml",
    "unite": "bot"
},
{
    "brand_id": "961",
    "generic_id": "48",
    "company_id": "151",
    "aky": "ambix",
    "brand_name": "Ambix",
    "form": "Syrup",
    "strength": "15mg\/5ml",
    "price": "30.00",
    "packsize": "100ml bot",
    "company_name": "Modern Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "1.00",
    "ext": "100ml",
    "unite": "bot"
},
{
    "brand_id": "3364",
    "generic_id": "48",
    "company_id": "163",
    "aky": "brox",
    "brand_name": "Brox",
    "form": "Syrup",
    "strength": "15mg\/5ml",
    "price": "40.13",
    "packsize": "100ml bot",
    "company_name": "Navana Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "1.00",
    "ext": "100ml",
    "unite": "bot"
},
{
    "brand_id": "3283",
    "generic_id": "48",
    "company_id": "167",
    "aky": "broculyt",
    "brand_name": "Broculyt",
    "form": "Syrup",
    "strength": "15mg\/5ml",
    "price": "40.12",
    "packsize": "100ml bot",
    "company_name": "NIPRO JMI Pharma Limited",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "1.00",
    "ext": "100ml",
    "unite": "bot"
},
{
    "brand_id": "962",
    "generic_id": "48",
    "company_id": "170",
    "aky": "ambokof",
    "brand_name": "Ambokof",
    "form": "Syrup",
    "strength": "15mg\/5ml",
    "price": "30.00",
    "packsize": "100ml bot",
    "company_name": "Novelta Bestway Pharmaceuticals Ltd.",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "1.00",
    "ext": "100ml",
    "unite": "bot"
},
{
    "brand_id": "6628",
    "generic_id": "48",
    "company_id": "171",
    "aky": "dilyt",
    "brand_name": "Dilyt",
    "form": "Syrup",
    "strength": "15mg\/5ml",
    "price": "30",
    "packsize": "100ml bot",
    "company_name": "Novo Healthcare and Pharma Ltd.",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "1.00",
    "ext": "100ml",
    "unite": "bot"
},
{
    "brand_id": "3231",
    "generic_id": "48",
    "company_id": "178",
    "aky": "boxol",
    "brand_name": "Boxol",
    "form": "Syrup",
    "strength": "15mg\/5ml",
    "price": "40.00",
    "packsize": "100ml bot",
    "company_name": "Opsonin Pharma Limited",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "1.00",
    "ext": "100ml",
    "unite": "bot"
},
{
    "brand_id": "3232",
    "generic_id": "48",
    "company_id": "178",
    "aky": "boxol",
    "brand_name": "Boxol",
    "form": "Paediatric Drops",
    "strength": "6mg\/ml",
    "price": "3.00",
    "packsize": "15ml bot",
    "company_name": "Opsonin Pharma Limited",
    "company_order": "0",
    "generic_name": "Ambroxol",
    "precaution": "Ambroxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
    "indication": "Mucolytic, Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, laryngitis, Pharyngitis, sinusitis and rhinitis associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis, Chronic pneumonia.",
    "contra_indication": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
    "side_effect": "Tablet: Gastrointestinal Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain.\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity.\r\n\r\nSyrup: Gastrointestinal, Respiratory, Mediastinal and Thoracic Disorders: Dyspepsia, nausea, vomiting, diarrhoea and abdominal pain; oral and pharyngeal hypoaesthesia; dry mouth and throat.\r\nNervous System Disorders: Dysgeusia (eg, changed taste).\r\n\r\nImmune System, Skin and Subcutaneous Tissue Disorders: Anaphylactic reactions including anaphylactic shock, angioedema, rash, urticaria, pruritus and other hypersensitivity. ",
    "pregnancy_category_id": "0",
    "mode_of_action": "Ambroxol is a metabolite of Bromhexine. It possesses mucokinetic (improvement in mucus transport) and secretolytic (liquefies secretions) properties. Ambroxol stimulates the serous cells of the glands of the mucous membrane of bronchi, increasing the content of mucus secretion. The mucolytic effect is associated with depolymerization and splitting of mucoproteins and mucopolysaccharide fibres, which leads to reduction in the viscosity of mucus. Expectoration of mucus is facilitated and breathing is eased considerably. Ambroxol stimulates production of phospholipids of surfactant by alveolar cells. Ambroxol has anti-inflammatory properties. In patients with COPD, it improves airway patency.",
    "interaction": "No clinically relevant unfavourable interaction with other medications has been reported.",
    "pregnancy_category_note": "",
    "adult_dose": "Syrup: Adults -10 ml (2 teaspoonful), 3 times a day. \r\nSR Capsule : Adults - 1 capsule, once daily ",
    "child_dose": "Paediatric Drops : \r\n0 - 6 months old - 0.5 ml, 2 times a day, \r\n6 - 12 months old - 1 ml, 2 times a day, \r\n1 - 2 years old -1.25 ml, 2 times a day. \r\n\r\nSyrup : 2 -5 years old - 2.5 ml (1\/2 teaspoonful), 2-3 times a day, \r\n5 - 10 years old - 5 ml (1 teaspoonful), 2-3 times a day, \r\n10 years old - 10 ml (2 teaspoonful), 3 times a day. \r\n\r\nSR Capsule : Children over 12 years old - 1 capsule, once daily ",
    "renal_dose": "",
    "administration": "Can be taken with or without food.",
    "packssize": "1.00",
    "ext": "15ml",
    "unite": "bot"
}
]
